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ABSTRACT 
The study aimed to assess factors affecting the uptake of community-based 
Tuberculosis care (CTBC) as experienced by patients in Lobatse in order to make 
recommendations to enhance the uptake of CBTC in this area.  
A cross-sectional study was conducted, using structured interviews amongst 101 TB 
patients in Lobatse who registered for directly observed treatment (DOT) for TB in the 
GOB’s health facilities from January 2011 to August 2013. The SPSS (version 21) was 
used to analyse the data. Univariate logistic regression models were used. Participation 
in CTBC was an outcome. 
The main predictors for participation in CBTC included, knowledge and attitudes 
towards CTBC (p=0.0003), perceived barriers and enablers towards this programme 
(p=0.0279), and patient satisfaction with this programme (p=0.0315). 
The research findings pertain to TB services in Lobatse, because the study was 
conducted in government health facilities implementing the Botswana National 
Tuberculosis Programme (BNTP) CTBC guidelines only in Lobatse. 
 
Key words: Botswana’s tuberculosis programme, directly observed treatment (DOT), 
experiences of tuberculosis patients, Health Belief Model, tuberculosis, uptake of 
community-based tuberculosis care 
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CHAPTER 1 
ORIENTATION TO THE RESEARCH 
1.1      INTRODUCTION 
 
Tuberculosis (TB), though declining, continues to be a catastrophic health problem 
alongside Human Immuno Deficiency Virus (HIV) infections across the globe. The 
World Health Organization (WHO) estimates that 8.7 million TB cases occurred in 
2011 and 13.0% of these cases were HIV positive persons. In the same year, 
globally 1.4 million TB deaths occurred (WHO 2012a:1), despite the availability of 
high quality and effective TB treatment. Tuberculosis is primarily a lung disease 
caused by the tubercle bacillus, known as Mycobacterium Tuberculosis (MTB), 
transmitted from “human-to-human” (Ministry of Health [MOH] 2011a:9). This 
demands a concerted effort to reach all TB patients, even the “unreached” as the 
WHO puts it, through early diagnosis and treatment.  
 
During 2011, Sub-Saharan Africa (SSA) disproportionately reported TB incident 
cases exceeding 260 cases per 100 000 population (WHO 2013a). The TB burden in 
SSA is driven by the HIV scourge and poverty which overburden the already 
overstretched health care system. Out of the reported 1.1 million cases who were 
both HIV-positive and incident TB cases, 79% were attributed to the SSA region 
(WHO 2013b). Botswana’s incident (new) TB cases were estimated by the WHO to 
be 455 per 100 000 population in 2011 (MOH 2013a:2), which “is unacceptably high 
for an upper middle-income economy” (MOH 2013b:3).  
 
The dual epidemic in SSA has necessitated re-thinking of other more economically 
viable methods  for TB control such as community-based TB care (CTBC) (MOH 
2011b:6). Botswana has embraced CTBC which has a low rate of uptake and has 
faced many challenges such as high attrition rates of volunteers and negative 
attitudes of health care workers (MOH 2011b:7-8; MOH 2011c:36-37; MOH 
2013a:12). 
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1.2      BACKGROUND TO THE RESEARCH PROBLEM 
 
Polit and Beck (2012:73) define a research problem as a disturbing state of affairs 
that requires a solution. The background to the problem considers CTBC 
implementation in Botswana at different levels, the challenges experienced globally, 
in SSA, in Botswana and in Lobatse.  
 
1.2.1      Community tuberculosis care implementation in Botswana 
 
Community involvement is the component of the “WHO Stop TB Strategy” that is 
aimed at community empowerment. The WHO’s internationally acclaimed Directly 
Observed Therapy (DOT) programme is the cornerstone of the “Stop TB Strategy” 
that is embodied in community-based care. The TB patient is regarded as a partner 
and has a shared responsibility with the treatment supporter towards completion of 
treatment. Community-based care has the potential for improving treatment 
outcomes, but it requires a well-established reporting system, diagnostic services 
and secure drug supply (Sukumani, Lebese, Khoza & Risenga 2012; WHO 2010:76).  
 
Community-based initiatives in Southern Ethiopia improved the accessibility of TB 
diagnostic and treatment services and improved treatment outcomes (Yassin, 
Datiko, Tulloch, Markos, Aschalew, Shargie, Dangisso, Komatsu, Sahu, Blok, 
Cuevas & Theobald   2013:e51828), just like in other parts of SSA. There were 
similar findings in the eastern region of Ghana which also contributed to reduction of 
TB-associated stigma in the community (Boateng, Kodama, Sata, Bonsu & Osawa 
2012:357-365).  A study conducted in Tanzania (Mkopi, Range, Lwilla, Egwaga, 
Schulze, Geubbels & Van Leth 2012) also acknowledged the fact that “Adherence to 
TB therapy under home-based directly observed treatment can be ensured in 
programmatic settings”. 
 
Botswana is a signatory to the WHO’s “Stop TB Strategy”. Central to the concept of 
Botswana’s National TB Programme (BNTP) is primary health care (PHC) which 
promotes community involvement as is done in other parts of SSA. The WHO’s 
directly observed therapy short-course strategy (DOTS) is the cornerstone of BNTP, 
together with CTBC, intending to make TB treatment affordable, accessible and 
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available to the community. Depending on eligibility, TB patients are given the 
opportunity to opt for the DOT point of their choice within at least two weeks of 
initiation of TB treatment. Botswana embraced a phased-in CTBC in 2004, following 
the pilot project that was co-ordinated by the WHO in SSA including Botswana 
between 1996 and 2000. The studies showed that community participation could 
improve TB treatment outcomes (MOH 2011b:6 &10-11). Studies conducted in 
Botswana have identified challenges in the implementation of CTBC (MOH 
2011d:12; MOH 2012:23; MOH 2013b:3, 12). These challenges have resulted in the 
sluggish uptake of CTBC despite the documented benefits attributed to it in 
Botswana and in other parts of SSA. The CTBC does not meet Botswana’s 75% 
target of enrolment of TB patients on CTBC (MOH 2013b:3). 
 
1.2.2   Challenges faced by Botswana’s community-based TB care  
 implementation 
 
The WHO identified structural problems associated with community-based care in 
2008 across participating countries, including SSA and Botswana.  Based on these 
problems, guidelines were developed to enhance community involvement in TB care.  
 
Challenges include a lack of clear implementation guidelines and indicators of 
success and poor reporting systems (WHO 2012a:2). The 2010 CTBC evaluation 
report confirms similar findings in Botswana (MOH 2010a:22). Community-based 
care aims at enhancing early diagnosis and effective treatment. Studies conducted in 
SSA show that there are patient and health system-related factors that contribute to 
the delay of TB detection (Belay, Bjune, Ameni & Abebe 2012:369; Saifodine, Gudo, 
Sidat & Black 2013:559). These findings might apply to Botswana.   
 
Several assessments were carried out in Botswana including the 2010 CTBC 
evaluation, the TB/HIV Knowledge, Attitudes and Practices (KAP) study and the 
2011 TB/HIV Implementation Report, revealing several challenges connected to 
CTBC implementation. These findings show how the uptake of CTBC can be 
undermined by barriers emphasising issues that need to be addressed in relation to 
the programme. Most challenges or barriers, amenable to health education, as 
spelled out in the CTBC policy (MOH 2011b:13-14; MOH 2011c:21, 30, 36-37; MOH  
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2013a:14), fall into  groups of factors classified as being patient, socio-cultural, 
economic, structural or health care system-related. 
 Patient-related factors 
Patient-related factors, impacting on the uptake of TB treatment, include: 
- Knowledge gaps regarding signs and symptoms of TB and a lack of 
awareness of the CTBC programme by TB patients 
- Misconceptions of TB transmission amongst TB patients 
- Lack of knowledge about TB transmission 
- Inadequate knowledge about the nutritional requirements of TB patients 
- Inadequate knowledge about the relationship between TB and HIV  
- “Self-stigma” when some patients do not disclose their TB status, this could 
interfere with the early diagnosis and treatment of TB and aggravate the 
spread of TB throughout the communities concerned (Masisi 2011; MOH 
2011c:21, 30; MOH 2013a:14). 
 
 Socio- cultural factors 
Cultural beliefs and misconceptions concerning transmission, prevention, and 
treatment of TB (such as regarding coffee as a cure for TB) were also identified 
(MOH2011c:30, 39). These misconceptions might lead to delayed health seeking 
behaviours, jeopardising the possibility of early diagnosis and effective treatment of 
TB. 
 Economic factors 
 
Poverty contributes to poor nutritional status which is a potential barrier to TB 
treatment adherence (MOH 2011c:30).  Poverty might also contribute to delayed 
health care seeking behaviours in cases where people might not have money to pay 
for transport to reach health care facilities. 
There is poor retention of community volunteers supporting TB care due to 
discrepancies in incentives for rewarding the volunteers. This has led to a 
questionable sustainability of existing community models of care due to limited multi-
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sectoral collaboration. Disparity in incentives has also caused negative attitudes of 
volunteers towards CTBC which has led to low geographic coverage of the 
programme in Botswana (MOH 2010a:34, 43; MOH 2011b:7-8; MOH 2013a:12; 
MOH 2013b:12). 
 
 Structural factors 
 
There were no clear guidelines for the implementation of the CTBC up until 2010 
(MOH 2012:23).The Botswana CTBC policy guidelines were launched in 2011. 
There was inadequate training of volunteers and health care workers (HCWs) on the 
implementation of CTBC and inadequate co-ordination with other care givers (MOH 
2013a:4). Inadequate training could explain the negative attitudes of both volunteers 
and HCWs about CTBC as well as weak monitoring and co-ordination of the 
programme.  “Weak monitoring and supervision of … community based projects 
pose a challenge” (MOH 2013a:12) to the implementation of CTBC (see quotation in 
annexure 14 of this dissertation). The TB treatment supporters lacked basic supplies 
such as pill boxes and medicine cabinets that could be securely locked up (MOH 
2013a:4). 
 
CTBC activities were not well integrated with the community HIV home-based care 
programme, hence the implementation of TB/HIV interventions at community level 
remained vertical (MOH 2011d:12; MOH 2013b:12). “Vertical models are those in 
which HIV or TB services stand alone and cross-refer patients to the other service 
for testing and treatment”  (Chimbindi, Bärnighausen & Newell 2013:237-240). 
 
 Health care system-related factors 
 
Irregular provision of services at a sub-national level, such as TB/HIV diagnostic 
services and TB drug depletions, were documented (MOH 2011c:37). This situation 
poses a threat for continuous optimal performance with respect to reaching and 
maintaining Botswana’s TB targets, possibly resulting in sustained sub-optimal 
services. 
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Botswana is at the stage of restoring its CTBC and the revised Botswana target was 
set at 75% during 2011. The CTBC uptake was raised from 9% in 2009 to 45% in 
2011. Lobatse was amongst the sub-optimal performing areas at a rate of 9% in 
2009 and 63.5% in 2012 which still falls short of the Botswana revised target of 75% 
(Lobatse District Health Management Team [DHMT] 2013:2; MOH 2010b:34; MOH 
2012:23). Lobatse was chosen for the study on the basis of high TB-related death 
rates, cumulatively at 11% between January 2011 and August 2013 despite the 
availability of free TB treatment at government facilities. These sub-optimal treatment 
outcomes, as well as low CTBC uptake, have prompted the study.  
 
It is important to understand factors affecting the uptake of CTBC in Lobatse so that 
existing gaps in the implementation of the programme could be bridged as Lobatse 
is falling short of reaching “the unreachable persons” through diagnosis and 
treatment. It is not clear why some patients continue to die during treatment in the 
presence of free TB therapy and free anti-retroviral treatment (ART) in Lobatse. The 
smear positive (most infectious) proportion of the total number of cases of pulmonary 
TB (PTB) was 77.2% in 2010, 64.1% in 2011 and 65.3% in 2012. The 2008-2012 
national strategic plan, as well as the global target, aimed to achieve 70% (MOH 
2012:2; Lobatse Electronic TB Register [ETR] 2013) and provides evidence for the 
need to improve finding persons suffering from TB, diagnosing and treating them, 
referred to as “case finding” in the local TB services.  
 
The treatment success (cured and completed) rate for new smear positive TB cases 
for the  cohort was 76.1% in 2010, 86.4% in 2011 and  71.2% in 2012 in Lobatse 
compared to the national and international targets of 85% during the periods under 
review (Lobatse DHMT 2013:2; Lobatse ETR 2013), as shown in Annexure 1. As 
long as persons who suffer from TB are not traced, diagnosed and treated 
effectively, they will continue to spread TB to other persons in their communities, 
increasing the number of TB sufferers in these communities. 
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1.3      STATEMENT OF THE RESEARCH PROBLEM 
 
Studies conducted in Africa, SSA and Botswana have revealed factors affecting the 
uptake of community-based TB programmes as patient-related, socio-cultural, 
economic, structural and health care system-related (MOH 2012:23; MOH 2013a:4; 
Mugisha, Semo, Ledikwe, Ncube, Firth, Achoki, Lere, Machao, Mwangemi, 
Makadzange, Mabreaden, Katholo, & Nkomo 2013:S93; Uwimana, Zarowsky, 
Hausler & Jackson 2012:233; WHO 2012a:2). Studies have shown that CTBC has 
better treatment outcomes compared to facility-based TB care (FBTC), but there is a 
need for intensified TB case finding and reduction of stigma (Mugisha et al 
2013:S93). Studies on factors affecting the uptake of CTBC in Lobatse have not 
been documented. Adequate knowledge of patients on the benefits of CTBC and 
adequate support of the programme could enhance effective uptake of the 
programme hence improving treatment outcomes and reducing stigma and 
avoidable deaths. Little is known about knowledge and involvement of TB patients in 
Lobatse’s CTBC and the extent to which CTBC is supported in Lobatse has not been 
documented. Adequate support for a TB programme in rural Malawi has contributed 
to low levels of drug resistance (Mboma, Houben, Glynn, Sichali, Drobniewski, 
Mpunga, Fine, French & Crampin 2013) and the same could be expected from 
effective CTBC in Botswana. 
 
1.4       AIM OF THE STUDY 
 
In this section the research purpose, objectives and questions will be addressed. 
 
1.4.1      Research purpose 
 
The purpose of the study was to assess factors affecting the uptake of CTBC, as 
experienced by patients in Lobatse, in order to make recommendations to enhance 
the uptake of CTBC in this area so that the TB treatment outcomes could be 
improved. 
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1.4.2      Research objectives 
 
The main objectives of the study were to determine: 
- Demographic characteristics of the respondents  
- Patients’ knowledge about TB 
- Patients’ knowledge of and attitudes concerning CTBC 
- Support structures used by TB patients participating in CTBC 
- Patients’ perceptions about factors influencing the adoption of a specific DOT 
option 
-  Factors influencing participation of TB patients in the CTBC 
 
1.4.3       Research questions 
 
The following research questions had to be addressed in order to achieve the 
research objectives: 
- What are the demographic characteristics of the respondents? 
- What do patients know about TB? 
- What do patients know of and think about CTBC 
- What support structures do patients have who utilise the CTBC option of TB 
treatment? 
- What factors influence patients’ decisions in the adoption of a specific DOT 
option? 
     
1.5  SIGNIFICANCE OF THE STUDY 
 
It is important to identify factors affecting the uptake of CTBC in Lobatse in order to 
reduce TB-related deaths and enhance the early diagnosis and treatment of TB and 
so that improved TB-treatment outcomes can be achieved in this district. This would 
reduce the number of TB patients in the communities, reducing the risk of TB 
infection of community members, and reducing health-care costs as well as reducing 
the TB-related mortality and morbidity rates in the communities concerned. The 
study will help to address the potential knowledge gap about CTBC amongst TB 
patients in Lobatse which could impact negatively on the utilisation of CTBC services 
in this geographic area.  
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Furthermore, the study could enhance the CTBC model through its research findings 
and expand the TB patients’ knowledge base about their important role in the CTBC 
which could influence its uptake in Lobatse and reduce TB-associated stigma. The 
study will attempt to generate ideas which could influence policy making about the 
involvement of patients in CTBC activities. The actual implementation of the policy at 
clinic level should be evaluated through the patients’ reported experiences. Based on 
the study’s findings, recommendations could be made to address patient-related, 
socio-cultural, economic, structural and health care system-related factors 
influencing CTBC in Lobatse. The information generated by the study might help to 
form a basis for curriculum development on issues of TB and CTBC in Botswana and 
form a basis for further research about community participation concerning TB-
related issues. 
 
1.6      DEFINITIONS OF KEY CONCEPTS 
 
The following concepts are defined as used throughout the study and during the 
report writing in order to ensure that the readers will share the researcher’s 
understanding of these concepts.  First the theoretical definitions of concepts will be 
provided followed by operational definitions, indicating the application of concepts in 
the current study. 
 
1.6.1      Tuberculosis (TB) 
 
“Tuberculosis is a communicable disease caused by the bacteria Mycobacterium 
tuberculosis [MTB], also known as the tubercle bacillus…Almost 80% of TB occurs in 
the lungs” (MOH 2011a:9).  
 
1.6.2      Community-basedTB care  
 
The CTBC involves direct delivery of TB services within the environment where the 
patient lives through community participation such as TB treatment supporters and 
volunteers of the patient’s choice. This enhances accessibility, acceptability, and 
affordability of TB care (MOH 2011b:9). 
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1.6.3      Directly observed therapy (DOT) 
 
DOT is a WHO recommended TB treatment method of supervision by a designated 
person who observes and records the intake of every dose which could be done at 
the health facility, at home, in the community or at the work place (WHO 2010:77).  
 
1.6.4      Factor 
 
A factor is “an element or cause that contributes to a result” (The Free On-line 
Dictionary of Computing 2013). 
 
1.6.5      TB Patient 
 
A TB patient is someone who has been diagnosed with tuberculosis and has been 
put on a full course of TB treatment (WHO 2010:24).  
 
1.7      OPERATIONAL DEFINITIONS  
 
The following operational terms were defined as used throughout this study and 
report writing in order to enhance a common understanding of the terms between the 
readers and the researcher.  
 
1.7.1      Community TB care  
 
The CTBC in this study refers to the community TB DOT programme, as 
recommended by Botswana’s MOH (2011a:1). 
 
1.7.2       Patient 
 
A patient is a TB patient on facility-based TB DOT or community-based TB DOT 
appearing in Lobatse’s TB Electronic Register and Paper Based Tuberculosis 
Register as from January 2011 till August 2013. They might have completed their TB 
treatment or might still be taking it. 
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1.7.3       Uptake 
 
Uptake refers to the utilisation of CTBC by individual patients aged 21-64 in Lobatse. 
 
1.7.4       Participation  
 
Participation implies the uptake of CTBC by patients including their active role in 
supporting TB treatment and reducing TB-related stigma and discrimination. 
 
1.7.5      Support 
 
Support refers to the effective role played by the TB patients, health facilities, 
community supported organisations (CSOs), faith-based organisations (FBOs), non-
governmental organisations (NGOs), and the community to enhance TB treatment 
outcomes through CTBC. 
 
1.7.6      Factor 
 
A factor implies any patient-related, socio-cultural, economic, structural and health 
care system-related aspects which could impact on the uptake of CTBC in Lobatse. 
 
1.8      THEORETICAL FOUNDATION OF THE STUDY 
 
The theoretical foundation adopted for this study is the Health Belief Model (HBM). 
 
1.8.1      Health Belief Model (HBM) 
 
This quantitative study was based on a theoretical framework so that the findings 
could be contextualised within this framework (Polit & Beck 2012:131). Becker’s 
Health Belief Model (HBM), as articulated by Weitz (2013:38-39), was adopted as an 
appropriate conceptual framework to enable the researcher to analyse findings and 
make recommendations to the Lobatse DHMT in terms of implementing effective TB 
care within the community context. A theoretical framework explains phenomena of 
12 
 
  
interest and provides a basis for assumptions and a philosophical stance to the study 
(Burns & Grove 2009:135).  The model has been designed to rationalise the 
adoption of healthy behaviours by healthy people (Weitz 2013:38).  Becker’s HBM 
helped to assess factors that affected the uptake of CTBC in Lobatse, as there had 
been a low uptake of CTBC falling below the Botswana target of 75%. Factors that 
were assessed included those that hinder or facilitate the uptake of CTBC. The 
underlying concept of the HBM is that health-related behaviour (uptake of CTBC) is 
affected by personal beliefs or perceptions of a risk (defaulting TB treatment and not 
getting cured from TB) presented by a health problem (acceptability, accessibility 
and affordability of TB treatment) and the value attached to the mitigating factors of 
the risks, implying the barriers and enablers influencing the utilisation of the CTBC 
services (Polit & Beck 2012:136).  
 
The basic assumption of this study implied that there was a knowledge gap about 
CTBC in Lobatse which impacted negatively on the utilisation of CTBC services by 
TB patients in this area. The study further acknowledged that there might have been 
an interplay of an array of factors affecting the utilisation of CTBC services by TB 
patients in Lobatse. The HBM was appropriate to assess factors affecting the uptake 
of CTBC in Lobatse. This is the case because personal perceptions about the CTBC, 
as a strategy to enhance adherence to TB treatment and reduce the risk of 
spreading TB and multi-drug resistant tuberculosis (MDR TB), might have been 
influenced by a spectrum of factors. Perceived barriers influencing the uptake of 
CTBC could predict the participatory role played by TB patients in TB control. The 
model might help to assess factors that influenced other TB patients to participate in 
CTBC or not to do so. The HBM is a framework designed to assess compliance with 
medical advice (Weitz 2013:38). In this study’s context medical advice implies the 
uptake of CTBC to enhance treatment outcomes. More details of the HBM model are 
discussed in chapter 2 of this dissertation. 
 
1.8.2      Theoretical constructs of the Health Belief Model (HBM) 
 
According to Weitz (2013:38-39) there were originally four main theoretical 
constructs of the HBM model, namely:  
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- Perceived susceptibility -  beliefs of susceptibility to a given health problem 
(implying the risk of getting a disease or condition such as becoming infected 
with TB) 
- Perceived threat (severity) - beliefs of the seriousness or the health problem 
which is TB in the case of the current study 
- Perceived benefits and costs - beliefs that embracing preventive strategies 
will significantly reduce the risk of getting the disease/condition (TB) 
- Perceived barriers - beliefs that no substantial impediments will make it hard 
for a person to adhere to the strategies preventing a disease of condition such 
as TB (Glanz, Rimer & Lewis 2008, cited in Remocker & Shea 2011; Weitz 
2013:39) 
 
A revised version of the HBM has added, cues to action, motivating factors and self-
efficacy which can affect the initial four factors. Individuals’ behaviour can be 
explained through these perceptions or beliefs and the additional constructs of the 
HBM (Polit & Beck 2012:136; Weitz 2013:39). The HBM helped to assess self-
efficacy through the level at which TB patients in Lobatse were motivated and 
exerted themselves in terms of achieving treatment outcomes. This was assessed in 
the form of informational inputs offered to TB patients by the health care workers and 
related entities.  
 
Modifying factors of the perceptions or beliefs include personality variables, patient 
satisfaction, demographic variables, psychosocial variables, and structural factors 
(Polit & Beck 2012:136; Weitz 2013:39).  Several studies have shown that barriers 
and perceived susceptibility gain pre-eminence in predicting healthy behaviours 
(Ogden 2012:50).  Studies related to community TB projects show that perceived 
barriers such as stigma influence the uptake of such projects. An example includes a 
study by Uwimana et al (2012:233) that identified HIV stigma and lack of disclosure 
in the community as affecting the utilisation of TB services. Figure 1.1 presents the 
tenets of the HBM and shows linkages that predict health behaviours. The model is 
explained in more detail in chapter 2. 
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1.8.3       Assumptions 
 
Assumptions involve statements that are taken to be true without having been 
subjected to scientific methods (Burns & Grove 2009:40). The objectives of this 
study were based on the assumption that TB patients might have limited knowledge 
about CTBC in Lobatse which could impact negatively on their utilisation of CTBC 
services in this area. 
 
 
 
 
 
 
 
 
 
 
 
Modifying            Individual beliefs  
Factors 
 
 
Figure 1.1 Health Belief Model: components and linkages 
                   (Glanz et al 2008, cited in Remocker and Shea 2011) 
 
1.9      RESEARCH METHODOLOGY 
 
Every research method has both strengths and weaknesses (Babbie 2013:114). This 
section briefly outlines the research design and methods adopted during the current 
study. The research methodology will be discussed in detail in chapter 3 of this 
dissertation. 
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1.9.1       Research design 
 
According to LoBiondo-Wood and Haber (2010:159), the research design serves 
unique multiple purposes that overlap, in a quantitative study. The research design 
reflects methods for addressing the research question and also presents a plan for 
data collection (Polit & Beck 2012:58). The statement is corroborated by Burns and 
Grove (2009:236) who stated that it is “the blueprint for conducting a study” and 
gives the researcher maximum control, thereby improving the validity of the study’s 
findings. The research design was meant to detail all the steps of this research 
project (Babbie 2013:112).  
 
A quantitative descriptive cross-sectional study design was adopted, which was non-
experimental to assess factors affecting the uptake of CTBC in the Lobatse district of 
Botswana.  
 
1.9.2       Quantitative design 
 
According to Polit and Beck (2010:16-17), a quantitative research design involves 
the collection of empirical data in a positivist paradigm; it deals with figures and 
quantities and involves precise measurements and statistical analyses of data. It is 
advantageous in that numbers used in a quantitative study enable measurement of 
quality hence making observations (factors affecting the uptake of CTBC) clearer. It 
has shortcomings in that it does not capture the broad spectrum of human 
experience. Further full meaning of phenomena (factors affecting the uptake of 
CTBC) might be lost in the quantitative data (Babbie 2013:25). The data collection 
instrument was a structured interview schedule, based on the objectives, the 
literature reviewed and the CTBC policy of Botswana guided by the HBM. 
 
1.9.3       Descriptive study 
 
A descriptive study involves the systematic collection and presentation of data to 
provide a clear picture of a particular phenomenon in a real life situation. The 
descriptive study could help to detect health practice-related problems but is not 
meant to measure causality (Burns & Grove 2009:237). The researcher makes 
16 
 
  
observations and describes these observations (Babbie 2013:91). The study helped 
to objectively assess and describe factors hindering or facilitating the uptake of 
CTBC, as reported by patients in Lobatse.  
 
1.9.4       Cross-sectional study 
 
A cross-sectional design was used for this study as it “involves observations of a 
sample, or cross-section, of a population or phenomenon that are made at one point 
in time” (Babbie 2013:105).  The data were collected all at the same time on relevant 
variables and from respondents who met the study’s inclusive criteria. 
 
1.9.5      Research setting 
 
The study was conducted at the six Government of Botswana’s (GOB’s) health 
facilities implementing Botswana’s CTBC policy guidelines, and other places 
convenient to the TB patients (respondents) in Lobatse.  
 
1.9.6      Research population 
 
A population can be persons, animals, events, or subjects with stipulated 
characteristics (LoBiondo-Wood & Haber 2010:221). In agreement with this study’s 
context, Babbie (2013:115) says a population is usually a set of people about whom 
the researcher wants to draw inferences. The population comprised 377 TB patients 
in Lobatse who were registered for DOT in the GOB’s health facilities from January 
2011 to August 2013, and who had been on treatment for at least three weeks, as 
they should have been taught about the CTBC option by that time, according to the 
2011 CTBC guidelines (data obtained from Lobatse’s ETR ). 
 
1.9.7      Data management and analysis 
 
Quantitative data were captured and analysed using the Statistical Package for 
Social Sciences (SPSS) version 21. Descriptive statistics were produced to present 
the data in frequency tables and cross tabulations as well as graphs and charts to 
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display the findings’ distributions. A statistician assisted the researcher with the data 
management and analysis (See  Annexure 2 of this dissertation). 
 
1.9.8      Data collection instrument 
 
A self-designed structured interview schedule, based on the study’s objectives, the 
literature reviewed, and the CTBC policy of Botswana, was used to collect data from 
the respondents. 
 
1.9.9      Data collection 
 
Data collection involves gathering information relevant to the research questions 
stipulated by the study (Creswell & Clark 2011:171). A structured interview schedule 
with closed-ended and open-ended questions was used in face-to-face individual 
interviews (see Annexure 3 – English and Setswana structured interview schedules). 
 
1.10      ETHICAL CONSIDERATIONS 
 
The study was cognisant of the three basic principles of the Belmont Report as 
stipulated in Amdur and Bankert (2011:19). These principles covered respect for 
persons, beneficence, and justice.  The ethical issues pertaining to this study will be 
discussed in chapter 3 of this dissertation. 
 
1.11       SCOPE AND LIMITATIONS OF THE STUDY 
 
The major limitation of this study is that the study focused only on one district, 
namely Lobatse, hence results might not be generalised beyond this study site. Only 
structured interviews were used to collect data.  Consequently no in-depth 
information could be obtained about the TB patients’ lived experiences of CTBC in 
the Lobatse district. 
 
1.12       STRUCTURE OF THE DISSERTATION 
 
This dissertation comprises five chapters, namely: 
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Chapter 1: Orientation to the research 
Chapter 2: Literature review 
Chapter 3: Research Methodology 
Chapter 4: Analysis and discussion of the research findings 
Chapter 5: Limitations, conclusions and recommendations. 
 
1.13       SUMMARY 
 
Chapter 1 provided background information about the occurrence of TB globally, 
regionally and nationally. The implementation of CTBC in Botswana was discussed 
alongside its implementation challenges. The following areas were addressed: the 
research problem, aim of the study, significance of the study, definitions of key 
concepts, theoretical foundation of the study, research methodology, ethical 
considerations, scope and limitations of the study, as well as the structure of the 
dissertation and a summary. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1       INTRODUCTION 
LoBiondo-Wood and Haber (2010:57) define a literature review as “a systematic and 
critical appraisal of the most important literature on a topic, as a key step in the 
research process that provides the basis of a research study”. This statement is 
corroborated by Polit and Beck (2012:57-58) as well as by Burns and Grove 
(2012:97) who stated that a quantitative study is usually done on the basis of 
published prior knowledge of scholars on a topic of interest and is written in an 
organised manner. The literature review serves the purpose of giving the study 
direction from development to implementation using both theoretical and empirical 
sources that are current in terms of the problem of interest (Burns & Grove 2009:90-
91). “A theoretical framework, which may have a schematic representation showing 
the suggested interconnectedness of the concepts, is usually subsumed under this 
section” (LoBiondo-Wood & Haber 2010:57) (see figure 1.1). 
The purpose of this chapter is to present the literature review relating to factors 
affecting the uptake of CTBC as experienced by patients in Lobatse. 
 
2.1.1       Literature review strategy 
 
The literature review was based on both published and unpublished sources in 
accordance with the seven constructs of the HBM and the associated modifying 
factors likely to affect the TB patients’ uptake of CTBC. The literature was reviewed 
such that it could help to identify factors affecting the uptake of CTBC. Ncho and 
Wright (2013) maintain: “To understand the process of decision making, it is always 
important to understand how people make decisions and the factors that influence 
their decisions”.    Hard copies and electronic reports on TB were obtained from the 
Lobatse DHMT, Botswana MOH, Botswana Central Statistics Office (CSO) and 
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WHO Country Representative Office in order to obtain local, national and 
international statistics and narrative data. Academic health databases including 
Google Scholar, SAGE, EBSCOHost, PubMed and ScienceDirect in the University of 
Botswana’s (UB) online library and the University of South Africa’s (Unisa’s) library 
were accessed. Other relevant databases such as CSO and digital forensics were 
accessed. Only documents written in English were selected. The literature search 
concentrated on high burden TB and HIV countries including SSA and Botswana to 
obtain data on experiences of patients about CTBC care.  The reviewed literature 
was limited in terms of addressing the question of interest “factors affecting the 
uptake of community TB care as experienced by patients in the Lobatse District of 
Botswana”. The literature review assisted in identifying factors influencing the 
adoption of health-enhancing behaviours including adherence to TB treatment, 
community TB and HIV projects. The main themes used in the literature search 
included: 
- Care seeking behaviour - community based 
- Tuberculosis treatment adherence - community-facility 
- Factors associated with low TB cure rates 
- Utilisation of TB health care services 
- Patient centred care 
- Community-based TB care  
- Patient and system delays in providing/using TB services 
- TB morbidity and mortality  
- TB country specific reports 
- TB in SSA  
- TB and the HBM 
 
The study findings in this literature review are presented with some caution because 
the reviewed research topics did not accurately address the topic of interest (factors 
affecting the uptake of [CTBC] in Lobatse). Challenges experienced by patients in 
the literature review were treated as factors influencing the health behaviour (uptake 
of CTBC) and were contextualised in this dissertation through the help of the HBM. 
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2.2      Summary of reviewed literature 
 
A summary of the literature review is presented according to the overview of TB and 
CTBC as well as the contextualisation of this information within the HBM’s major 
tenets. 
 
2.2.1      Overview of Tuberculosis (TB) 
 
The discussion that follows under this section covers, TB definitions, modes of 
transmission of TB, factors influencing TB transmission, risk for developing TB, TB 
diagnosis, TB treatment, DOTS, supervision and support of TB patients, TB 
treatment outcomes and CTBC. Such an overview of TB-related issues could help to 
understand the background against which CTBC was implemented in the Lobatse 
district of Botswana 
 
2.2.1.1      What is Tuberculosis? 
 
The “Stop TB Strategy” envisions a “TB-free world” (WHO 2012b:4). The causative 
organism for TB is MTB which is a bacterium also called the tubercle bacillus. The 
bacillus is an organism that requires oxygen for metabolism (an aerobe) and takes 
time to grow, thriving better in oxygen-rich environments of the body. An example 
includes the oxygen-rich apices of the lungs which explains why approximately 80% 
of TB occurs in the lungs (PTB). Other different body tissue locations might be 
affected by TB known as extra-pulmonary TB (EPTB) such as TB of the larynx (MOH 
2009:5; MOH 2011a:9;WHO 2012b:3).  
 
2.2.1.2      TB transmission in the general population 
 
Tuberculosis spreads from a lung or larynx of a TB infected person to other people 
through coughing, talking, sneezing, singing or any means that can cause the spread 
of the droplet nuclei (also known as TB bacilli) into the air. The droplet nuclei harbour 
MTB, and are as tiny as 1-5 microns in size such that they cannot be seen with a 
naked eye. The bacilli can quickly get killed when directly exposed to sunlight and 
good ventilation, both natural and mechanical. The end result of inadequate 
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ventilation is the suspension of the droplet nuclei in the air for some hours. Inhalation 
of these droplets by TB free persons who share the same airspace with the TB 
patient could result in TB infection. If the inhaled bacilli reach the alveoli of the lungs, 
they might be destroyed by macrophages (white blood cells that ingest bacteria or 
foreign organisms found in the body - including the alveoli of the lungs in the case of 
TB). Infection is established through the multiplication of bacilli to the extent that they 
cannot be contained by the alveolar macrophages. The bacilli may be transported to 
other body organs through the blood stream or the lymphatic system. A competent 
immune response to TB usually prevents the development of the disease (MOH 
2009:5; MOH 2011a:9-10; WHO 2012b:3).  
 
Socio-economic status has been identified as a critical factor in the epidemiology of 
TB. Environments exposing people to TB bacilli include overcrowding, poor lighting 
and poor ventilation which increase the risk for TB transmission. Severe malnutrition 
is also a risk factor for “developing TB”. This implies that poverty-stricken parts of the 
developing world (including SSA and Botswana to a certain extent) are experiencing 
a high incidence of TB because of unfavourable socio-economic conditions (MOH 
2009:6; MOH 2011a:10; MOH 2011c:36), aggravated by the HIV pandemic in these 
areas of the world.  
 
2.2.1.3       Factors that influence TB transmission 
 
Highly infectious TB patients are at a greater risk of transmitting TB to other people. 
Infectiousness is determined by the amount of droplet nuclei expelled by the patient 
into the air (MOH 2009:5).  
 
Factors influencing infectiousness include: 
 Patients with TB  of the lungs or larynx  
 Poor cough etiquette 
 Patients with smear positive sputum (most infectious) 
 Patients with cavities in the lungs 
 Patients undergoing bronchoscopy or sputum induction 
 Delayed initiation of anti-TB therapy (ATT) (MOH 2009:5) 
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Early diagnosis and effective treatment, as well as health education about the spread 
of TB, can help to reduce the number of persons suffering from TB in specific 
communities. 
 
2.2.1.4       Risk for developing TB disease following infection 
 
The stage at which the body has the ability to contain TB infection such that it does 
not become active TB is called latent TB infection (LTBI). Generally the competent 
immune system of healthy people arrests MTB so that it does not multiply to cause 
disease (MOH 2009:7). Risk factors for TB disease following infection include:  
 HIV/AIDS 
 Diabetes 
 Cancer 
 Immunosuppressive medication 
 Silicosis 
 Severe kidney disease 
 Alcoholism  
 Smoking  
 Drug use 
 Malnutrition and 
 Being a child younger than 5 years of age (MOH 2009:7; MOH 2011a:10; 
WHO 2012a:1). 
 
The probability of developing TB is greatly increased at 10% per annum in people 
living with HIV as opposed to a 10% lifespan risk in HIV negative people. The 
progression from the LTBI to active TB is much faster in people living with HIV as 
opposed to HIV-negative people (MOH 2009:8; MOH 2011a:56; WHO 2013c) 
because HIV weakens the immune system (MOH 2011a:10) by decreasing the 
person’s CD4 cell count. The resurgence of TB came about in the 1980s with the 
advent of the HIV epidemic, primarily in SSA (MOH 2011a:9). According to the WHO 
(2012b:3) there were close to 9 million new cases of TB across the globe in 2011 
and 1.4 million TB deaths of which 430 000 were attributed to TB/HIV co-infections. 
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In the same period under review, SSA reported more than 260 per 100 000 
population of new (incident) cases of TB and 79% of the world’s TB/HIV incident dual 
infections of TB and HIV (WHO 2013b). More than 95% of people who died from TB 
or TB-associated conditions during 2012 were in Africa (WHO 2013c). Botswana’s 
TB/HIV co-infection rate in 2010 was estimated at 68% and in 2011 was estimated at 
64%, indicating that Botswana was experiencing a high rate of the TB/HIV dual 
infections like other parts of SSA. In the same period under review Botswana 
experienced an estimated 455 per 100 000 population of incident TB cases, which 
does not tally with the country’s upper middle income economic status (MOH 
2013b:3), as shown in Annexure 4 of this dissertation. The preliminary report of the 
fourth Botswana AIDS Impact Survey (BAIS IV) demonstrated a national HIV decline 
from 17.6% in 2008 to 16.9% in 2013 according to Botswana’s President Lieutenant 
General Seretse Khama Ian Khama (Masolotate 2013:3 - see Annexure 5).  
 
Millennium development goal (MDG) 6 is committed to “combating HIV/AIDS, 
malaria and other diseases including TB… [to] have halted by 2015 and begun to 
reverse the incidence, prevalence and death rates associated with tuberculosis” 
(MOH 2013b:16). The WHO declared TB as an emergency in the African region in 
2005 and advocated for unusual measures that could urgently contain the TB 
epidemic. Emergency strategic plans had to be put in place with the aim of improving 
TB case findings and treatment success rates (MOH 2013b:16; WHO 2012b:3). The 
world is reported to be on track with respect to containing TB morbidity and mortality. 
There has been a global sustained decline of TB incidence over the years which was 
reported at the rate of 2.2 between 2010 and 2011. Since 1990, TB deaths have 
gone down by 41% against a 50% target set for 2015 (WHO 2012b:8) 
 
Men are at a higher risk of developing TB than women and adults in the income 
generating age group are mostly affected by TB (WHO 2012b:3). CTBC might help 
to identify patients with smear positive TB, and TB of the lungs and the larynx.  If 
these patients are diagnosed early and treated effectively the risk of spreading TB in 
the community can be reduced.  
 
Smear positive PTB patients are likely to spread TB to other people and should be 
the focus of TB infection control and contact tracing efforts (MOH 2011a:14; WHO 
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2010:25) especially in the homes of infectious TB patients. Contact tracing plays a 
vital role in identifying TB patients as well as in containing the spread of TB in the 
community. Once a patient has been diagnosed with smear positive PTB, the health 
facility TB focal person, and the community volunteer must trace all close contacts 
and screen them for signs and symptoms of TB. Following screening, TB suspects 
should be subjected to sputum smear microscopy. Close contacts might involve a 
family member, a school mate or a working colleague closely interacting with the 
infectious TB patient (MOH 2011a:16). The longer a person stays in close contact 
with an infectious patient, the greater the risk of getting infected. The degree to 
which one is at increased risk of getting infected with TB is also determined by the 
intensity of exposure to TB infection (MOH 2009:6; MOH 2011a:14). The presence of 
preventive services, such as CTBC aiming at early diagnosis and early treatment of 
infectious TB patients, could reduce the spread of TB in the community. These 
services might prevent the occurrence of TB disease in TB infected patients by the 
use of Isoniazid Preventive Therapy (IPT) (MOH 2009:6). Factors such as poor 
cough etiquette and delay in initiation of ATT could also be curbed through health 
education provided to the community through CTBC services.  
 
2.2.1.5      TB diagnosis  
 
Prevention of morbidity and mortality and TB transmission could be achieved 
through early and accurate diagnosis of TB. Initially a person (TB suspect) is 
screened for signs and symptoms of TB, and then assessed through medical history 
and physical examination to determine the possibility of being a TB patient. The 
radiographic and microbiologic methods then follow to confirm the diagnosis of TB 
(MOH 2011a:18). Across the globe, diagnosis of TB is usually achieved through 
sputum smear microscopy in which the sputum samples are subjected to 
microscopic scrutiny to observe TB bacteria. With recent TB diagnostic trends, rapid 
molecular tests for the diagnosis of TB and drug-resistant TB are increasingly used. 
Culture methods which are the current yard stick for the diagnosis of TB patients are 
used in countries with advanced laboratory capacity (WHO 2012b:3).  
 
Reaching TB suspects early and diagnosing them via quality assured bacteriology is 
an aspect of the WHO DOTS strategy (WHO 2012b:4). The international targets 
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advocate for a 70% diagnosis of sputum-smear positive TB people by 2015 (MOH 
2013b:16). Reportedly there is either an underreporting or a failure to reach a third of 
persons considered to have TB within existing health systems (WHO 2012a:1).  
 
In Botswana sputum culture is done at the National TB Reference Laboratory 
(NTRL) in Gaborone for selective patients and smear microscopy is commonly used 
because of its cost-effectiveness and ability to yield results within 24-28 hours  (MOH 
2011a:19-20). In principle, all HIV positive people in Botswana have to be screened 
for TB and also, all TB patients have to be screened for HIV. Co-infection with 
TB/HIV renders a person prone to EPTB which may complicate the diagnosis of TB 
(MOH 2011a:18). TB/HIV dual infection constitutes a deadly combination both 
expediting the progression of each other from infection to disease. The WHO has 
recommended an integration of TB/HIV services which encompass preventive and 
curative strategies to decrease the number of deaths attributable to these conditions 
(MOH 2011a:10, 18; WHO 2013c).  
 
2.2.1.6      TB treatment  
 
There is a need for early diagnosis in TB suspects and for the rapid initiation of TB 
treatment for sputum smear positive patients. Infectiousness of a TB patient can be 
effectively decreased through the early initiation of TB treatment which reduces the 
risk of infectiousness within two weeks of commencement. The mortality rate of TB 
increases with delayed initiation of ATT (MOH 2009:6; MOH 2011a:18 & 29). Early 
diagnosis and treatment of TB patients can reduce TB-related deaths in Lobatse. 
 
According to the Botswana’s MOH the main objectives of TB treatment include: 
 Curing the patient and restoring his/her quality of life and productivity 
 Preventing death from active TB or its subsequent effects 
 Preventing relapse of TB 
 Preventing the development of drug-resistance 
 Preventing the transmission of TB to others (MOH 2011a:29). 
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A 95% cure rate of TB is possible with DOTS (MOH 2011a:29). The WHO 
international targets aim at an 85% cure rate for smear positive TB patients by 2015 
but the highest rate ever attained was 87% in 2010 (MOH 2011a:29; MOH 
2013b:10). In 2010 Botswana’s treatment success rate was at 81.4 % indicating a 
sub-optimal performance against the 85% international target (MOH 2013b:10). 
 
In summary TB treatment objectives indicate that the overall success of TB therapy 
is beneficial to the patient, close contacts and the community at large. Drug-sensitive 
TB is treated for a period of six months with four drugs in the standard regimen of 
first-line drugs which include: isoniazid, rifampicin, ethambutol and pyrazinamide. 
Both new and retreatment cases of TB are treated by first-line TB drugs.  Treatment 
for drug-resistant TB takes longer and is expensive with toxic drugs. The current TB 
treatment regimens recommended by the WHO to treat patients with MDR TB takes 
up to 20 months (WHO 2012b:3). The management of TB is complicated by MDR TB 
and extensively drug-resistant TB (XDR TB) (MOH 2011a:9). The type of bacteria 
that is resistant to at least isoniazid and rifampicin, the most powerful first line TB 
drugs, cause MDR TB. Other underlying factors attributed to MDR TB include: 
inappropriate administration of TB treatment such as use of poor quality drugs and 
incorrect drug use. MDR TB is responsive to second-line TB treatment but it has 
limited options (WHO 2013c).  
 
The WHO estimates that 3.7 % of new cases and 20% of cases treated in the past 
have MDR TB (WHO 2012b:8). The most unresponsive TB (XDR TB) is the type of 
MDR TB that responds to a very limited number of TB drugs, indicating the need to 
employ effective strategies to treat TB (WHO 2013c). Approximately nine cases of 
XDR-TB cases have been reported in Botswana by 2012 (MOH 2013a:3). Patients 
with dual infection are at an increased risk of mortality hence interventions such as 
co-trimoxazole preventive therapy (CPT) and ART might be beneficial to them (MOH 
2011a:18), especially if the diagnosis is made early and treatment commenced 
timeously. Low-and middle-income countries (including SSA and Botswana) account 
for 95% of TB-associated deaths (WHO 2013c).  In Botswana 13% of adult deaths 
are attributed to TB, claiming 40% of lives of people living with HIV/AIDS (MOH 
2013b:10). Botswana has a successful national ART programme. However, only an 
estimated 45% of people with TB/HIV co-infection have been provided with ART in 
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2011 indicating sub-optimal performance against national targets, based on the 
international targets (MOH 2013a:3). The 2008-2012 Botswana National Strategic 
Plan indicated that 90% of the TB/HIV co-infected patients would have started ART 
by 2012 (MOH 2012:2). 
 
2.2.1.7      The Directly Observed Treatment Strategy (DOTS) 
 
In a quest to contain the problem of MDR TB and XDR TB, the WHO recommended 
DOTS as a cost-effective approach in 1993 (MOH 2011a:9; WHO 2012b:3). The 
WHO “Stop TB Strategy” was launched in 2006 with DOTS as its foundation as well 
as advancing the interests of DOTS (Raviglione & Uplekar 2006:952-955, cited in 
WHO 2010:15). Pursuing and expanding high quality DOTS is the first component of 
the “Stop TB Strategy”. Standardised treatment, supervision and support of the 
patient are critical aspects subsumed under DOTS. The DOTS also advocates for 
the effective supply of drugs and their management as well as monitoring and 
evaluation of “performance and impact” (WHO 2012b:4) which could be measured 
through TB treatment outcomes. Services offered under CTBC, are patient centred 
in that they have the potential to reach even the person in the utmost remote areas 
to provide TB diagnosis and treatment services. 
 
2.2.1.8      Supervision and patient support 
 
In order to enhance adherence to TB treatment, the WHO DOTS advocates for 
supervision and support of TB patients during the treatment period. Supervision and 
support constitute a comprehensive framework that is cognisant of the patient’s 
clinical and social needs. 
 
Patients undergoing TB care are treated as partners in accordance with the 
“Patients’ Charter for TB Care” and they are expected to play an effective role in TB 
control such as adhering to treatment and improving community health. In their 
partnership role, patients must be assisted to take their TB treatment regularly till 
completion. The health care system, however, retains the responsibility for providing 
adequate and appropriate diagnostic and treatment services and for monitoring the 
outcomes of TB treatment. Providers of care also have the responsibility to render 
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appropriate care and to identify and address treatment interruptions.  The patient has 
to be watched taking every dose to ensure that the right drug, the right dose and the 
right time are observed during the course of TB treatment (MOH 2011a:30; WHO 
2010:77). Regular supervision and support also imply TB-related health education 
and the resolution of identified stumbling blocks that might affect the TB patient’s 
treatment adherence levels. Non-adherence to treatment, adverse reactions to drugs 
and a declining physical condition of the TB patient should be identified and referred 
for remedial actions (WHO 2010:77). A Tanzanian study showed that a TB patient 
does not necessarily have to be observed on a daily basis for adherence to TB 
treatment. However, these authors did not dispute the fact that there is a need for 
regular motivation and supervision of TB patients (Mkopi et al 2012:e51828) which 
could be attained through CTBC.  
 
Adherence to long-term treatment has different facets that could be influenced by the 
interaction of five sets of factors, namely: patient-related and treatment-related 
factors, condition-related factors, socio-economic factors, health care team and 
system-related factors (WHO 2003:11-15 cited in Muture, Keraka, Kimuu, Kabiru, 
Ombeka & Oguya 2011:696). Socio-economic factors such as inadequate income, 
financial challenges, lack of social support, low educational status and the inability to 
afford health services have been associated with poor adherence to TB treatment in 
SSA (Dodor & Afenyandu 2005:827-832 cited in Muture et al 2011:696).  Preventive 
care services such as CTBC have been put in place to advance DOTS services in 
order to curb the problems of adherence and enhance treatment outcomes. This 
study has the potential of identifying factors affecting TB treatment adherence 
alongside the primary outcome of the study which is factors affecting the uptake of 
CTBC in the Lobatse district of Botswana.  
 
In order to promote adherence to TB treatment and attain success, the cooperation 
of the patient has to be solicited. Daily provision of DOT could be done either by the 
HCW or the treatment supporter through FBTC or CTBC. A patient-centred approach 
(PCC) is critical in ensuring adherence as it considers the patient’s needs such as 
enhancing access to treatment, convenience, and meeting other needs, such as 
psychosocial needs. The PCC approach goes a long way in reaching people of low 
social status and the most at risk groups.  Hence it has the potential for reaching the 
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“unreached” persons providing early diagnosis and rapid treatment services. The 
WHO also advocates for removal of stumbling blocks affecting adherence to 
treatment such as irregular supplies of drugs, TB treatment that is not free or not 
affordable, the lack of incentives for patients and negative attitudes of health care 
providers (WHO 2010:77-79). 
 
2.2.1.9      Tuberculosis treatment outcomes and targets 
 
Accuracy and timelines are the vital necessities in reporting treatment outcomes and 
when evaluating TB control efforts, as shown in box 1.  The treatment outcome for 
each patient has to be recorded in the facility and TB register by the HCW at the 
completion of treatment (MOH 2011a:35). The “Stop TB Partnership” has come up 
with a quantitative framework for measuring the decline in TB prevalence and 
mortality rates in order to operationalise the MDG’s objectives. Eradication of TB by 
2050 is a goal of the “Stop TB Partnership” (MOH 2013b:16). 
 
BOX 1 
Definitions of treatment outcomes for patients suffering from drug-susceptible 
TB 
Cured:  A patient who was initially sputum smear-positive and who was sputum smear-negative in 
the last month of treatment and on at least one previous occasion 
Completed treatment: A patient who completed treatment but did not meet the criteria for cure or 
failure. This definition applies to sputum smear-negative patients with pulmonary TB and to patients 
with extra-pulmonary disease 
Died:  A patient who died from any cause during TB treatment 
Failed: A patient who was initially sputum smear-positive and who remained sputum-smear positive 
at  month five or later during TB treatment 
Defaulted: A patient whose treatment was interrupted  for two consecutive months or more 
Not evaluated: A patient whose TB treatment outcome is unknown 
Successfully treated:  A patient who was cured or who completed treatment 
Cohort:  A group of patients in whom TB has been diagnosed, and who were registered for 
treatment during a specified time period (such as the cohort of new sputum smear-positive  cases 
registered in the calendar year 2010). This group forms the denominator for calculating treatment 
outcomes. Some countries monitor outcomes among cohorts defined by sputum smear/or culture, 
and define culture and failure according to the best laboratory evidence available for each patient. 
 
Source: WHO 2012b:38 
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2.2.1.10      Community-based TB care  
 
Component 5 of the “Stop TB Strategy” is two-pronged because it aims to involve 
both the patient and the community where the patient assumes TB control (WHO 
2012b:4). This implies that health services are being taken to the community, hence 
making CTBC the cornerstone of DOT.  
 
The TB patient and the community members are expected to be actors (partners) in 
TB control.  Patients who are cured of TB, alongside family members and co-workers 
of TB patients, FBOs and other community members and CBOs, including NGOs, 
can play roles in CTBC (MOH 2011b:4; WHO 2010:78). The TB patient plays an 
active role in selecting the treatment supporter (MOH 2011b:9). A study in China 
demonstrated that patients, who had doctors as their treatment supporters, had a 
reduced risk for non-cure as opposed to those without a treatment supporter. Also 
patients having family members as their treatment supporters had a lower risk of 
non-cure than patients without treatment supervisors (p=0.07) (Ai, Men, Guo, Zhang, 
Zhao, Sun, Zhang, He, Van Der Werf & Van Den Hof 2010:112), indicating the 
importance of treatment support.  The essence of CTBC is to make TB treatment 
accessible, acceptable, affordable, available and convenient to the TB patient (MOH 
2011b:9; WHO 2010:75-76). It is important to give health education to both the 
patient and the treatment supporter to prevent treatment interruptions (MOH 
2011b:13). 
 
CTBC has the potential to enhance early diagnosis and treatment of TB and 
treatment adherence hence preventing MDR TB and XDR TB. Prevention of 
untreatable or hard to treat TB might reduce TB morbidity and mortality hence 
improving the quality of life of communities and saving the nation of Botswana and 
Lobatse DHMT extra health care costs.  
 
Former TB patients are well positioned to stem TB-associated stigma and contribute 
to the development of community TB control measures as they have first-hand 
experience with TB (WHO 2010:75). The involvement of cured former TB patients as 
ambassadors for TB control in the community also goes a long way to remove 
barriers to TB diagnosis and treatment.  
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2.3    Health Belief model (HBM)  
 
The HBM is applied to identify possible factors associated with the uptake of CTBC. 
The HBM is operationalised such that it could provide insights about CTBC and also 
assist with data analysis. The subheadings that follow were adapted according to the 
major constructs of the HBM and the modifying factors. 
 
2.3.1       TB patients’ beliefs about their susceptibility to default TB treatment 
 
If patients do not perceive the threat to default treatment and not getting cured from 
TB, they might not see the need to embrace the CTBC concept. The assumption is 
that people who are knowledgeable about the advantages of CTBC (especially with 
respect to prevention of defaulting treatment) are likely to embrace the programme 
and improve treatment outcomes. 
 
According to Botswana’s CTBC guidelines every patient has to be taught about both 
CTBC and FBTC TB treatment options, including the advantages and disadvantages 
of each DOT option. Advantages of CTBC include those for the patient (such as the 
likelihood to enhance compliance and treatment outcomes and enhancement of 
health seeking behaviour by the family of the patient), community and health facility 
(MOH 2011b:9-11). This is meant to assist the patient to evaluate the personal risk 
of defaulting treatment and make an informed choice about the DOT option. The 
concept of CTBC endorses the “Stop TB Strategy” of involving TB patients and their 
communities in enhancing adherence to TB treatment and  it has been found to be 
the most effective “Stop TB” treatment strategy built upon DOTS (MOH 2011b:6). 
“DOTS is considered to be a cost-effective, safe and effective mainstream strategy 
to control TB” (Stop TB country profile 2006; Hane et al 2007:541 cited in Sukumani 
et al 2012). Patients might have reasons for adopting CTBC (MOH 2011b:11) 
despite living in close proximity to the health facility as such they should be allowed a 
DOT option of their choice. Mkopi, Range Amuri, Geubbels, Lwilla, Egwaga, Schulze 
and Van Leth (2013:101) found that a quarter of the patients in their study in 
Tanzania were not given any chance to choose a DOT option which could impact 
negatively on TB treatment outcomes.  
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2.3.2       TB patients’ beliefs about the seriousness of TB, defaulting TB  
               treatment and not getting cured from TB  
 
 
A study conducted in remote poor areas of the Shaanxi Province in China by Ai et al 
(2010:112) recommended that family members of TB patients should be adequately 
trained to be treatment supporters to augment for lack of doctors in remote areas in 
order to reduce interruptions of TB treatment resulting in non-cure treatment 
outcomes. The reviewed literature across the globe, including SSA, shows that 
failure to adhere to TB treatment comes with setbacks such as MDR-TB, resulting in 
sub-optimal TB cure rates (Werb, Mills, Montaner & Wood 2010:464-469 cited in 
Mkopi et al 2012:e51828; Naidoo, Peltzer, Louw, Matseke, Mchunu and Tutshana 
2013:396).  A study on adherence to TB therapy conducted in the United Republic of 
Tanzania among patients on CTBC showed that non-adherence is rectifiable and 
cannot with certainty predict poor treatment outcomes (Mkopi et al 2012:e51828). 
Non-adherence is complex and dynamic with an interplay of a wide spectrum of 
factors affecting treatment behaviour (Munro, Lewin, Smith, Engel, Atle & Volmink 
cited, in Cramm; Finkenflϋgel, Møller & Nieboer 2010:72). One of the contributing 
factors to non-adherence to TB therapy is HIV/TB co-infection (Naidoo et al 
2013:396).  
 
For the reason that non-adherence factors are numerous and unique to individuals, 
the WHO advocates for PCC such as CTBC which includes volunteers to reach even 
the utmost rural areas (WHO 2010:78-79). The potential shortcoming of this PCC 
endeavour is that adherence to treatment cannot be guaranteed when done by 
someone who is not a HCW (Mkopi et al 2012:e51828). Inadequate implementation 
of key elements of the PCC by HCWs may impact negatively on adherence of 
patients and subsequently on TB treatment outcomes (Mkopi et al 2013:101).  In line 
with the WHO guidelines, the CTBC in Botswana attempts to bridge this gap through 
offering health education to both the patient and the treatment supporter as well as 
by regular consultative meetings between the treatment supporter and the nurse.  
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Amongst infectious diseases across the globe, TB remains an important factor 
affecting morbidity and mortality rates (Lonnroth, Castro, Chakaya, Chauhan & Floyd 
2010:1814-1829 cited in Reed, Choi, Lee, Lee, Kim, Park, Lee, Zhan, kang, Hwang, 
Carroll, Cai, Cho, Barry, Via & Kornfeld 2013 ; Gupta, Wood, Kaplan, Bekker & Lawn 
2013). Investigating TB-related morbidity and mortality is not part of this research, 
should the aetiology for TB-associated morbidity and mortality surface during data 
collection it shall be captured under chapter four of this study. 
 
There is a need to emphasise to TB patients that the benefits of cure from TB (such 
as embracing CTBC) outweigh the barriers to adherence to treatment (MOH 
211b:13). A study on patients with TB or HIV infection in Burkina Faso identified that 
being aware of how a disease is transmitted is one of the TB treatment adherence 
predictors (Méda, Lin, Sombié, Maré, Moresky & Chen 2013). On the contrary the 
study by Cramm et al (2010:72) found that knowledge is not always a predictor of 
treatment initiation and adherence, but that health seeking behaviour might also be 
affected by other factors such as stigma.  
 
The assumption is that when people believe that TB is curable, but that it might have 
catastrophic consequences with delayed diagnosis and treatment and defaulting 
treatment, they are more likely to embrace CTBC. However, other contributing 
factors affecting health seeking behaviour, such as stigma, need to be assessed in 
this study as well.  
 
2.3.3      The belief that embracing CTBC will significantly reduce the risk of  
              spreading TB and MDR-TB and of treatment failure 
 
 
The study by Yassin et al (2013:e63174) in Ethiopia has identified a wide scope of 
potential benefits associated with the adoption of community-based initiatives which 
include improved accessibility of TB diagnostic and treatment services  even to 
marginalised persons such as women, children and the poor. The community-based 
approaches resulted in improved treatment outcomes (Yassin et al 2013:e63174). 
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Free TB services, including diagnosis and treatment services, are offered in the 
GOB’s health facilities and this should be known by patients, families and 
communities. Kabongo and Mash (2010) conducted a study in the Kweneng district 
of Botswana and identified CTBC as being complementary to FBTC, not necessarily 
that it supersedes the latter in terms of enhancing treatment outcomes. The overall 
success rate for both patients on CTBC and FBTC was 83% which was slightly lower 
than the WHO target of 85%. Contrary to these findings, Mugisha et al (2013:S93) 
found that “CTBC offers better treatment outcomes than FTBC care in the Botswana 
setting”, with a success rate of 89.5%.  
 
The two studies by Kabongo and Mash (2010) and Mugisha et al (2013:S93) 
addressed a common objective of assessing the outcomes of CTBC versus FBTC.  
However, they used different study designs and populations which could have 
influenced their study findings. Kabongo and Mash (2010) used mixed methods (of 
both quantitative and qualitative designs) which had an added advantage of 
gathering data about patients’ experiences of both DOT options, including those who 
mixed the options. The study managed to enumerate advantages and disadvantages 
of both DOT options but it was confined to the Kweneng west sub-district. The focus 
of the study was on the effectiveness of CTBC. Mugisha et al’s (2013:S93) study 
used a cross-sectional cohort analysis design involving 14 districts in Botswana by 
retrospectively reviewing routinely available data. The focus in Mugisha et al’s 
(2013:S93) study was on treatment outcomes, hence the study could not generate 
lived experiences of patients concerning their DOT options as the data were 
collected from the patients’ TB registers only.  
 
The common agreement across both studies is that the CTBC is good but contact 
tracing, which remains a challenge, has to be intensified. There is no evidence in 
both studies indicating any follow-up visits of the treatment cohorts to establish their 
true outcomes. Complete and accurate records of routinely recorded data rarely exist 
and this might have had an impact on both studies’ findings with respect to treatment 
outcomes. The Kabongo and Mash (2010) study, which was evaluating the 
effectiveness of CTBC, used the routinely available data including patients’ cards but 
also conducted in-depth interviews with different sub-groups that comprised the 
study population. Varied sub-groups which comprised patients on DOT options,  
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volunteers and HCWs were likely to provide information on diverse experiences 
about CTBC and FBTC towards the improvement of CTBC.  One of the limitations 
reported by the authors was that there was “late” introduction of CTBC in the 
Kweneng sub-district which is likely to account for uneven enrolments in DOT 
options. One of the recommendations of the study was that research should be 
conducted to explore the benefits of allowing patients to choose their own DOT 
options.  
 
This study has the potential of identifying the benefits of both options (FBTC and 
CTBC) during conducting structured interviews on factors affecting the uptake of 
CTBC.  There are many factors which might have led to the preference of a given 
DOT option, such as convenient access. However, it is important to identify factors 
that might influence the uptake of CTBC in Lobatse. If these factors could be 
identified and addressed, TB morbidity and mortality rates might decline in this area. 
According to Botswana’s MOH, limited operational CTBC research has been done in  
Botswana implying that the  effectiveness of CTBC remains largely unknown in this 
country (MOH 2013a:16). The assumption is that when patients perceive the benefits 
of CTBC with respect to early diagnosis and treatment, as convenient, cost effective, 
acceptable and available, they are more likely to participate in the programme than 
patients who do not have this information.  
 
2.3.4      TB patients’ beliefs about barriers and enablers influencing their 
               participation in the CTBC programme  
 
Mkopi et al (2013:101) concluded that in order for PCC to be effective, there is a 
need for HCWs to be trained regularly and to be effectively supervised in a 
supportive milieu. HCWs might sometimes pose barriers to the adoption of patients’ 
health seeking behaviours such as portraying negative attitudes towards CTBC 
(MOH 2011b:8, MOH 2013a:12). These findings are corroborated by Moser et al 
(2006:176 cited in Ncho & Wright 2013) who reported that negative attitudes of 
HCWs have been found to delay health seeking behaviours. Delays in health 
seeking behaviours such as late diagnosis of TB has been associated with both 
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patient-related factors (such as a lack of knowledge) and health care-related factors 
(Belay, Bjune, Ameni & Abebe 2012:369; Saifodine et al 2013:559).  A study 
conducted in Botswana reported that perceived barriers to TB control included 
irregular laboratory and X-Ray services at clinic level (MOH 2011c:36-37). 
 
Several studies have identified stigma as the main barrier to health seeking 
behaviour, delaying early diagnosis and treatment of TB (Cramm et al 2010:72; Dias, 
De Oliveira, Turato & De Figueiredo 2013:595; Murray, Bond, Marais, Godfrey-
Faussett, Ayles & Beyers 2012; Uwimana et al 2012:233). However, stigma might 
not always impact on health seeking behaviours. A South African study found that 
most patients utilised the clinics closest to their homes for TB and HIV services, 
indicating that stigma did not impact on their decisions about the place of health care 
utilisation (Chimbindi et al 2013).  Their chances of being recognised by family 
members and friends at these clinics did not deter them from visiting the nearest 
clinics. These patients demonstrated an element of self-efficacy. “The term stigma 
does not imply that a condition is immoral or bad, only that it is commonly viewed 
that way” (Weitz 2013:138).  Similarly, Bowling (2009:31-32) says stigma is the 
resultant effect of the way a society reacts in respect of a health condition (TB) which 
manifests through labelling of people as deviants hence, damaging their identity. TB 
is further stigmatised by the advent of HIV that has led to its resurgence in SSA, 
including Botswana, and reversing the gains that had been made on controlling and 
eliminating TB.   A study, conducted in the Eastern Cape Province of South Africa, a 
place disadvantaged by poverty and unemployment, reported that respondents had 
misconceptions that everyone with TB infection would also get HIV eventually. “[A] 
full 95% of respondents believe[d] people with TB tend to hide their TB status 
because they are afraid of what others may say” (Cramm et al 2010:72).  The results 
are consistent with the Botswana TB/HIV 2011 KAP study’s findings in which some 
people in certain areas of the community reported “self-stigma” to the extent that 
they did not want to be associated with taking TB treatment and they associated TB 
and/or HIV with promiscuity. However, in the same study 83.5% of the interviewed 
households disagreed with the statement that “All TB patients also have HIV”, 
implying that they did not necessarily regard all TB patients as being HIV-positive 
(MOH 2011c:27, 30). 
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Some people manage stigma through confronting its basis (Weitz 2013:138). 
Patients have to serve as ambassadors in the fight against TB and HIV-associated 
stigma and their role can be more conspicuous in CTBC. Enshrined in the patients’ 
charter are patients’ rights, responsibilities and obligations geared towards “Stop TB” 
initiatives.  These aspects include the right to adhere to treatment and the right to 
contribute to community health through health education. People with tuberculosis 
have first-hand experience with TB.  Hence they could help to effectively reduce 
stigma in the community and enhance treatment completion of other patients (MOH 
2011a:117-118; WHO 2010:75). 
 
2.3.5       Health education offered to patients and their families by HCWs 
 
Srinivasan (2009 cited in Ncho & Wright 2013) asserts that insufficient knowledge, 
concerning treatment options, might interfere with health seeking behaviours. A 
cross-sectional study in Tanzania by Mkopi et al (2013:101) showed that proper 
health education of TB patients and reliable treatment supporters and understanding 
the treatment plan, positively affected treatment completions in the CTBC 
programme. These findings indicate that adequate health education, and  quality  
treatment supporters can serve as reminders (cues to action) about adopting desired 
health behaviours such as CTBC that influence treatment outcomes. The presence 
of volunteers in the community such as family members or co-workers might 
influence participation of both active TB patients and former TB patients in CTBC 
services. Patients’ adequate TB knowledge cannot be overemphasised as it guides 
decision making towards health behaviours. Saifodine et al (2013:559) emphasised 
the need for improved TB knowledge to reduce patients’ delays in seeking health 
care and in dispelling misconceptions.  
 
Having knowledge about the signs and symptoms and transmission of TB enables 
the community to embrace health seeking behaviours thus curtailing the spread of 
TB. Such data are vital in informing policy making concerning information, education 
and communication modalities aimed at TB control (Sreeramareddy, Kumar & 
Arokiasamy 2013:16). 
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2.3.6      Patients’ motivation to achieve TB treatment cure outcomes 
 
Self-efficacy is “the belief in one’s ability to perform a certain task, self-efficacy is a 
key construct in understanding and modifying health behaviours” (Bandura 1986, 
1995 cited in LoBiondo-Wood & Haber 2010:485). A study in the Netherlands has 
identified “a lack of patients’ motivation to make lifestyle changes” (Geense, Van De 
Glind, Visscher & Van Achterberg 2013) as one of the barriers influencing health 
promotion activities. This might be the case with the adoption of CTBC. Health 
promotion, in respect of TB, is achieved through the advocacy, communication and 
social mobilisation strategy (ACSM) in Botswana with the aim of building “community 
efficacy to combat TB” (MOH 2013a:8). In this study’s context, self-efficacy for health 
behaviours is defined by the partnership role played by patients in terms of TB 
control. The patients’ charter for TB care states that patients are active members in 
TB care services with respect to information sharing with the health provider, 
observing treatment and educating the community, thereby reducing TB-associated 
stigma (WHO 2012:75). Participation of TB patients in CTBC in the context of this 
study is considered as confidence to adhere to treatment and contribute to early TB 
diagnosis and treatment in the community.  
 
2.3.7      Modifying factors  
 
Modifying factors of the beliefs include patients’ satisfaction levels with the services, 
demographic variables, psychosocial variables, and structural factors that might 
influence TB patients to choose a DOT option. Several studies have revealed that 
diverse variables might impact on health seeking behaviours of individuals. A 
Chinese systematic review and meta-analysis study found that the major 
determinants of patients’ diagnostic delays encompassed socio-economic and 
demographic factors. Findings were mainly blamed on low educational status, 
poverty, stigma and poor TB knowledge. Health facility factors included being under 
resourced, lack of expertise and geographical barriers (Li, Ehiri, Tang, Li, Bian, Lin, 
Marshall & Cao 2013:156). Botswana’s national health policy also attests to the fact 
that varied socio-economic needs impact on one’s health (MOH 2011e:10). 
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2.3.7.1      Patients’ satisfaction with health care services 
 
Mkopi et al (2012: e51828) concluded that regular treatment supplies, meticulous 
identification of supporters and close proximity to the patients’ residences are 
critically important in adherence of patients receiving community DOT. Treatment 
supporters might include family members or any one chosen and accepted by the 
patient (MOH 2011b:9). The 2011 KAP study in Botswana identified inconsistencies 
in service provision such as irregular diagnostic services and TB treatment shortages 
as potential impediments to the control of TB (MOH 2011c:36-37). These findings 
might apply in Lobatse. Secure drug supplies, access to diagnostic services and 
effective reporting systems are pivotal to the success of CTBC in terms of expanding 
access (WHO 2010:76). The smooth running of CTBC is an indicator of patient 
satisfaction that can influence its uptake in the community. Integral to DOTS is its 
sensitivity and supportive role to the needs of the patient indicated by the PCC 
approach (WHO 2010:78). Negative attitudes of both the HCWs and the volunteers 
have been implicated in low uptakes of CTBC in Botswana (MOH 2013a:12; MOH 
2011c:8). Another way of enhancing patients’ satisfaction is through observance of 
the patients’ charter. The charter includes “the right to care, dignity, information, 
privacy, food supplements and/or other types of support and incentives, if needed” 
(WHO 2010:75). The theory of self-efficacy advocates that self-determination and 
self-motivation (Bowling 2009:44) enable individuals to embrace health seeking 
behaviours such as CTBC. 
 
2.3.7.2       Demographic variables 
 
A cross-sectional household survey in India, comprising 198 718 participants with a 
response rate of 91.6%, associated knowledge about TB transmission with being 
male, being a Hindu or Muslim, and listening to the radio (Sreeramareddy et al 
2013:16). Knowledge informs decision making hence demographic factors such as 
gender play an important role in acquiring knowledge. However, a South African 
study did not show any discrimination concerning attitudes and perceptions across 
age groups or educational levels indicating commonality of perceptions and attitudes 
across the study population. The study further showed that knowledge about  
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TB and demographic variables such as age and level of education were superseded 
by predominant attitudes and perceptions such as stigmatisation of TB  and 
considering TB to be an African disease in the studied community (Cramm et al 
2010:72).  
 
- Age 
 
A study conducted in China indicated that age did not have any relationship with 
patients’ delays in seeking diagnosis and treatment. A patient aged 60 or older was 
not at a greater risk of delay than younger persons (Li et al 2013:156). A Nigerian 
study showed that awareness of TB signs increased with age, implying that lifetime 
experiences increased patients’ TB knowledge (Desalu, Adeoti, Fadeyi, Salami, 
Fawibe & Oyedepo 2013). In a conflicting report, adherence to treatment was likely 
to occur amongst the young patients. In Tanzania , the probability of adherence to 
TB treatment by patients in the 35-44 year age group was lower than in the patients 
aged 25 or younger (OR: 0.77; 95%CI: 0.59-0.99;p˂0.049) (Mkopi et al 2012:e51828).  A 
study conducted in Korea “to evaluate the differences in clinical characteristics and 
treatment outcomes between older and younger tuberculosis (TB) patients” found 
that there was no difference in treatment success and adverse drug reaction rates 
between the old and the young patients (Kwon, Chi, Oh, Kim, Kim, Lim, & Kim 
2013:121).   
 
- Gender 
 
Gender might influence one’s health seeking behaviours. A study in China reported 
that the probability of female patients’ delay in health seeking behaviours was higher 
than among male patients (Li et al 2013:156). In Indonesia, care seeking behaviour 
among individuals with TB symptoms was associated with being female and 
presenting with many symptoms. The delay in seeking medical help was identified 
amongst men, students and the self-employed (Ahmad, Richardus & De Vlas 
2013:51-57). A study in Tanzania showed that the probability of adherence to 
treatment by females was double that of their male counterparts (OR:2.04; 95%CI:1.24-
3.02;=0.003) (Mkopi 2012:e51828). In another study conducted in South-Africa, being 
male was associated with non-adherence to TB treatment (Naidoo et al 2013:396). 
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These findings generally imply that gender is associated with decisions about health 
seeking behaviour such as adopting CTBC. This study is yet to show whether 
gender had any impact on the uptake of CTBC in Lobatse. 
 
- Educational status  
 
The findings of a study investigating awareness of warning signs, risk factors, and 
TB treatment among urban Nigerians presented predictors of awareness of TB 
warning sign  as: “age( r+0.12), higher family income(r+0.10), higher level of education 
(r+0.10) and belonging to Christian faith (r+0.11)” (Desalu et al 2013). Other studies 
have associated educational level, with socio-economic status, patients’ TB 
knowledge, cultural beliefs and decision making such as delays in seeking help. In 
Mozambique, some groups who were disadvantaged in terms of social status, 
education, and employment experienced delays in terms of seeking health care 
(Saifodine 2013:559). Findings show that educational status plays a decisive role in 
health seeking behaviour and might impact on someone’s social status and other 
economic dimensions. Poor social status has been attributed to poor adherence to 
treatment including TB treatment and ART (Naidoo et al 2013:396). The WHO has 
recommended the use of incentives for TB patients such as food rations (WHO 
2010:79) in an attempt to bridge the socio-economic gap and improve treatment 
adherence. 
 
- Marital status 
 
In the reviewed literature there was no record of the relationship between marital 
status and health seeking behaviour. Should any information in relation to marital 
status crop up during data collection, it shall be captured in chapter four.  
 
- Psychosocial variables 
The provision of pyscho-social support by the community, including former TB 
patients, remains a critical aspect during the course of TB treatment (MOH 2011c:36; 
WHO 2010:76&78). The aim of Botswana’s 2013-2017 National TB strategic 
framework “is to reduce the morbidity, mortality and psycho-socio-economic burden  
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and impact associated with TB, by 2017” (MOH 2011c:14).  In agreement, Naidoo et 
al (2013:396) concluded that there is a need for an all-encompassing programme to 
address the needs of TB patients with or without HIV, including psychosocial 
counselling, poverty, alcohol abuse and tobacco use. This conclusion follows 
findings in the same study that psychosocial aspects such as poverty, HIV status of 
one’s partner, co-morbidity, being a high risk for alcohol-abuse are critical predictors 
of non-adherence and HIV treatment. These studies’ findings indicate that 
psychosocial needs of TB patients might influence their decision making with respect 
to health seeking behaviours and might apply to factors affecting the uptake of CTBC 
in Lobatse. The assumption is supported by Mavhu et al (2010 cited in Murray et al 
2012) that HIV/AIDS has a negative social impact on TB in terms of affecting patient 
behaviour.  Provision of psychosocial support (which is central to CTBC) remains 
one of the vital necessities to reaching out to the community in terms of TB control 
(MOH 2011c:36). In agreement Dias et al (2013:595) concluded that TB treatment 
affects patients’ psychosocial wellbeing in different ways hence health workers have 
to explore mitigating factors and facilitate sharing of the patients’ anxiety, suffering 
and biological and psychological changes. Peer pressure such as use of ART 
“adherence” clubs has positively influenced health seeking behaviour in Malawi 
(Luque-Fernandez, Cutsem, Goemaere, Hilderbrand, Schomaker, Mantangana, 
Mathee, Dubula, Ford, Hernὰn & Boulle 2013). The CTBC guidelines in Botswana, in 
line with the WHO “Stop TB Strategy”, recommend patient support groups and 
participation of former TB patients as role models in the CTBC programme (MOH 
2011b:14; MOH 2013a:6-7). 
 
- Cultural beliefs 
 
Global studies, including SSA and Botswana, have identified cultural beliefs as one 
of the impediments to early TB diagnosis and treatment and to TB treatment 
adherence. There also is a noted interplay between cultural beliefs and socio-
economic status which might influence health seeking behaviour. This assumption is 
supported by Ncho and Wright’s (2013) findings that some family members had to 
calculate the financial cost before they could decide whether to visit the health facility 
or the traditional practitioner. Storla et al (2008 cited in Murray et al 2012) agree that 
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a broad spectrum of social factors such as poverty, preference for traditional 
practitioners, low educational status, low awareness of TB and other related factors 
are the main contributing factors to delay the utilisation of “a well-run treatment 
service” that observes the WHO DOTS strategies. These findings imply that socio-
economic and cultural factors may cause delays in adopting CTBC, which might 
apply to the CTBC in the Lobatse district. 
 
- Structural factors  
 
The WHO recommends structural initiatives such as concomitant treatment of HIV 
and patient and peer support groups to reduce stigma associated with TB. People 
with TB/HIV co-infection have an increased risk of mortality (WHO 2012b:79). In 
response to the co-epidemics of TB and HIV, the WHO launched the monitoring of 
“the implementation and expansion of collaborative TB/HIV activities in 2004” (WHO 
2012b:75). In line with the WHO guidelines TB/HIV activities in Botswana are 
integrated at community level even though still on a small scale (MOH 2013b:12-13). 
The Botswana TB ACSM Strategy 2013-2017 has been launched in 2013 in an 
attempt to provide a framework for ACSM interventions related to TB (MOH 
2013a:iv) which might scale up TB/HIV collaborative services and bridge TB 
knowledge gaps. The Botswana 2011 KAP study identified key knowledge gaps on 
TB transmission amongst TB patients despite the fact that they could successfully 
identify signs and symptoms associated with TB: for example 85.7% of patients 
could at least identify one major symptom of TB (MOH 2011c:20-21). These findings 
are consistent with studies conducted elsewhere. Results from a nation-wide cross-
sectional household survey in India showed that only 29.7% of the study’s 
respondents had no misconceptions about TB transmission (Sreeramareddy et al 
2013). 
 
Botswana’s Minister for Presidential Affairs and Public Administration, Honourable 
Masisi, in his official opening speech during the 2011 World TB Commemoration 
Day, mentioned that CTBC is one of the cornerstones of TB control in Botswana. 
However, the challenge is that there has been a lack of awareness of CTBC among 
the TB patients contributing to its low uptake (Masisi 2011). Inadequate knowledge 
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about TB and CTBC, concerning patients in Lobatse, is an assumption underlying 
this study. The Kabongo and Mash (2010) study, conducted in the Kweneng west 
sub-district of Botswana, indicated organisational issues including inadequate 
knowledge of patients about the existence of CTBC. The findings of the same study 
also revealed knowledge gaps of CTBC amongst volunteers. The recommendations 
to that effect were that volunteers might benefit from continuous support in the form 
of training and HCWs’ support, incentives and basic equipment. According to 
Botswana’s CTBC guidelines, Namibia which is a relatively small population, just like 
that of Botswana, has been found to be performing very well in respect of treatment 
success. Factors contributing to its success include effective pathways including a 
multi-sectoral approach, such as the use of family members as treatment supporters, 
high levels of community involvement and community support organisation, paid 
community health promoters and urban DOT points (MOH 2011b:8). Botswana has 
embraced some of these initiatives such as urban DOT points (MOH 2012:23). 
 
2.4       SUMMARY 
 
The literature review covered the overview of TB and studies that could possibly lead 
to the identification of factors affecting the uptake of CTBC in Lobatse. Studies were 
mainly considered according to their relevance to the topic of interest in different 
countries with high burden of TB and HIV. The presentation of the literature review 
was based on the major constructs of the HBM model and its modifying factors. 
Factors identified in the review that are likely to affect CTBC include patient-related 
factors, socio-cultural factors, economic factors, structural factors and health care 
system-related factors. 
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CHAPTER 3 
RESEARCH METHODOLOGY 
 
3.1      INTRODUCTION 
 
Research methodology implies “the process of research” (Creswell & Clark 2011:41). 
In this section the following aspects are addressed: study design, research methods, 
data collection methods, data analysis, ethical considerations, scope and limitations 
of the study. The study adopted a quantitative research methodology, and data were 
collected through structured face-to-face interviews conducted by four research 
assistants and the researcher using a self-designed structured interview schedule 
(see Annexure 3).   
 
3.2      STUDY DESIGN 
 
The researcher adopted a quantitative descriptive cross-sectional study design to 
assess quantifiable factors affecting the uptake of CTBC as experienced by patients 
in Lobatse. The researcher aims at selection of a study design that yields both 
internal and external validity (LoBiondo-Wood & Haber 2010:170).   
 
3.2.1      Internal validity 
 
Internal validity refers to the appropriate selection of a study population and absence 
of errors in measurement in the study (Friis & Sellers 2009:386). In this study, the 
researcher ensured that the questions in the tool addressed the study objectives and 
the respondents interviewed met the inclusion criteria. The statistician and the 
study’s supervisor were requested to ensure that every item in the structured 
interview schedule addressed the objectives of the study. The statistician ensured 
that no errors of measurement occurred. 
 
 
47 
 
  
3.2.2       External validity 
 
Friis and Sellers (2009:389) defined external validity as the extent to which the 
results of a study can be generalised “beyond a set of observations to some 
universal statement”. In this study generalisation of the results might be limited only 
to the TB patients in Lobatse who are on DOT in government facilities, as this study 
was done to fulfil the requirements of a dissertation of limited scope.  
 
3.2.3      Quantitative design 
 
Factors affecting the uptake of CTBC were summarised and described by using the 
Statistical Package for Social Sciences (SPSS) version 21. Quantification enables 
aggregation, comparison and summarisation of data (Babbie 2013:25). 
 
3.2.4      Descriptive study 
 
Factors hindering or facilitating the uptake of CTBC, as reported by patients in 
Lobatse, were assessed, described and categorised. The researcher wanted to 
assess whether limited knowledge about CTBC could be a factor influencing the 
patients’ utilisation of CTBC services in Lobatse.   
 
3.2.5      Cross-sectional study 
 
A cross-section of TB patients (N=101) aged 21-60 years, who were registered for 
DOT across the six GOB health facilities implementing CTBC guidelines, were 
interviewed face-to-face by using a structured interview schedule about factors 
affecting their uptake of CTBC in Lobatse.  
 
Each respondent was interviewed only once. The researcher and the four research 
assistants managed to conduct face-to-face interviews with all 101 accessible TB 
patients within 16 days, from 8th to 23rd November 2013.  
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3.2.6     Research setting 
 
The research was conducted at participating GOB’s clinics including: Motswedi Clinic 
, Peleng Central Clinic, Peleng East Clinic, Tsopeng Clinic, Wood Hall Clinic and 
Athlone Hospital Out Patients’ Department (OPD) in Lobatse. These GOB health 
care facilities provide both facility DOT and CTBC. Other respondents who were 
registered for DOT at all the five council clinics and Athlone Hospital’s OPD were 
met at their homes or any neutral places convenient for them.  Lobatse is an urban 
area with people of low socio-economic status concentrated at Peleng and Wood 
Hall neighbourhoods, where four of the five GOB’s clinics are located. 
 
For reporting purposes to the MOH of Botswana, GOB’s health facilities offering TB 
services in Lobatse are captured under Lobatse district, excluding health care 
facilities within the catchment area because of logistic reasons. In 2011, Lobatse’s 
population was estimated to be 29 007 according to the 2011 Central Statistics 
Office (CSO 2011).   
 
The 2001-2013 population projections of Botswana estimated Lobatse’s 2011 
population at 31 075 and the 2013 population at 31 835 (CSO 2005).  According to 
the 2001-2013 population projections, there is a significant decline in the population 
of Lobatse. The 2013 population is likely to decrease because some institutions were 
closing down and relocating to locations outside Lobatse such as Lobatse Tiles and 
the Botswana High Court of Justice. Other than regular transfers, completion of 
studies and quest for employment, this contributes to high mobility of people in and 
out of Lobatse. The Botswana Meat Commission also has significantly reduced its 
staff numbers.   
 
3.3      RESEARCH METHODS 
 
This section covers the steps followed in data collection for this study and includes 
population, target population, sampling frame, accessible population, advocacy, 
sampling technique and sample size determination. 
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3.3.1    Population 
 
The population comprises the total aggregate of elements of the researcher’s 
interest and it is composed of two groups. It comprises the target population and the 
accessible population (Burns & Grove 2009:344; Polit & Beck 2012:273-274). A 
sample is selected from a study population as its subset (De Vos, Strydom, Fouché 
& Delport 2011:223).  
 
The population comprised 377 TB patients in Lobatse who were registered for DOT 
at the GBO’s health facilities where CTBC guidelines had been implemented from 
January 2011 till August 2013.  The study population had to be on TB treatment for 
at least three weeks as it is expected that they would have been taught about the 
CTBC option according to 2011 CTBC guidelines by that time (data obtained from 
Lobatse’s TB register, see Annexure 1).  
 
3.3.2     Target population 
 
 
The target population implies the total number of respondents to which the 
researcher wants to generalise the findings of the study and who meet the eligibility 
criteria to participate in the study (Bothma, Greef & Mulaudzi 2010:124; Burns & 
Grove 2009:343-344; Polit & Beck 2012:274). The target population for this study 
were all TB patients in Lobatse who were registered for DOT at the GOB’s health 
facilities from January 2011 to August 2013 (N=377), excluding those patients in the 
selected three cohorts who died, transferred, were not evaluated and those who 
were younger than 21 and older than 64 years (n=154) at the time of data collection.  
This implies that the target population size was estimated by determining that the 
total population comprised 377 persons and subtracting those 154 who did not meet 
the inclusion criteria, yielding a total of 223 persons (377-154=223). 
 
3.3.3     Sampling frame 
 
A sampling frame comprises all eligible TB patients residing in Lobatse who were 
registered for DOT at the GOB clinics in Lobatse’s and at Athlone Hospital’s OPD 
between January 2011 and August 2013 and who were 21-64 years old at the time 
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of the study. They were 223 (N=223), according to statistics supplied by the TB co-
ordinator and as calculated in section 3.3.2. 
 
3.3.4      Accessible population 
 
The accessible population (N=223)  comprised eligible TB patients residing in 
Lobatse who registered for DOT from Lobatse GOB clinics and Athlone Hospital’s 
OPD between 1 January 2011 and 31 August 2013 and were 21-60 years old. The 
target population was accessible within Lobatse’s geographical area. The researcher 
and four research assistants used their own cars to reach the respondents during 
data collection with the help of the information obtained from the health facilities 
about patients’ particulars. The research team carried the list of the target group with 
them in case some of the respondents might need to be replaced when they could 
not be found or reached on the contact numbers. 
 
3.3.5      Advocacy 
 
The creation of awareness about the research started during the week of the 1st 
November 2013 and continued throughout the data collection period. The research 
team members were introduced to the prospective respondents (for familiarisation 
and for giving consent) by the primary care givers at the participating health facilities 
and at patients’ homes. 
 
Prior to meeting the research team members, the potential respondents were made 
aware of the study by the nurses, TB focal persons, health educators, health 
education assistants (HEAs), health promoters, and treatment supporters (primary 
care givers) as patients came for their daily DOT and routine visits to these clinics. 
Those patients who had completed treatment were informed by the TB focal persons 
and health facility staff as well as DOT supporters (mostly family members) about 
their possible involvement in the study. Community volunteers could not assist as 
they were involved in a measles campaign during this phase of data collection.  
Prospective respondents who did not have phone numbers were followed up by the 
health education assistants. These potential respondents were briefed about the 
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purpose of the study by the primary care giver which was later reinforced by a 
research team member.  
 
3.3.6    Sampling technique 
 
The researcher used systematic random sampling to select patients who were 
registered at the GOB’s health care facilities where Botswana’s CTBC policy 
guidelines were implemented. Systematic random sampling was used to select 
respondents from the sampling frame (N=223), Lobatse ETR, that is, the target 
population of TB patients in Lobatse who were registered for DOT in the GOB’s 
health facilities from January 2011 to August 2013.  In this method, each respondent 
had a chance to be selected into the sample at predetermined intervals (Polit & Beck 
2012:282-283). In order to determine the sample size (n=144 as calculated in section 
3.3.7), the (accessible) population (N=223) was accepted. The sampling interval (k) 
was determined by dividing N by n (K= ), hence K= 1.5486. Therefore, every 2nd TB 
patient in the accessible population was selected, starting at patient number three on 
the list, which means odd numbers such as 3, 5, and 7 were used. This sampling 
interval allowed the researcher to get only 111 patients from the sampling frame. In 
order to reach the required sample, the sampling frame was revisited and using even 
numbers such as 2, 4, 6, the 33 patients were added to make a sample size of 144 
patients.  
 
The research team carried the list of the target group with them in case some of the 
respondents needed to be replaced when they could not be found or reached on the 
contact numbers. Only (N=101) TB patients meeting the selection criteria were 
interviewed on a face-to-face basis. The sample size of (N=144) TB patients could 
not be reached due to deaths, mental illness, refusal to participate in the study, 
patients receiving streptomycin injections at clinics and inaccessible phone numbers 
on four separate attempts. Other reasons included the unavailability of contacts, 
wrong residential addresses, relocations to unknown addresses, patients being ill 
and hospitalised, and not being found on four separate visits as these homes had 
seemingly been abandoned (see table 3.1).  
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This discussion means that 70.1% of the prospective respondents were interviewed. 
According to Groves and Couper (1998 cited in Bowling 2009:289), a response rate 
below 60% is generally unacceptable. However a response rate is considered good 
at 75% or more (Bowling 2009:289). It was apparent during data collection that 
29.7% (n=30) of the patients had come from neighbouring villages such as 
Digawana to stay in Lobatse during the recuperation period to be nearer to the 
hospital and that they left the area once they had been cured or had completed their 
treatment.  It was also apparent that 80.2 % (n=81) of the patients had rented homes 
indicating a likelihood that they could move elsewhere. As many as 33.3% (n=27) of 
those 81 who rented accommodation stayed at crowded places where up to five 
people rented a room in one house. Being accompanied by a health education 
assistant in some instances helped to identify homes of people who had agreed to 
be interviewed. It was difficult to find house numbers because generally house 
numbers in Lobatse are not ordered according to streets. Some houses had no 
numbers, some had old (previously assigned) numbers whilst others had new 
(currently assigned) numbers. The HEAs were helpful as they were familiar with the 
neighbourhoods around their clinics. Generally TB focal persons did not know 
patients who had completed treatment because of job rotations that occurred in April 
2013 between Athlone Hospital and the five clinics participating in the study. These 
staff movements in health facilities follow relocations of clinics from the Ministry of 
Local Government to the MOH on the 1st of April 2010 (MOH 2010c:10).  
 
Where patients had no phone numbers, the TB focal persons also could not help to 
trace such houses.   Moreover 21.8% (n=22) of the respondents stayed at more than 
one house within Lobatse, adding to the challenges of tracing the respondents. 
Respondents scheduled their interviews from 6am to 8pm. Ten (9.9%) respondents 
had to reschedule their interviews because their relatives indicated that they had 
gone drinking early in the morning of their scheduled interviews.  According to the 
Yamane formula, the researcher has a 95% confidence level that a sample size of 
65-75% (70.1% in the case of this study) respondents would be representative of the 
population being studied (Mora & Kloet 2010). 
 
Patients were introduced to researchers by phone where necessary. The research 
team consulted or contacted each respondent on the sampling frame to make an 
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appointment for an interview, if the patient agreed to be interviewed. The patient was 
requested to identify a suitable date and time and place for the interview, with an 
option to be interviewed at the participating health facilities.  This was deemed 
essential as some patients might have preferred not to be interviewed at their homes 
as their TB status could get disclosed by home visits from interviewers.  A total of 91 
(90.1%) respondents preferred to be interviewed at their homes, three (3.0%) 
preferred to be interviewed at their work places during their lunch hours and only 
seven (6.9%) were interviewed at the health facilities, sometimes even after clinic 
hours.   
Cognitively impaired patients, the very ill, the elderly and mentally challenged 
persons were excluded from the study as they might not have been able to provide 
objective responses. In this study’s context elderly persons (≥65 years according to 
Lobatse’s ETR) were excluded from the study as age might impact on their well-
being. The very ill might experience exhaustion due to TB disease and TB-related 
morbidity.  The researcher was available at each study site prior to and during data 
collection and was able to identify selected respondents falling into these categories 
that should not be interviewed. The four research assistants helped to identify 
persons who should not be interviewed. In such cases, additional respondents were 
selected from the target population, following the same sampling technique as used 
to select the initial sample. 
 
3.3.7      Sample size determination 
 
To select the sample size, Yamane’s formula was used in order to estimate the 
minimal population size with a 95% confidence interval and a 5% level of precision. 
Therefore the sample was calculated as follows: 
n = N/ 1+N (e)2  
where N is the population, n being the sample size and e level of precision taken at 
0.05 as shown by Mora and Kloet (2010). 
Hence n = 223/ (1+223(0.05)2 = 143.1782 
Hence n = 144 
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TABLE 3.1   REASONS FOR NOT INTERVIEWING 144 RESPONDENTS 
Reasons  Frequency   % 
Deaths 4 3.3 
Mental illness 5 4.1 
Declining to participate in the study 4 3.3 
Patients receiving streptomycin injections at clinics 3 2.5 
Inaccessible phone numbers after four attempts  6 4.9 
Unavailability of  contacts 8 6.6 
Wrong residential addresses  14 11.5 
Relocations  to unknown addresses 65 53.3 
Patients being too ill and/or being hospitalised 3 2.5 
Patients not found on four separate visits 10 8.2 
Total 122   100.2 
 
Despite repeated efforts to recruit respondents to achieve the aim of interviewing 
144 patients, only 101 could be interviewed. 
 
3.4      DATA COLLECTION METHOD 
 
The discussion on data collection methods include the data collection instrument, 
reliability and validity of the data collection instrument, and administration of the data 
collection instrument. 
 
3.4.1      The data collection instrument  
 
The data collection instrument was a structured interview schedule, based on the 
study’s objectives, literature reviewed and the CTBC policy of Botswana. (Please 
find interview schedule in English and in Setswana, attached as Annexure 3). The 
instrument was compiled in English and translated into Setswana by the researcher.  
The four research assistants agreed that the English-Setswana translations 
conveyed the same meaning for every item/question.  Thereafter a Setswana-
English translator verified that the meanings were the same in both languages. 
 
3.4.1.1       Reliability 
 
A good research design should be valid and be able to produce reliable results.  
Babbie (2013:188) defines reliability as the ability of the technique to produce 
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consistent results when repeated several times on the same object. To ensure 
reliability, the tool was pre-tested at Bontleng Clinic in Gaborone on nine patients 
who met the study’s inclusion criteria and who were willing to be interviewed. These 
patients were excluded from participation in the actual study. Each research 
assistant conducted two interviews and the researcher conducted one interview. The 
pre-test helped the researcher to check the relevance of the questions, to estimate 
the time required for interviews during the actual study, check consistency of the 
responses and also to estimate the non-response rate. No comprehension 
challenges were encountered during the pre-test interviews, because the four 
research assistants had access to both the English and the Setswana versions of the 
interview schedule and could translate any statement. Approximately 30 minutes 
were required to complete each interview. 
 
The statistician compiled Cronbach alpha coefficients to ensure that there was 
equivalence of the items. Cronbach alpha coefficients were 0.890 indicating internal 
consistency of the instrument.  The instrument could be considered to have internal 
consistency if the Cronbach alpha coefficients exceeded 0.70 (LoBiondo-Wood & 
Haber 2010:299).  
 
The inter-rater reliability coefficient of the four research assistants could not be 
determined because the same patients was never interviewed more than once.  
However, the statistician did not identify any major discrepancies in the information 
obtained by the four interviewers during the pre-test nor during the actual data 
analysis.  The researcher was always available during the data collection phase and 
checked every completed interview schedule to address potential shortcomings with 
the interviewer. 
 
3.4.1.2      Validity  
 
Validity shows to which extent a measure accurately measures the concept it is 
supposed to measure (Babbie 2013:191). To ensure this, the items of the 
questionnaire were developed in relation to the research objectives so that these 
questions should provide answers to the set objectives after data collection. 
Criterion-related validity was assessed by five experts (TB focal persons), working at 
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five different health care facilities, who ensured that every item was relevant to the 
TB policy implemented at the clinic. According to Babbie (2013:191) criterion-related 
validity is the “… degree to which a measure relates to some external criterion”.  A 
content validity index (CVI) was compiled by requesting these five persons to 
indicate to what extent they considered every item to be directly relevant to the TB 
policy implemented at their clinic on a 5-point scale.  In each case 1 indicated no 
relevance and 5 indicated absolute relevance.  The five experts rated 30 items 
starting from question 9-29 in section B. Eighteen items scored a CVI of 5, 3 items 
scored a CVI of 4.8, 8 items scored a CVI of 4.6 and only 1 item had a CVI of 4.4 
hence no item was discarded  because no item scored below a CVI of 4. On the 
overall the instrument had a CVI of 97.6%, assuring the researcher that the 
instrument accurately reflects the concept (LoBiondo-Wood & Haber 2010:289).  
 
The interview schedule comprised the following sections: 
 
SECTION A:  Biographical data of the respondents 
SECTION B:  TB-related knowledge of the respondents 
SECTION C:  CTBC knowledge and attitudes of the respondents  
SECTION D:  DOT option selected by the respondents  
SECTION E:  TB patients’ responsibilities including adherence to treatment   
 
3.4.4   Administering the data collection instrument 
 
The structured interview schedule was pre-tested on nine TB patients registered at 
Bontleng clinic in Gaborone and they were excluded from participation in the actual 
study.   
 
The researcher obtained space at the participating clinics so that the four research 
assistants could interview patients at these clinics, if the respondent preferred this 
interview venue. Otherwise interviews were conducted in patients’ homes or 
wherever patients preferred the interviews to be conducted and at a time suitable to 
each individual respondent.   
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3.4.4.1   Research assistants 
 
Three lecturers from the Institute of Health Sciences, Lobatse (IHS-L) and a 
psychology graduate were trained as research assistants to conduct the structured 
interviews. The researcher also conducted some interviews, amounting to five 
interviewers. The researcher trained the four research assistants to conduct the 
interviews and to adhere to ethical principles. They were conversant with research 
procedures. The research assistants had to explain the purpose of the study, the 
importance of participating in the study, and the voluntary nature of such 
participation to the respondents, and obtain informed consent (by signature or finger 
print) before any interview could commence. Questions were clarified where 
necessary.  
 
Interviews were conducted in both Setswana and English depending on the 
language that each respondent preferred. After every interview, the researcher and 
research assistant checked if all the questions had been answered so that missing 
items could be addressed before the respondent left the interview site. No 
respondent was coerced to answer any specific question, explaining why some items 
remained incomplete.  
 
Each patient’s statements were recorded verbatim in English or Setswana as all 
interviewers were fully bilingual.  The researcher translated the Setswana statements 
into English and a Setswana-English translator checked that the exact meaning was 
conveyed in the English translations. (A letter verifying the translator’s inputs is 
attached as Annexure 8).  
 
3.5      DATA ANALYSIS 
 
A statistician helped with the data management and analysis. Quantitative data were 
captured and analysed using the SPSS version 21. A decision was taken to recode 
the variables on age, educational status, religion, employment and marital status. 
This decision was informed by the fact that in the use of univariate analysis, some of 
the categories for educational status, religion and marital status came out empty 
(with no frequencies) which would render the chi-squares invalid. Age groups of the 
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respondents were categorised into two groups, age group 21-35 and age group 36 
and older. The educational status of the respondents was similarly allocated into two 
groups, primary and lower and secondary and higher. As for religion, the 
respondents were categorised into Christians and non-Christians.  The employment 
status of the respondents was categorised into the employed and unemployed, 
whereas the marital status was categorised into married and not married.  
 
Descriptive statistics were calculated to present data and analysis tools included 
frequency tables, cross tabulations and custom tables. Independent t-tests were 
used to check if knowledge about TB varied with gender. The Pearson Chi-square 
tests were performed to establish relationships between enrolment on the 
programme and perceptions about the programme. Univariate logistic regression 
models were used and odds ratios together with their confidence intervals are 
reported with participation in the CTBC programme (binary-variable) used as an 
outcome. A significance level of 0.05 was adopted for this study’s findings.  
 
The dependent variables under consideration included knowledge about 
identification of TB, signs and symptoms of TB, TB treatment, TB/HIV co-infection 
and knowledge and attitudes towards CTBC.  
 
In establishing the level of knowledge, a score of 1 was allocated to a correct 
response and a score of 0 to an incorrect response in each of the variables that fall 
under each knowledge variable. All the scores were summed and calculated and 
means were used. Average scores at or above 50% of the total possible average 
mean score on TB knowledge were accepted as good knowledge levels and mean 
scores below average were regarded as having poor knowledge levels. Traditional 
beliefs about causes of TB were also computed through mean scores of 
respondents. A similar system for awarding scores and computing mean scores in 
this section was adopted for assessing CTBC support by patients participating in 
CTBC. Knowledge variables were constructed from questions 14a to 18j and support 
questions were constructed from question 27a to 27e (see table 3.2). 
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Variables indicating the respondents’ perceptions about factors that influence the 
adoption of a specific DOT option were constructed from question 19a)-19n). An 
open ended question, 19o was posed to respondents to briefly explain reasons for 
their choice of DOT option over the other, whether CTBC or FBTC. The respondents’ 
answers were recoded into, patient-related factors, sociocultural-related factors, 
socioeconomic-related factors, structural-related factors and health system-related 
factors. 
 
Factors influencing participation of TB patients in the CTBC were analysed through 
demographic factors of respondents, TB knowledge variables including knowledge 
and attitudes of respondents regarding CTBC and the HBM variables.  Questions 
addressing specific tenets of the HBM are indicated in table 3.3. 
 
TABLE 3.3: CONSTRUCTION OF THE HEALTH BELIEF MODEL  VARIABLES   
 
 
 
  
TABLE 3.2: CONSTRUCTION OF KNOWLEDGE AND SUPPORT VARIABLES   
 
 
Variable Construction 
Knowledge about TB (Max= 9) Sum (Q14a up to Q14i) 
Knowledge about signs/symptoms (Max= 5) Sum (Q15a up to Q15e) 
Knowledge about treatment (Max= 10)  Sum (Q16a up to Q16h) 
Knowledge about TB/HIV relationship (Max=5) Sum (Q17a up to Q17e) 
CTBC knowledge and  attitudes (Max= 10) Sum (Q18a up to Q18j) 
Traditional beliefs about causes of TB Sum (Q15f up to Q15h) 
TB support Sum(Q27a up to Q27e) 
Questions pertaining to specific tenets of the HBM  
Variable Structured interview item numbers 
Perceived susceptibility Sum (16a, 16c, 18a) 
Perceived severity Sum (16b,16d,18b) 
Perceived benefits Sum (18d,19d,19e,19f,19g) 
Perceived barriers and enablers Sum (16g,18f,18g,19j,18i,19l) 
Cues to action Sum (16i,16j,19b,19c,19h) 
Motivation/self-efficacy Sum (27a-27d) 
Patient satisfaction Sum(18h,18i,19a,19k,19l,19n) 
Psychosocial variables 
Structural factors 
Sum (19j, 19m) 
Sum (17d, 19i) 
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3.6      ETHICAL CONSIDERATIONS 
 
The study was cognisant of the three basic principles of the Belmont Report as 
stipulated in Amdur and Bankert (2011:19). These principles imply respect for 
persons, beneficence, and justice as indicated by LoBiondo-Wood and Haber 
(2010:250). 
 
Minimal risks were anticipated in the study as only structured interviews were 
conducted and no physical examinations were done. Some risk was anticipated of 
unintentional violation of confidentiality if the patient had not disclosed his/her TB 
status to neighbours and opted to be interviewed at home. The neighbours might 
know that the home visitors conducted TB-related research. To counteract this risk, 
each patient had the opportunity to select the date, time and place of the interview 
when the appointment for the interview was made. Interviews were conducted at 
convenient times and places for patients to avoid stigma and discrimination if their 
neighbours became aware of their TB status as a result of home visits to conduct the 
interviews.   
 
There were no anticipated physical risks. The research assistants were capable of 
handling minor discomforts encountered by respondents and to accompany any 
respondent to an appropriate health care worker, if necessary. The researcher was 
also available by mobile phone to attend to minor discomforts or refer patients. 
However, only one respondent who completed her TB treatment in 2012 
experienced some discomfort by feeling hot and finding it difficult to breathe after 
signing a consent form.  A nurse attended to the respondent in the consulting room 
of the health facility. The patient rescheduled the interview but later declined to be 
interviewed. 
 
3.6.1      Specific ethical issues 
 
The special ethical issues covered in this section included, confidentiality, self-
determination and autonomy, respect for persons, justice and beneficence. 
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3.6.1.1    Confidentiality 
 
Confidentiality can be considered as an extension of privacy, which entails 
agreements between individuals that impose restrictions on private information, (De 
Vos et al 2011:119).  Each research assistant signed a confidentiality form (see 
Annexure 7) undertaking to treat all information confidentially and not to record any 
names or identifying information on any interview schedule.  
 
Respondents’ signed consent forms were placed into one container and the 
completed interview schedules into a different container.  In this way no signed 
consent form could be linked to any completed interview schedule, ensuring 
anonymity. Completed interview schedules were kept under lock and key to assure 
anonymity and confidentiality. Only the researcher and the statistician and the 
study’s supervisor could access these completed documents.  After the acceptance 
of the research report, these documents would be destroyed and the data entered on 
the computer (protected by a secure password) would also be deleted. 
 
The researcher compiled a list of the selected respondents’ code numbers reflected 
on their interview schedules and matched these with their clinic file numbers to 
ensure that auditing would be possible should any information require cross-
checking or should the health care authorities wish to confirm any findings. This also 
ensured that no respondent was interviewed twice. This list was kept under lock and 
key by the researcher and no one else had access to it. 
 
No respondent’s name would be mentioned in any report and no personal identifiers 
such as cell phone numbers, identification numbers, and residential or postal 
addresses were recorded.   
 
3.6.1.2    Self-determination and autonomy 
 
The written information on the consent forms was verbally explained to each 
respondent so that he/she could make an informed decision as to whether or not to 
participate in the study.  Edwards (2009:22 cited in Pera & Van Tonder 2011:62) 
recognises the need for ‘decisional privacy’ which involves observance of the 
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patient’s right to make autonomous decisions.  The respondents were informed 
about their right to refuse and/or withdraw from the study at any particular time even 
after signing the consent form. It was explained to respondents that the study was 
purely voluntary and that no remuneration would be paid. No respondent was 
coerced to answer any specific question/item.  
 
3.6.1.3    Respect for persons 
 
According to the Belmont report, respect for persons involves observing a sense of 
autonomy when dealing with individuals as well as protecting people with diminished 
autonomy (Amdur & Bankert 2011:20). “With regard to patients, autonomy may be 
diminished by factors such as age and mental status or affected by illness and/or 
medication” (Pera & Van Tonder 2011:62). Patients were assured that their 
participation or non-participation in the study would not affect their treatment at 
health facilities in any manner whatsoever.  Cognitively impaired patients, those who 
were ill, the elderly and mentally challenged were excluded from the study as they 
might have been unable to provide objective information or they might have become 
exhausted due to TB-related morbidity. 
 
3.6.1.4     Justice  
 
Justice entails fairness. Denying persons a benefit they are entitled to for no good 
reason or undeservedly imposing a burden constitutes injustice (LoBiondo-Wood & 
Haber 2010:250). The purpose of the study was explained to the prospective 
respondents as assessing factors affecting the uptake of CTBC by patients in 
Lobatse. Informed consent was obtained from each respondent through a signed (or 
thumb printed) consent form (see Annexure 10).  
 
The contact details of the Health Research Unit Health officer in the MOH were given 
to respondents in case of any queries. The respondents were able to ask questions 
about the study and the interview before granting consent (see Annexure 10). 
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3.6.1.5    Beneficence 
 
The principle of beneficence also involves evaluation of the risks and expected 
benefits of respondents (Amdur & Bankert 2011:24). The current study sought 
information about the respondents’ knowledge about TB and CTBC, their support 
structures and factors influencing their adoption of a specific DOT option in the 
Lobatse area. The respondents were informed about the possibility of publication of 
results as aggregate data, but that no person’s name would be mentioned. There 
was no need to interfere with any treatments. The respondents were not influenced 
to change their decision about CTBC. Although individual respondents might not 
benefit directly from being interviewed, their participation might help to enhance the 
implementation of CTBC, and thereby to help improve the TB treatment outcomes in 
the Lobatse area. Respondents might experience an indirect benefit in that people 
close to them such as family members might benefit from CTBC in future because of 
the exposure that respondents might have gained during the study.  
 
3.6.2     Capacity building and scientific integrity of the study  
 
A thorough literature review on CTBC was done. Integrity was achieved through 
maintaining veracity in data analysis and report writing, dissemination and 
publication of results, peer review and approval of the research report.  All sources 
quoted or used in the dissertation were acknowledged by supplying complete and 
correct references and by including a complete list of references.  The statistician 
checked the data entries on the computer during the data cleaning process and 
assisted with the data analyses and interpretations.   
 
The study’s findings might be presented at the DHMT for the purposes of information 
sharing with the management and implementers of CTBC. Findings shall further be 
presented at national and international conferences. The conference will accord the 
researcher an opportunity to share research findings and benchmark best practices 
from other presenters in meeting the MDGs, which will be used to enhance the 
learning and teaching process and also benefit the health care professionals and 
volunteers working in Lobatse’s DHMT. 
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3.6.3   Permission to conduct the study 
 
The study dealt with human subjects (respondents) hence the proposal had to 
undergo the scrutiny of ethical committees to assure that methods used were 
ethically sound  (Amdur & Bankert 2011:5). The process was meant to allow vetting 
and to safeguard the wellbeing of the respondents (Oliver 2010:41). 
 
The protocol was submitted to the University of South-Africa for approval by the 
Higher Degrees Committee of the Department of Health studies, and for granting 
ethical clearance. Subsequent to having obtained this clearance the protocol was 
submitted to Lobatse’ Institutional Review Board  and Health Research Unit in the 
MOH of Botswana for ethical approval. Permission to access health facilities and 
respondents for pre-testing the tool and for conducting interviews for the actual study 
was sought from the Gaborone DHMT co-ordinator and trom the Lobatse DHMT 
coordinator.  
 
Following permission to access health facilities the researcher had consultative 
meetings about the research with the Bontleng Clinic management, Athlone Hospital 
management, the DHMT nursing superintendent and management for participating 
clinics including TB focal persons. These meetings were necessary because in order 
to access sites and individuals, permissions have to be granted by people 
overseeing sites (Creswell & Clark 2011:175) (see Annexures 11, 12 and 13). Every 
respondent signed or thumb printed a consent form before any interview 
commenced. 
 
3.7       SUMMARY 
 
This chapter presented the research method adopted to investigate factors 
influencing peole’s decisions to participate in the CTBC programme in the Lobatse 
area of Botswana.  The study adopted a quantitative, descriptive and cross-sectional 
design. Structured interviews were conducted with 101 patients. The data were 
analysed by using the SPSS version 21 software, with the assistance of a 
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statistician.  The ethical considerations that were observed by the researcher and 
research assistants were explained. 
 
The next chapter will present the analysis and discussion of the data obtained from 
the 101 structured interviews conducted with the selected patients in the Lobatse 
area. 
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CHAPTER 4 
ANALYSIS AND DISCUSSION OF THE RESEARCH 
FINDINGS 
 
4.1      INTRODUCTION 
The chapter presents the analysis and discussion of this study’s findings, organised 
according to the broad themes of the study, namely: 
 Demographic characteristics 
 Knowledge about TB 
 Knowledge about and attitudes  towards CTBC 
 Perceptions about factors that influence the adoption of a specific DOT option 
 Support  of TB patients  participating in the CTBC programme 
 Factors influencing participation of TB patients in the CTBC programme 
 
Independent t-tests were used to check whether knowledge about TB varied with 
gender. The Pearson Chi-square tests were performed to identify relationships 
between enrolment in the programme and perceptions about the programme. 
Univariate logistic regression models were used and participation in the CTBC 
programme (binary-variable) was used as an outcome.  A significance level of 0.05 
was adopted for this study’s findings. Respondents’ responses to open ended 
questions were recoded according to emerging themes, quantified and used to 
substantiate the quantitative data. Relevant examples of respondents’ verbatim 
statements are given. 
 
4.2      RESPONDENTS’ DEMOGRAPHIC CHARACTERISTICS 
 
This section addresses the demographic characteristics of the respondents. In this 
chapter N indicates the total number of 101 respondents, n indicates any total not 
amounting to 101, and f indicates any frequency within N or n. 
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4.2.1      Gender 
 
A total of 101 patients were interviewed, of whom 55.4% (f=56) were females and 
44.6% (f=45) were males, indicating that there were more female than male 
respondents. Figure 4.1 presents a percentage distribution of the gender of the 101 
respondents.  
 
 
Figure 4.1: Gender of respondents (N=101) 
 
4.2.2      Age 
The age distribution of the respondents is presented in table 4.1. Respondents aged 
21-25 comprised 5.9% (f=6) of the sample, followed by 8.9% (f=9) aged 26-30 and 
21.8% (f=22) aged 31-35, implying that 36.6% (f=37) of the sample were up to 35 
years old, thus falling within Botswana’s ‘youth category’. The Revised National 
(Botswana) Youth Policy defines youth as “…persons of ages 15-35 years” (Ministry 
of Youth Sports & Culture 2010:5).  Regarding other age groups of the respondents, 
23.8% (f=24) were 36-40 years of age, 15.8% (f=16) aged 41-45, 8.9% (f=9) aged 
46-50, 9.9% (f=10) aged 51-55 and 5.0% (f=5) aged 56-60. These statistics show 
that TB affects people of different age groups including those in their economically 
productive ages, indicating a need for CTBC in Lobatse. Adults in the economically 
productive age group are globally affected by TB, according to the WHO (2012b:3). 
44.6  Males 
55.4  females
Male
Female
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Table 4.1: Age group of respondents(N=101) 
Age group  Frequency Percentage 
21-25 6 5.9 
26-30 9 8.9 
31-35 22 21.8 
36-40 24 23.8 
41-45 16 15.8 
46-50 9 8.9 
51-55 10 9.9 
56-60 5 5,0 
Total   101 100.0 
 
 
4.2.3       Education 
 
Table 4.2 portrays respondents’ qualifications showing that 46.5% (f=47) had 
secondary education, 24.8% (f=25) had primary education, 14.9% (f=15) had no 
schooling and 9.9% (f=10) had obtained certificates (the nature of these certificates 
was not recorded and thus remains unknown). The diploma and the degree holders 
comprised 2.0% each respectively. These findings show that the minority (14.9%; 
f=15) of the respondents had no schooling. The “universal primary education” offered 
in Botswana claimed a national literacy rate of 81.2% for 2003/2004 (MOH 
2011e:10), corresponding with this study’s finding that 85.1% of the respondents had 
acquired some schooling.  
 
Table 4.2: Respondents’ educational qualifications (N=101) 
 Education level Frequency Percentage 
No schooling 15 14.9 
Primary 25 24.8 
Secondary 47 46.5 
Certificate 10 9.9 
Diploma 2 2.0 
Degree 2 2.0 
Total 101 100.1 
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4.2.4      Respondents’ religious affiliations 
 
The religious affiliations of respondents are presented in table 4.3, showing that 
84.2% (f=85), were Christians, 11.9% (f=12) had no religious affiliation, Muslims and 
Traditional African Religions comprised 2.0% (f=2) respectively, implying that the 
majority of the respondents were Christians. Christianity accounts for approximately 
80% of the existing religions in Botswana (Embassy of Botswana 2010), concurring 
with this study’s finding that 84.2% of the respondents were Christians. 
 
Table 4.3: Religious Affiliation of respondents (N=101) 
Religion  
Frequency Percent 
Christian 85 84.2 
Muslim 2 2.0 
Traditional African 2 2.0 
No affiliation 12 11.9 
Total 101 100.1 
 
 
4.2.5    Respondents’ employment status 
 
Figure 4.2 presents the employment status of the 101 respondents and shows that, 
38.6% (f=39) were formally employed full time, 37.6% (f=38) were unemployed, 
11.9% (f=12) were self-employed, 6.9% (f=7) were part time formally employed and 
only 5% (f=5) were employed doing ‘piece jobs’. These findings show that 
cumulatively 62.4% (f=63) of the respondents had some kind of employment.  This 
might be associated with Lobatse being an urban area where people come to seek 
employment or to study. 
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Figure 4.2: Employment status of respondents (N=101) 
 
4.2.6      Marital status 
 
Out of 101 respondents, 52.5% (f=53) were single, 25.7 % (f=26) were cohabiting, 
12.9 (f=13) were in committed relationships, 5.9% (f=6) were married and those 
separated, divorced and widowed comprised 1% (f=1) each respectively (see table 
4.4). 
 
Table 4.4: Marital Status of respondents (N=101) 
Marital status  Frequency Percent 
Single 53 52.5 
In a committed relationship 13 12.9 
Co- habiting 26 25.7 
Married 6 5.9 
Separated 1 1.0 
Divorced 1 1.0 
Widowed 1 1.0 
Total 101 100.0 
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4.2.7      Persons normally living in the respondents’ homes 
 
Respondents were asked with whom they normally lived in their homes.  These 
findings indicate that 17.8% (f=18) lived with their partners, 14.9% (f=15) lived with 
their parents, 13.9 % (f=14) lived with their relatives and 13.9% (f=14) lived with their 
children, 7.9% (f=8) lived with their partners and children, while 3.0% (f=3) lived with 
their spouses and their children and 3.0% (f=3) lived with their spouses only. Those 
who lived alone comprised only 12.9% (f=13) of the sample, implying that 87.1% 
(f=88) stayed with someone who could help to implement CTBC.  This reasoning 
might be corroborated by a study conducted in China, which showed that having a 
family member as a treatment supporter yielded better cure rates as opposed to 
having no treatment supporter (Ai et al 2010:112). However, the ages of children of 
respondents in this study, were not determined to find out whether these children 
were old enough to administer treatment to their parents. 
 
Table 4.5:   Persons with whom respondents normally lived in their homes  
          (N=101) 
 
  Frequency Percent 
Alone 13 12.9 
Spouses 3 3.0 
Parents 15 14.9  
Relatives 14 13.9  
Siblings 13 12.9  
Partners                                                      18 17.8  
Partners and children  8 7.9 
Children 14 13.9  
Spouses and children 3 3.0 
Total 101  100.3 
 
4.2.8      The type of TB  
Of the 101 respondents, 90.1% (n=91) had PTB while 9.9% (n=10) had EPTB, as 
shown in figure 4.3.  Out of the 91 respondents with pulmonary TB, 46.2% (f=42) 
were males while 53.8% (f=49) were females. These findings are consistent with the 
MOH (2011a:9) report which shows that approximately 80% of TB occurs in the 
lungs in Botswana. 
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Figure 4.3: Type of TB of respondents (indicated in percentages)   (N=101) 
 
4.3       KNOWLEDGE ABOUT TB 
 
Table 4.6 presents respondents’ knowledge scores indicating the means (average 
scores), about TB-related issues (including knowledge variables about TB for males 
and females and the two groups combined). Table 4.6 presents findings about the 
respondents’ knowledge concerning TB identification, signs and symptoms of TB, 
traditional beliefs about causes of TB, TB treatment and TB/HIV interaction. These 
variables are treated individually and their individual relationships with TB patients’ 
gender were examined. Independent t-tests were used to check whether knowledge 
about TB varied with gender.  The only finding that was statistically significant was 
knowledge about signs and symptoms of TB (p=0.032). Knowledge scores are 
reported in means per knowledge variable.  Average scores at or above 50% of the 
total possible average score are accepted as being knowledgeable and those with a 
below average score are considered not to be knowledgeable.  
 
4.3.1      Respondents’ knowledge about the identification of TB (N=101) 
 
The 101 respondents scored an average of 6.87 out of a maximum score of 9, about 
knowledge on the identification of TB, indicating that they were fairly knowledgeable 
about the identification of TB. Another study in Botswana comprised in-depth 
90,1
9,9
Lungs
Other part of the body
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interviews with TB patients.  This response to the open ended question showed that 
the majority of that study’s participants knew that TB could be directly transmitted 
through close contact with an infected individual.  
 
Table 4.6: Respondents’ average knowledge scores about TB-related issues  
         (males, females and the two groups combined)  
   
  Male Female p-
value  
Total 
 Knowledge about TB 
identification (Max= 9) 
7.02  6.75  0.2650 6.87  
 Knowledge about 
signs/symptoms of TB 
(Max= 5) 
3.91  3.54  0.032 3.72  
 Knowledge about TB 
treatment (Max= 10)  
9.38  9.55  0.4720 9.48  
 Knowledge about 
TB/HIV relationship 
(Max=5) 
3.76  3.91  0.4400 3.84  
 Knowledge and 
attitudes towards   
CTBC (Max= 10) 
Traditional beliefs about 
causes of TB (Max= 3) 
CTBC support (Max= 5) 
 
 
7.47  
 
1.47  
 
2.91              
6.89  
 
1.37 
 
2.79  
0.1620 
 
0.6310 
 
0.578 
 
7.15  
 
1.41  
 
2.84  
However, other researchers reported TB-related misconceptions (MOH 2011c:23) 
such as attributing TB to having asthma. The MOH’s (2010a:26-27) CTBC report 
shows that 58% of TB patients knew that coughing could transmit TB but about 21% 
of TB patients, who participated in that study, believed that sharing eating utensils, 
eating together, shaking TB patients’ hands or touching TB patients could transmit 
TB (MOH 2010a:26-27).  This study’s information could not be compared with TB-
related misconceptions reported by other researchers in Botswana. 
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4.3.2      Knowledge about signs and symptoms of TB (N=101) 
 
The 101 respondents scored an average of 3.72 out of 5 on knowledge about the 
signs and symptoms of TB indicating that they were knowledgeable. Males (44.6%; 
f=45) scored 3.91 indicating a slightly higher knowledge level than females (55.4%; 
f=56) who scored 3.54. An overall mean score of 3.72 out of 5 shows that 
respondents were knowledgeable about signs and symptoms of TB though 
knowledge gaps might need to be identified. The Botswana 2011 TB/HIV KAP 
Study’s report, based on interviews conducted with TB patients, identified major 
gaps in respondents’ TB-related knowledge. An example includes “It’s like I just got 
the disease, I don’t understand the depth of TB, I just know that I got TB” (MOH 
2011c:21). Another Botswana study involving TB patients showed that “… most 
respondents managed to identify major signs and symptoms of TB such as coughing 
for more than three weeks, weight loss and chest pains” (MOH 2010a:26).  These 
research reports support the current study’s finding that most Botswana TB patients 
knew the signs and symptoms of TB.  
 
4.3.2.1      Traditional beliefs about causes of TB 
 
All 101 respondents scored an average of 1.41 out of a total score of 3 on traditional 
beliefs about causes of TB, indicating that traditional beliefs had a limited impact on 
the respondents’ TB-related perceptions. Females (55.4%; f=56) scored lower at 
1.37, than males (44.6%; f=45) who scored 1.47, about traditional beliefs’ impact on 
the causes of TB, indicating that these beliefs had a smaller influence on females in 
this study. However, a p value of 0.6310 suggests that traditional beliefs about 
causes of TB were not significantly associated with gender.  A study conducted in 
Nigeria by Desalu et al (2013) showed that awareness of TB signs was predicted by 
education, income and Christianity. In the current study, respondents with at least 
secondary education comprised 60.4% (f=61) of the sample, indicating that 
education might have had an impact on knowledge about TB. The employed 
respondents, including those doing piece jobs, comprised 62.4% (f=63) of the 
sample. The generation of income has been associated with TB-related  
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knowledge in another study (Cramm, Koolman, Møller & Nieboer 2011:e34) because 
health-related information can be obtained through social connections (Harling, 
Ehrlich & Meyer 2008:492-505 cited in Cramm et al 2011:e34). Christianity might 
have had an influence on the traditional beliefs of respondents because 84.2% 
(f=85) of the sample were Christians.  
 
4.3.3      Respondents’ knowledge about TB treatment 
 
The 101 respondents scored an average of 9.48 out of 10 on knowledge about TB 
treatment, indicating that the respondents had high knowledge levels about TB 
treatment. Females (55.4%; f=56) scored slightly higher on TB treatment at 9.55 out 
of 10 compared to males (44.6%; f=45) who scored 9.38. Based on p=0.4720 there 
was no significant association between knowledge about TB treatment and gender. 
In Africa, including Botswana, generally women are caretakers (MOH 2007 cited in 
Kabongo & Mash 2010) and this might explain why females had slightly higher 
knowledge levels about TB treatment than males. As caretakers of family members, 
women have more frequent contact with health facilities and with health care 
workers, granting them more opportunities to receive health education about various 
aspects, including TB, than their male counterparts. 
 
4.3.4      Knowledge about the TB/HIV relationship  
 
Overall the 101 respondents scored an average of 3.84 out of 5 on knowledge about 
the relationship between TB and HIV. Females (55.4%; f=56) scored slightly higher 
(3.91 out of 5) on knowledge about the relationship between TB and HIV indicating 
that females were slightly more knowledgeable about the TB/HIV relationship than 
males who scored 3.76 (44.6%; f=45).  However, this finding was not significant with 
a p value of 0.4400.  Botswana’s health care system offers ante natal care (ANC), 
prevention of mother-to-child transmission (PMTCT), postnatal care and family 
planning services where women receive health education about HIV and also about 
TB and about the correlation between HIV and TB. Thus women’s more frequent 
exposure to TB/HIV health education might have provided the women with more 
knowledge than their male counterparts had. Botswana’s “scaled-up” and “integrated 
collaborative TB/HIV activities” focus on early diagnosis and treatment of TB, which 
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is consistent with the WHO’s aims (WHO 2013d). The impact of integrating TB/HIV 
services with maternal, neonatal and child health services in Namibia has shown 
positive results such as ART coverage of 85% (WHO 2013e) indicating its ability to 
disseminate TB/HIV related information. This approach has been adopted by other 
countries, including Botswana, and this might produce similar results in future in 
Botswana. 
 
4.4      KNOWLEDGE ABOUT AND ATTITUDES TOWARDS CTBC 
 
This section addresses knowledge and attitudes of respondents towards CTBC. The 
101 respondents scored an average of 7.15 out of 10 on knowledge and attitudes 
towards CTBC indicating that they had adequate knowledge and positive attitudes 
towards CTBC. The males (44.6%; f=45) scored higher (7.47out of 10) on knowledge 
about and attitudes towards CTBC programme compared to females (55.4%; f=56) 
who scored 6.89, indicating that males had higher knowledge levels and more 
positive attitudes towards CTBC than females. However, males’ CTBC enrolment 
(68.9%; f=31) remained lower than that of females 73.2% (f=41). These findings 
were not statistically significant, p=0.1620, indicating no significant association 
between gender and knowledge about and attitudes towards CTBC (see table 4.6). 
On the basis of the available evidence, no reasons could be provided to explain why 
males were more knowledgeable about CTBC than females, as females seemed to 
be more knowledgeable about other TB-related aspects.  Although these findings 
lacked statistical significance, a KAP study, about TB conducted amongst community 
members in Ethiopia, also showed that females were less likely than males to: 
 have good levels of TB-related knowledge 
 show positive attitudes towards TB and 
 maintain good TB-related practices (Bati, Legesse & Medhin 2013:734). 
 
Men do not like visiting the health facilities because they perceive that as being a 
sign of weakness and as bread winners of their families they dislike standing in long 
queues.  This programme might be a convenient option for males in this study 
because CTBC offers privacy and is less time consuming compared to FBTC.   
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A study, conducted in Zimbabwe about masculinity as a barrier to men’s use of HIV 
services, showed that men wanted to display a sense of control, strength, good 
health and economical productivity (Skovdal, Campbell, Madanhire, Mupambireyi, 
Nyamukapa & Gregson 2011: 13).  
 
4.5        PROVIDING SUPPORT TO TB PATIENTS PARTICIPATING IN CTBC 
 
This section addresses support of TB patients according to gender, treatment 
completion, enrolment into the CTBC programme and completion of their TB 
treatment.  
 
4.5.1     Support according to gender (N=101) 
 
A total of 101 respondents scored an average of 2.84 out of 5 on support and 
participation in CTBC activities such as regular attendance of TB support group 
meetings/activities, encouraging TB suspects to seek early TB treatment and 
encouraging other TB patients to adhere to their treatment. The males scored an 
average of 2.91 out of 5 compared to females who scored an average of 2.79 out of 
5 indicating slightly greater participation for males than for females (see table 4.6). 
Given a p value of 0.578, there was no statistically significant association between 
CTBC support and gender. 
 
4.5.2      Support according to completion of TB treatment (n=81) 
 
Of the 101 respondents 80.2% (f=81) had reportedly completed their TB treatment.  
Only 50.6% (f=41) out of the 81 respondents who had completed treatment, were 
treatment supporters for other TB patients. These findings show low levels of support 
provided to other people’s TB treatment. As many as 75.9% (f=22) of patients on 
FBTC and 73.6% (f=53) of those on CTBC indicated that they were aware of TB 
patients’ rights. As 62.4% (f=63) of the 101 respondents were employed, they might 
have been unable to supervise other patients’ TB treatment adequately. Staying 
alone at home implied that 12.9% (f=13) of the 101 respondents might not have had 
ready access to treatment supporters at home.  
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The WHO recommends that former TB patients should be involved in CTBC 
activities including supervising treatment of TB patients (WHO 2010:78). Cured TB 
patients’ responsibilities include contribution to community health and sharing a 
sense of unity with other patients striving to get cured from TB (MOH 2013a:39).  
 
4.5.3      Support according to enrolment into CTBC (n=72) 
 
Of the 72 CTBC respondents, 12.1% (f=7) attended TB support group meetings, 
70.7% (f=41) encouraged TB suspects to seek treatment, 75.9% (f=44) encouraged 
patients to adhere to their TB treatment, 41.4% (f=24) had publicly shared TB-related    
messages and 44.8% (f=26) were treatment supporters. 
 
The CTBC support and participation variables, reported by the 72 patients who 
participated in the CTBC programme, had percentages below 50% except for two 
variables: encouraging TB suspects to seek treatment (56.9%; f=41) and, 
encouraging patients to adhere to their TB treatment (61.1%; f=44).  
 
4.5.4      Support according to enrolment in the CTBC programme and  
     completion of treatment (n=58)   
 
Out of 72 respondents who had enrolled in the CTBC programme, 80.6% (f=58), had 
reportedly completed their treatment of whom only 12.1% (f=7) regularly attended 
support group meetings, 70.7% (f=41) encouraged others to seek treatment, 75.9% 
(f=44) encouraged others to adhere to their treatment, 41.4% (f=24) had publicly 
given health education about TB and 44.8% (f=26) were treatment supporters.  
 
Support groups such as “ART adherence clubs” have been found to enhance health 
seeking behaviour (Luque-Fernandez et al 2013). Positive results of adequate TB 
programme support, in terms of low levels of drug resistance, were documented in 
rural Malawi (Mboma et al 2013:e58192).  No similar study could be traced that was 
done in Botswana. 
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4.6      FACTORS AFFECTING PATIENTS’ ADOPTED DOT OPTION (N=101) 
 
This section addresses this study’s findings about respondents’ factors that 
influenced TB patients’ adoption of the DOT option as either CTBC or FBTC. The 
cut-off point for determining the major reasons for adopting of CTBC was 75%. The 
Chi-square test was applied to identify predictors for adopting CTBC. In this study 
there were more respondents (71.3%; f=72) who had enrolled for CTBC than for 
FBTC (28.7%; f=29) as shown in table 4.7.  Out of the 72 respondents who had 
enrolled in CTBC, 43.1% (f=31) were males whilst 56.9% (f=41) were females. The 
CTBC enrolment in this study falls short of the Botswana target of 75% (MOH 
2013a:4) but some improvement occurred from 63.5% recorded in 2012 (MOH 
2012:23). 
 
Table 4.7: Total number and percentages of individuals enrolled in the  
                   CTBC programme 
CTBC programme enrolment       F 
Enrolled 72/101 (71.3%) 
Not enrolled 29/101 (28.7%) 
 
Table 4.8: Chi-square test of independence: factors influencing patients’ 
        option for CTBC or FBTC   
Question Statement  CTBC 
 
FBTC 
 
p-value 
for CTB C 
f % f 
 
% 
Q 19a) A chance for a personal 
decision about my DOT option 
60 83.3 18 62.1 0.021 
Q19b) Adequate information on TB 66 91.7 23 79.3 0.083 
Q19c) Adequate information on the 
DOT option chosen  
65 90.3 16 55.2 0.000 
Q19d) Cost saving opportunities 47 65.3 16 55.2 0.343 
Q19e) Desire to fight TB stigma 47 65.3 17 58.6 0.530 
Q19f) Desire to control TB in the 
community 
 
55 76.4 24 82.8 0.685 
Question Statement     p-value 
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4.6.1      Respondents’ perceptions about factors influencing their option 
    for CTBC or FBTC 
 
Table 4.8 presents quantitative data on respondents’ perceptions about factors that 
affected their selection of either the CTBC or the FBTC DOT option. The prominent 
reasons for adopting CTBC (according to the percentages of respondents) were 
having adequate information about TB (91.7%; f=66), having adequate information 
about the DOT option selected (90.3%; f=65), nearness of the DOT option, an 
opportunity for making a personal decision about the DOT option (83.3%; f=60), the 
desire to control TB in the community (76.4%; f=55) and adequate integration of TB 
services with other health care services (75%; f=54).  
 
Based on Chi-squares, the following factors were important: having a chance to 
make a personal decision about CTBC (p=0.021), adequate information about the 
DOT option chosen (p=0.000) and regular TB diagnostic services (p=0.047) were the 
only significant factors for adoption of CTBC by respondents in this study. Previous 
studies in Botswana showed that challenges encountered by laboratory and x-ray 
services contributed to irregular TB service provision (MOH 2011c:37). Moreover, 
access to diagnostic services has been identified as one of the integral factors to the 
CTBC 
 
FBTC for CTBC 
Q19g) Nearness of the DOT option f   
61 
% 
84.7 
f 
26 
%  
89.7 
 
0.718 
Q19h) Awareness of TB patients’ 
rights 
53 73.6 22 75.9 0.734 
Q19i) Adequate integration of TB 
services with other health care 
services 
54 75.0 23 79.3 0.210 
Q19j) Adequate community support 42 58.3 19 65.5 0.272 
Q19k) Adequate TB drug supply  49 68.1 24 82.8 0.135 
Q19l) Regular TB diagnostic 
services 
48 66.7 25 86.2 0.047 
Q19m) Availability of incentives 40 55.6 18 62.1 0.549 
Q19n) Quality of health care services 51 70.8 22 75.9 0.609 
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success of CTBC by the WHO (2010:76). Thus this study’s finding that laboratory 
and x-ray facilities are important considerations influencing TB patients’ treatment 
decisions, has been supported by both the MOH’s and the WHO’s standpoints. 
 
4.6.1.1      Respondents’ reasons for choosing CTBC (n=72) 
 
This section presents the responses for the 72 respondents regarding their reasons 
for choosing CTBC in response to an open ended question. The responses were 
categorised into relevant groups and quantified, providing the following summary:  
- Factors related to convenience (27.8%; f=20) 
- Work-related factors (27.8%;f=20) 
- Health condition-related factors (13.9%;f=10) 
-  Instruction by HCWs (12.5%; f=9) 
- Self-efficacy (6.9%; f=5) 
- Quality of health care services (2.8%;f=2) 
- Treatment-related factors (2.8%; f=2) 
- Self-stigma (2.8%; f=2) 
- Factors related to financial constraints ( 2.8%;f=2) 
 
Although the majority (83.3%; f=60) of CTBC respondents made a personal decision 
to enrol in the programme and as many as 90.3% (f=65) had adequate information 
about this programme, 12.5% (f=9) of the enrolled patients were reportedly 
influenced by HCWs. The MOH recommends adequate health education about DOT 
options so that each patient can select the option most acceptable, accessible, and 
convenient to him/her (MOH 2011b:11). The following verbatim statements illustrate 
some patients’ understanding of the CTBC concept and also of making personal 
choices about the CTBC programme: 
 
“This option helped me to continue working without interruption. The rule at …clinic 
was that a patient takes treatment for two weeks then joins CTBC programme, like it 
or not.” 
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“I was not given a chance to choose a DOT option for myself. I was instructed to take 
treatment at home because my weight had improved and again my sister was there 
to supervise my treatment.” 
 
The convenience of CTBC reported by 27.8% (f=20) of the respondents is consistent 
with the finding that most (84.7%; f=61) of the respondents reported nearness of the 
DOT option as a factor that influenced their choice of CTBC. The choice of the 
programme was also associated with work, ill health and financial status indicating 
the convenience of CTBC to the employed (f=27.8%; f=20), the very ill (13.9%; f=10) 
and the financially constrained persons (2.8%; f=2). The following statements 
present examples of what respondents reported verbatim regarding factors related to 
convenience of CTBC: 
“I was unable to go to the health facility daily.” 
“I had a problem of going to the hospital every morning so community TB care was 
convenient for me.” 
 
The privacy offered by the CTBC was reportedly an influential factor to patients 
experiencing self-stigma (2.8%; f=2). Although the desire to fight TB stigma was not 
rated as a major factor for selecting CTBC programme (65.3%; f=47), as shown in 
table 4.8, the verbatim responses of 2.8% (f=2) of the patients indicate an element of 
stigma in the community. Self-stigma might be exemplified by the following 
statements: 
 
“I chose CTBC because I was not comfortable to take treatment openly at the clinic.” 
“I was shy to collect my treatment at the health facility and it was costly to do that. 
CTBC is convenient for me.” 
 
These statements about self-stigma might be corroborated by findings of other 
studies which indicated that TB patients accept CTBC because of its benefits which 
include enhancement of TB knowledge and reduction of stigma in the community 
(Wandwalo, Makundi, Hasler & Morkve 2006:284-289 cited in Mbongo and Mash 
2010). 
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Other factors not related to the findings reported in section 4.6.1, regarding selection 
of CTBC, include self-efficacy (6.9%; f=5) and treatment-related factors (2.8%; f=2). 
The following statements are examples of self-efficacy as voiced by some patients in 
response to an open-ended question: 
“I felt community TB care was good in that I could take treatment without cheating 
myself.” 
“I chose community TB care because I wanted to be responsible for my treatment.” 
 
4.6.2      Factors influencing respondents’ FBTC option (n=29) 
 
The major reasons for adopting FBTC were reportedly nearness of the DOT option 
(89.7%; f=26), regular TB diagnostic services (86.2%; f=25), adequate TB drug 
supplies (82.8%; f=24), desire to control TB in the community (82.8%; f=24), 
adequate information about TB (79.3%; f=23), awareness of TB patients’ rights 
(75.9%; f=22) and quality of health care services (75.9%; f=22).   
 
4.6.2.1      Responses to an open-ended question for selecting FBTC (n=29) 
 
The following discussion addresses 29 respondents’ reasons for the adoption of 
FBTC in response to an open-ended question.  These responses were categorised 
and quantified (by calculating the frequency and percentage for every category).  
The identified categories were: 
-  Treatment-related factors (37.9%;f=11) 
- Convenience (27.6%; f=8) 
- Instruction by HCWs (27.6%; f=8) 
- Family support-related factors (6.9%; f=2) 
 
Nearness of the FBTC service point was rated by 89.7% (f=26) of the respondents to 
influence them to adopt the FBTC programme. Only 27.8% (f=8) of the respondents 
identified this factor in response to an open-ended question but the following 
statements illustrate their standpoints: 
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- “Most of the time I am at the hospital so it was convenient for me to take 
treatment there.” 
- “I was nearer to the clinic that is why I chose facility based TB care.” 
 
Though respondents had indicated that a chance for a personal decision about 
FBTC (62.1%; f=18) and adequate information about FBTC (55.2%; f=16) influenced 
their adoption of FBTC, 27.6% (f=8) of the respondents reported that they were 
influenced by the HCWs to adopt the FBTC programme. Srinivasan (2009) cited in 
Ncho and Wright (2013) emphasised the importance of health education by stating 
that inadequate knowledge regarding treatment options, might interfere with health 
seeking behaviours.  
 
The following statements demonstrate respondents’ perceptions of HCWs’ 
influences on their decisions: 
- “I have not chosen my DOT option; nurses forced me to take treatment at the 
clinic. I have never been taught about the possibility of taking treatment at 
home.” 
- “They did not give me a choice. I was told to come every day for my 
medication at the clinic.” 
 
The practice of forcing patients to adopt CTBC might impact negatively on TB 
treatment outcomes (MOH 2011b:11) and is contrary to programme implementation 
guidelines in Botswana. The MOH advocates for patients to adopt the DOT option of 
their choice because they might have reasons for adopting CTBC even if they stay 
closer to the clinic (MOH 2011b:11). However, it cannot be derived from the 
available information whether or not the HCWs might have had reasons for advising 
patients to take their TB medicines at the health facilities.  These patients might have 
previously defaulted on their TB treatment, might not have responded to TB 
treatment or might have additional health-related problems such as diabetes, 
alcoholism or hypertension. 
 
Other influencing factors for adoption of FBTC mentioned in response to an open-
ended question but not reflected under section 4.6.2 (in response to closed ended 
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questions) of this dissertation include family support (6.9%; f=2) and treatment-
related factors (37.9%; f=11). Respondents reported as follows: 
- “I chose to collect my treatment from the clinic because at home there was no 
one committed to assist.” 
- “Facility based TB care is a better option, because the health workers give me 
due care as compared to community TB care because sometimes family 
members tend to be negligent and do not care”. 
 
The following statements refer to treatment-related factors that influenced 
respondents to adopt FBTC: 
- “At the clinic the nurse watches you take treatment. At home one cannot be 
sure that you are taking treatment.” 
- “I take treatment at the clinic because I have a five year old on TB treatment.” 
 
4.7      FACTORS INFLUENCING PARTICIPATION OF TB PATIENTS IN THE 
           CTBC PROGRAMME 
 
This section addresses findings of a univariate logistic regression model on factors 
influencing the participation of TB patients in the CTBC programme as presented in 
table 4.10. These variables are treated individually and their individual relationship 
with participation of TB patients in the CTBC programme. The discussion is based 
on the HBM including modifying factors. Odds ratios (OR) are used for categorical 
variables and regression coefficients are used for continuous variables. The OR is 
an “estimate of relative risk used in logistic regression as a measure of association; 
describing the probability of an event” (LoBiondo-Wood & Haber 2010:582). 
Therefore univariate logistic regression analysis was conducted to examine the 
effects of the independent variables on the odds of being enrolled in the CTBC 
programme. The aim of the logistic regression is to determine the accuracy of 
predicting an outcome (CTBC participation) based on one or more predictor 
variables (Burns & Grove 2009:560). 
 
The OR of more than one (OR>1.0) indicates that respondents were likely to be 
influenced by a given variable to participate in the CTBC programme’s activities. On  
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the other hand, the OR of less than one (OR<1.0) indicates that respondents were 
unlikely to be influenced by a given variable to participate in the CTBC programme 
(LoBiondo-Wood & Haber 2010:445; Grove et al 2013:575). A variable with a co-
efficient of greater than zero (positive) was treated as likely to influence participation 
of respondents in CTBC and a variable with a coefficient of less than zero (negative) 
was treated as being unlikely to influence CTBC programme participation.  
 
In the use of univariate logistic regression analysis, some of the categories for 
educational status, religion and marital status had no frequencies. These variables 
were recoded. Age groups of the respondents were categorised into two groups; age 
group 21-35 and age group 36 and older. Age group 21-35 was recoded from the 
following ages: 21-25 (5.9%; f=6), 26-30 (8.9%; f=9) and 31-35, (21.8%; f=22). Age 
group 36 and older was recoded from the following ages; 36-40 (23.8%; f=24), 41-45 
(15.8%; f=16), 46-50 (8.9%; f=9), 51-55 (9.9%; f=10) and 56-60 (5%; f=5) (see table 
4.1).  
 
The educational status of 101 respondents was similarly allocated into two groups, 
up to and including primary education and at least secondary education. The 
respondents with up to primary educational level were recoded from the following 
groups: primary education (24.8%); f=25) and no schooling (14.9%; f=15). Recoding 
for those with at least secondary education was achieved through the following 
groups: secondary (46.5%; f=47), certificate (9.9%; f=10), and diploma and degree 
holders who shared 2% each respectively (see table 4.2).  
 
As for religion, respondents were categorised into Christians and non-Christians and 
recoded from the following groups: Christians (84.2%; f=85) and non-Christians 
(15.8%; f=16), no religious affiliation (11.9%; f=12), traditional African religions and 
Muslims (2%; f=2) each, as shown in table 4.3.  
 
The employment status of respondents was categorised into employed and the 
unemployed. The unemployed (37.6%; f=38) category retained the original code of 
being unemployed while the employed group (62.4%; f=63) were recoded from full 
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time formally employed (38.6%; f=39), self-employed (11.9%; f=12), part-time 
formally employed (6.9%; f=7) and those doing piece jobs (5.0%; f=5) as shown in 
figure 4.2. The marital status was categorised into married and not married and the 
married category (8.9%; f=9) was recoded from the following: married (5.9%; f=6), 
separated (1.0%; f=1), divorced (1.0%; f=1) and widowed (1.0%; f=1). The not 
married category (91.1%; f=92) comprised the following: single (52.5%; f=53), 
cohabiting (25.7%; f=26), being in a committed relationship (12.9%; f=13), as shown 
in table 4.4.  
 
The HBM variables and their modifying factors were constructed from a variety of 
items under different questions in the interview schedule (see annexure 3) and item 
numbers are indicated against each variable in this section. Table 4.9 presents the 
101 respondents’ mean scores in relation to the HBM variables and the modifying 
factors. A mean score that is at or above 50% of the maximum score is treated as 
high and a mean score below 50% is taken to be low. These mean scores were used 
to conduct the regression analyses.  
 
4.7.1        Mean scores for the HBM’s modifying factors 
 
This section addresses mean scores for the HBM’s modifying factors.  
 
4.7.1.1    Patient satisfaction  
 
 
A mean score of 2.03 out of a maximum of 6 represents the following variables of 
patient satisfaction as rated by respondents (with the relevant structured interview 
schedule item number in brackets): 
 Treatment supporters are not difficult to find (18h) 
 Health care providers are committed to CTBC (18i) 
 A chance for a personal decision about my DOT option (19a) 
 Adequate TB drug supply (19k) 
 Regular TB diagnostic services (19n)  
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The mean scores for all items pertaining to patients’ levels of satisfaction with the 
service were below 50% of the maximum score, indicating that the respondents were 
not satisfied with the services.  
 
4.7.1.2      Psychosocial variables      
 
The respondents scored an average of 0.76 out of 2 on psychosocial variables 
based on the following variables: 
 Adequate community support (19j) 
 Availability of incentives (19m) 
 
The mean score of 0.76 for psychosocial variables was below 1 (50% of the 
maximum score of 2), meaning that respondents’ average scores on psycho social 
factors were low.  This implies that the respondents did not receive adequate 
community support and that incentives were not available, according to their 
perceptions. 
 
4.7.1.3      Structural variables  
 
The mean score of respondents on structural variables was 1.53 out of 2 which 
means it was above 50% (or above 1 out of a maximum of 2). This mean score 
means that respondents regarded CTBC services to be adequately integrated into 
other health care services. The structural variables were constructed from the 
following variables: 
- TB/HIV services are well integrated into CTBC (17d) 
- Adequate integration of TB services with other health care services (19i) 
 
4.7.2      The mean scores for the HBM variables 
 
This section addresses the mean scores for the HBM variables. 
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4.7.2.1      Perceived susceptibility 
 
The average score for perceived susceptibility was 2.57 out of 3, indicating that 
respondents’ perceived themselves to be susceptible to TB infections. The variables 
used to construct perceived susceptibility include: 
 TB treatment has to be taken daily under direct supervision (16a) 
 A TB patient who travels has to arrange with the clinic that he/she gets 
enough medicines (16c) 
 CTBC can reduce the number of people who miss TB treatment (18a) 
 
4.7.2.2       Perceived severity 
 
The mean score of the respondents for perceived severity variables was 2.65 out of 
3, showing that respondents were aware of the potential severity of TB infections.  
Perceived severity variables were constructed from the following variables: 
 Missing TB treatment carries the risk of spreading TB that does not respond 
to treatment (16b) 
 A patient with TB of the lungs must have regular sputum checks done (16d) 
 CTBC can increase identification of people with TB of the lungs in the 
community (18b) 
 
4.7.2.3      Perceived benefits       
 
The mean score of respondents on variables of perceived benefits was 1.91. This 
mean score was below 2.5 out of a maximum of 5 indicating that respondents did not 
perceive the CTBC programme to hold many benefits for them.  The perceived 
benefits variable was constructed from the following variables: 
 I do not see the value of CTBC (18d) 
 The programme offers cost saving opportunities (19d) 
 Desire to fight TB stigma (19e) 
 Desire to control TB in the community (19f) 
 Nearness of the DOT option (19g) 
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4.7.2.4    Perceived barriers and enablers 
 
Respondents scored an average of 4.22 out of 6. This mean score shows that 
respondents’ average score for perceived barriers and enablers was high, implying 
that they were aware of some factors that impacted negatively (barriers) and 
positively (enablers) on their utilisation of CTBC services. The following variables 
comprised the variable of perceived barriers and enablers: 
 TB can be cured by traditional medicine (16g) 
 CTBC makes me uncomfortable (18f) 
 It does not feel good to enrol for the CTBC (18g) 
 Adequate community support (19j) 
 Health care providers are committed to the CTBC (18i) 
 Regular TB diagnostic services (19l) 
 
4.7.2.5      Cues to action 
 
The respondents scored an average of 4.31 out of 5 which means respondents were 
aware of factors helping them to adhere to their TB treatment. The following 
variables comprised the cues to action variable: 
 I have been given health education on the importance of taking treatment 
daily (16i) 
 My family has been given health education on the importance of taking 
treatment daily (16j) 
 Adequate information on TB (19b) 
 Adequate information on the DOT chosen (19c) 
 Awareness of TB patients’ rights (19h) 
 
4.7.2.6      Self-efficacy 
 
Regarding motivation, the mean score for respondents was 2.30 out of 5 indicating 
that they might not have perceived themselves to be capable of sustaining their TB 
treatment due to their own efforts.  
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Table 4.9: The HBM variables and modifying factors’ mean scores (N=101) 
 
HBM variables and 
modifying  factors  Mean score 
Maximum  
score 
Perceived susceptibility 
(Max=3) 
2.57 3 
Perceived severity 
(Max=3) 
2.65 3 
Perceived benefits 
(Max=5) 
1.91 5 
Perceived barriers and 
enablers (Max=6) 
4.22 6 
Cues to action (Max=5) 4.31 5 
Motivation (Max=5 2.30 5 
Patient satisfaction 
(Max=6) 
2.03 6 
Psychosocial variables 
(Max=2) 
0.76 2 
Structural factors (Max=2) 1.53 2 
 
The variables which comprised the variable for motivation included: 
 I regularly attend TB support group meetings (27a) 
 I encourage others to seek treatment if they experience possible signs of TB 
(27b)  
 I encourage others to adhere to their TB  treatment (27c) 
 I have publicly given health education on TB-related messages (27d) 
 I am a TB treatment supporter (27e). 
 
 
 
Table 4.10: Univariate logistic regression of factors influencing respondents’  
          participation in the CTBC programme 
 
Covariate   Odds Ratio p-Value 
Age group 21-35 1.26 (0.21, 7.28) 0.7970  
Gender Male 1.23 (0.52, 2.93) 0.6330 
Educational status Up to primary 0.60 (0.24, 1.49) 0.2661 
Employment status Unemployed 0.42 (0.16, 1.11) 0.0800 
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Covariate   Odds Ratio p-Value 
Marital status Not married 1.45 (0.28, 7.45) 0.6536 
Covariate   Odds Ratio p-Value 
The following continuous 
variables have regression 
coefficients reported 
 Coefficient  
TB knowledge  0.11 (-0.25, 0.46) 0.5530 
Treatment knowledge  -0.13 (-0.58, 0.32) 0.5660 
Knowledge of symptoms  0.15 (-0.33, 0.63) 0.5500 
TB/HIV relationship knowledge  -0.08 (-0.53, 0.37) 0.7240 
Knowledge and attitudes 
towards CTBC 
 0.48 (0.22, 0.74) 0.0003 
Traditional beliefs about 
causes of TB  
 -0.07 (-0.50, 0.37) 0.7700 
Perceived susceptibility  -0.05 (-0.82, 0.71) 0.8930 
Perceived severity  -0.35 (-1.20, 0.50) 0.4180 
Perceived benefits  0.30 (-0.23, 0.83) 0.2670 
Motivation  -0.28 (-0.80, 0.25) 0.2997 
Perceived barriers and 
enablers 
 0.47 (0.05, 0.90) 0.0279 
Cues to action  0.31 (-0.09, 0.71) 0.1320 
Patient satisfaction  0.56 (0.05, 1.07) 0.0315 
Psychosocial variables  0.30 (-0.24, 0.85) 0.2743 
Structural variables  -0.05 (-0.65, 0.55) 0.8807 
 
4.7.3      The relationship between modifying factors and the adoption of CTBC 
 
The modifying factors include; demographic characteristics, patient satisfaction, 
psychosocial variables, and structural factors that might have influenced TB patients 
to choose a specific DOT option. This relationship was analysed according to the 
univariate logistic regression findings.  
 
4.7.3.1      The relationship between demographic characteristics and 
                 respondents’ adoption of CTBC 
 
Being a male enhanced participation in CTBC, OR= 1.23.  Respondents in age 
group 21-35 were more likely to participate in CTBC indicating that being younger 
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than 36 years of age, influenced participation in the programme, OR=1.26. 
Respondents who were not married were more likely to participate in CTBC, 
OR=1.45. The patients with up to primary level education and those who were 
unemployed were less likely to participate in CTBC, OR=0.60 and OR=0.42 
respectively. Based on p values higher than 0.05 for demographic characteristics, 
demographic factors did not influence respondents’ adoption of CTBC.  Although not 
statistically significant these findings are consistent with findings of other studies in 
which socio-economic and demographic factors reportedly influenced health seeking 
behaviours. Examples of such studies include; Li et al (2013:156), Saifodine 
(2013:559) and Ahmad et al (2013:51-57).  Contrary to these findings another study 
reported that knowledge about TB and demographic factors, including age and 
educational levels, were surpassed by attitudes and perceptions such as 
stigmatisation of TB (Cramm et al 2010:72).   
 
4.7.3.2      The relationship between patients’ satisfaction and adoption of  
                 CTBC 
 
Patients’ satisfaction levels with the health care services were likely to influence their 
selection of a specific DOT option with a coefficient of 0.56 and these findings were 
statistically significant, p=0.0315. Patient satisfaction factors such as regular 
treatment supplies, cautious identification of supporters and being close to the 
patients’ dwelling places were found to be vital to health seeking behaviour 
(adherence) of patients on CTBC (Mkopi et al 2012:e51828). Factors linked to 
patient satisfaction such as lack of confidence of health care workers in community 
oriented initiatives had previously posed challenges to the CTBC programme in 
Botswana (MOH 2013a:12).  
 
However 70.8% (f=51) of respondents on CTBC indicated that quality of health care 
services influenced them to adopt the programme (see table 4.8). The patients’ 
responses to open-ended questions showed mixed feelings of respondents about 
their choice of DOT options as shown in section 4.6.1.1. Reportedly some patients 
did not choose the CTBC DOT option as HCWs reportedly made this decision for a 
few patients (12.5%; f=9).  However, the reasons for these reported actions of the 
HCWs are unknown.  It is possible that there might have been valid reasons why 
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HCWs made this decision in the patients’ best interests. As many as 83.3% (f=60) of 
the respondents on CTBC selected the programme out of their own free will and 
90.3% (f=65) understood what CTBC programme encompassed (see table 4.8). 
These findings are consistent with findings of respondents’ knowledge about and 
attitudes towards CTBC in which the overall mean score of respondents was 7.15 
out of 10, indicating good knowledge levels and positive attitudes (see table 4.6).  
 
4.7.3.3       The relationship between psychosocial variables and the adoption  
                  of CTBC 
 
A coefficient of 0.30 indicates that psychosocial variables were likely to have 
influenced the adoption of CTBC. However, p= 0.2743 implies that psychosocial 
variables did not influence the adoption of CTBC (see table 4.10). There might be 
reasons as to why psychosocial variables in this study did not influence adoption of 
CTBC such as the small sample of 101 respondents.  
 
The following sources might exemplify the importance of psychosocial variables in 
health care seeking behaviours. The Botswana TB ACSM advocates for tackling of 
psychosocial, cultural and financial barriers to enhance the successful 
implementation of the “Stop TB Strategy” (MOH 2013a:7) including CTBC. A study 
conducted in South-Africa about non-uptake of HIV testing showed that there was a 
need for concerted efforts to involve individuals in the “social support networks” of 
patients to offer sustained support and motivation (Kigozi, Heunis, Wouters & Van 
Den Berg  2011:110).  
 
4.7.3.4      The relationship between structural variables and adoption of CTBC 
 
Structural factors were insignificant influences in the patients’ choice of CTBC as 
their preferred DOT option in this study, with a coefficient of -0.05 and p=0.8807. 
Previous studies in Botswana indicated that structural factors posed barriers to 
CTBC such as the integration of TB/HIV into community TB services which showed 
that such incorporation happened on a small scale only (MOH 2013b:12-13).  
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4.7.4       The relationship between TB knowledge variables and adoption of  
               CTBC 
 
Findings in this section show that TB knowledge and knowledge about TB symptoms 
were likely to influence the respondents’ participation in CTBC, with coefficients of 
0.11 and 0.15 respectively. Knowledge and attitudes towards CTBC were likely to 
enhance participation in CTBC, with a coefficient of 0.48 and these findings were 
statistically significant, p=0.0003. Tuberculosis treatment knowledge, with a 
coefficient of -0.13, TB/HIV relationship knowledge with a coefficient of -0.08, and 
traditional beliefs about causes of TB with a co-efficient of -0.07, were unlikely to 
influence respondents’ participation in CTBC. In view of a p value of less than 0.05, 
the only TB-related knowledge variable that was associated with adoption of CTBC 
was knowledge and attitudes towards CTBC (see table 4.10). As indicated by a 
significance level of p=0.0003, the predictor for adoption of CTBC was respondents’ 
knowledge and attitudes towards this programme (see table 4.10). In another study 
TB patients emphasised the importance of diffusion of TB/HIV relationship 
information in their decision making about HIV testing (Kigozi et al 2011:110) 
indicating the importance of knowledge in health seeking behaviours.  
 
The descriptive information of the current study’s findings, as shown in table 4.6, 
shows a mean score of 7.15 out of 10 on knowledge and attitudes of respondents 
towards CTBC.  This indicates that patients were knowledgeable about and had 
positive attitudes towards CTBC. Based on the 2012 low uptake of CTBC in Lobatse 
(63.5%), the assumption of this study as indicated in section 1.8.3 was that TB 
patients might have had limited knowledge about CTBC in Lobatse which could 
impact negatively on their utilisation of CTBC services in this area. However, the 
respondents in this study had high levels of knowledge and positive attitudes which 
might have influenced their improved uptake levels of CTBC to 71.3% (f=72). 
Previous observations of CTBC knowledge amongst patients in Botswana were 
reportedly limited which was associated with the low uptake of the programme 
(Masisi 2011).  
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4.7.5      The relationship between the Health Belief Model’s variables and the 
              adoption of CTBC 
 
The HBM variables discussed in this section include perceived susceptibility, 
perceived severity, perceived benefits, and perceived barriers and enablers. Other 
relevant variables include cues to action and self-efficacy. Their relationship to the 
adoption of CTBC was analysed through the univariate logistic regression model as 
shown in table 4.10.  
 
 Perceived susceptibility  
 
TB patients’ beliefs about their susceptibility to default TB treatment was unlikely to 
have an impact on these patients’ choice of CTBC, with a co-efficient of -0.05 and 
these findings were statistically insignificant, p=0.8930 (see table 4.10). Literature 
shows that susceptibility falls within the vital perceptions for informing decisions 
about adoption of healthier behaviours (Weitz 2013:38; Glanz et al 2008, cited in 
Remocker & Shea 2011) which in the context of this study is CTBC.  
 
 Perceived severity 
 
The TB patients’ beliefs about the seriousness of TB, defaulting TB treatment and 
not getting cured from TB were unlikely to have influenced their selection of the 
CTBC DOT option, with a coefficient of 0.35 but these findings were statistically 
insignificant, p= 0.4180 (see table 4.10). The reviewed literature indicated that 
perceived severity influences health seeking behaviours (Weitz 2013:39; Glanz et al 
2008, cited in Remocker & Shea 2011).  
 
 Perceived benefits 
 
The belief that embracing CTBC will offer convenience and significantly reduce the 
risk of spreading TB in the community was likely to have influenced respondents to 
adopt the CTBC option, with a coefficient of 0.30 but these findings were statistically 
insignificant, p=0.2670 (see table 4.10). Perceived benefits have been shown in 
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previous studies’ findings to influence health seeking behaviours (Weitz 2013:39; 
Glanz et al 2008, cited in Remocker & Shea 2011)).  
 
 Perceived barriers and enablers 
 
Beliefs about barriers and enablers, influencing respondents’ participation in the 
CTBC programme, were likely to have influenced adoption of the programme, with a 
coefficient of 0.47. These findings were statistically significant with p=0.0279 
suggesting that barriers and enablers influenced respondents’ adoption of the CTBC 
option (see table 4.10).  Perceived barriers and perceived susceptibility are the main 
predictors of healthy behaviours according to Ogden (2012:50).  
 
 Cues to action  
 
Health education offered to patients and their families was likely to have influenced 
the adoption of CTBC, with a coefficient of 0.31 and p=0.1320. This p value 
exceeding 0.05 suggests that cues to action did not influence the respondents’ 
adoption of CTBC (see table 4.10).The reviewed literature shows that health seeking 
behaviour is also influenced by cues to action (Weitz 2013:39).   
 
 Self-efficacy  
 
The respondents’ motivation to achieve TB treatment cure outcomes was unlikely to 
have influenced respondents to adopt CTBC, with a coefficient of -0.28 and these 
findings were statistically insignificant at p=0.2997. On the basis of these findings, 
self-efficacy did not influence adoption of CTBC (see table 4.10). However self-
efficacy was one of the emerging themes under the discussion of information 
obtained in response to the open-ended questions in section 4.6.1.1 though reported 
by the minority (6.9%; f=5). Self-efficacy has been cited as an influencing factor in 
adoption of behaviour change in the reviewed literature (Glanz et al 2008, cited in 
Remocker & Shea 2011).  
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4.8       SUMMARY 
 
This chapter presented the demographic characteristics of respondents, as well as 
their knowledge about TB, their knowledge and attitudes towards CTBC, their 
perceptions about factors affecting the selection of their DOT option and factors 
influencing participation of TB patients in the CTBC programme.  
 
The descriptive statistics indicate that the respondents’ knowledge about signs and 
symptoms of TB varied with gender p=0.032.  There was a good chance that 
respondents made their own personal decisions about the selection of their preferred 
DOT option with p=0.021.  
 
Having adequate information about CTBC (p=0.000) and having access to regular 
TB diagnostic services (p=0.047) were predictors of adopting CTBC. After controlling 
for confounding variables through logistic regression, it was found that the main 
predictors for participation of the respondents in CTBC included, knowledge and 
attitudes towards CTBC (p=0.0279), perceived barriers and enablers towards this 
programme, and patient satisfaction about this programme (p=0.0315). Findings, 
obtained in response to open-ended questions, indicated the adoption of a DOT 
option was influenced by patient-related factors, socio-cultural related factors, socio-
economic-related factors, structural-related factors and health system-related 
factors.  Reportedly a minority of the respondents were influenced by HCWs to 
select a specific DOT option, but there might have been valid reasons for such 
influences from the HCWs which could not be ascertained on the basis of the 
available information obtained during the structured interviews.  
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CHAPTER 5 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
 
 
5.1      INTRODUCTION  
 
The main purpose of this study was to assess factors affecting the uptake of CTBC, 
as experienced by TB patients (aged 21 to 64) in the Lobatse region of Botswana.  
Based on these research findings, recommendations would be made to enhance the 
uptake of the CTBC programme in this area. Contrary to what was planned earlier 
on, the discussion addresses findings for age group 21-60 only. This is so because 
no respondents were older than 60. The research results, presented and discussed 
in chapter 4 of this dissertation, form the basis for answering the research questions 
which were formulated in Chapter 1 as follows: 
 What do patients know about TB? 
 What do patients know and think about CTBC? 
 How do patients support the CTBC programme? 
 What do patients perceive as factors influencing the adoption of a specific 
DOT option? 
 What factors influence participation of TB patients in the CTBC programme?   
 
5.2      FINDINGS, CONCLUSIONS AND RECOMMENDATIONS IN TERMS OF  
 THE  STUDY’S OBJECTIVES 
 
In order to determine whether the objectives of the study were met, each objective 
will be listed and relevant findings will be presented so that conclusions can be 
drawn and recommendations can be made in the same subsection in order to avoid 
unnecessary repetitions. 
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5.2.1  Determining patients’ knowledge about TB 
 
5.2.1.1   Findings 
 
The 101 respondents had mean scores that exceeded 50% of the maximum scores 
in all TB-related knowledge variables, indicating that the majority were 
knowledgeable about TB identification (6.87 out of 9), signs and symptoms of TB 
(3.72 out of 5), treatment (9.48 out of 10),  and the TB/HIV relationship (3.84 out of 
5). The overall mean score for traditional beliefs about causes of TB indicated that 
most respondents knew that traditional healers might be unable to cure TB (1.41 out 
of 3). The mean scores for knowledge about signs and symptoms of TB were higher 
than 50% of the maximum scores averaging for males (3.91 out of 5) and for females 
(3.54 out of 5) and a p value of 0.032 suggests that men were more knowledgeable 
about TB signs and symptoms than women. Out of the 72 CTBC respondents, 
91.7% (f=66) had received adequate information about TB and of the 29 FBTC 
respondents 79.3% (f=23) had received adequate information about TB, implying 
that the CTBC respondents had reportedly received more and/or better TB-related 
information than those patients who opted for the FBTC.  
 
5.1.1.2  Conclusions 
 
This study’s respondents were knowledgeable about TB but CTBC respondents had 
slightly better TB knowledge than FBTC respondents and men were slightly more 
knowledgeable than women.  
 
5.1.1.3  Recommendations 
 
The HCWs should be informed that the TB patients were knowledgeable about TB-
related aspects and be congratulated with this achievement.  However, health 
education about TB should be sustained and reinforced at every visit to the clinic. 
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5.2.2 Identifying patients’ knowledge about and attitudes towards CTBC 
 
5.2.2.1   Findings 
 
The overall mean score for patients’ knowledge and attitudes regarding CTBC (7.15 
out of 10) indicates that the majority were knowledgeable about and had positive 
attitudes towards CTBC. However, as the 72 respondents on CTBC did not score 10 
out 10, there is still a need to scale-up CTBC-related health education in Lobatse. 
The responses discussed in section 4.6.1.1 of this dissertation show that some 
patients (12.5%; f=9) might not have been taught about CTBC and might not have 
made their own independent decisions to adopt this programme.  However, there 
might have been valid reasons for HCWs’ actions in this regard, such as previous 
defaulting, hypertension, alcoholism, diabetes mellitus or being HIV-positive. 
 
5.2.2.2  Conclusions 
 
Most, but not all, respondents knew about CTBC and had positive attitudes about 
CTBC.  A few respondents did not make their own independent decisions about 
adopting a specific DOT option. 
 
5.2.2.3   Recommendations 
 
Future research should identify TB patients who lack CTBC information and find out 
which factors might have impacted negatively on their knowledge levels in order to 
address such aspects during future health education sessions.  Future research 
should adopt both quantitative and qualitative research designs and involve both TB 
patients and HCWs to identify whether, and if so why, HCWs do not encourage all 
TB patients to decide independently on their DOT option. 
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5.2.3 Determining whether TB patients support the CTBC programme 
 
5.2.3.1   Findings 
 
Based on an overall mean score of 2.84 out of 5 for the 101 respondents, support for 
the CTBC programme was slightly above average in Lobatse. However, support of 
the CTBC programme, provided by CTBC patients who completed their TB treatment 
(n=58) was below average on attendance of TB support group meetings (12%; f=7), 
in publicly giving TB-related health education (41.4%; f=24) and being treatment 
supporters (44.8%; f=26).  
 
However, 70.7% (f=41) of the respondents encouraged others to seek treatment and   
to adhere to their treatment (75.9%; f=44). As many as 73.6% (f=53) of the 72 
respondents on CTBC and 75.9% (f=22) of respondents on FBTC were reportedly 
aware of TB patients’ rights.   
 
5.2.3.2    Conclusions  
 
Most respondents supported the CTBC programme. Few patients who completed 
their TB treatment on the CTBC programme, attended TB support group meetings, 
provided TB-related health education in public or were TB treatment supporters. 
 
5.2.3.3   Recommendations 
 
Future research should attempt to identify reasons why not all patients supported the 
CTBC programme’s activities and suggest ways of addressing any identified 
shortcomings.  While TB patients receive treatment, they should be informed about 
TB support group meetings and invited to attend these meetings.  At such meetings 
TB patients, who have completed their treatment, should receive information about 
and be encouraged to practise providing TB-related health education to the 
community.   
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5.2.4 Determining respondents’ perceptions about factors influencing their 
adoption of a specific DOT option 
 
5.2.4.1    Findings 
 
Based on the findings of p=0.021, p=0.000 and p=0.047, self-determination, 
adequate information about CTBC and regularly available TB diagnostic services 
influenced patients’ choice of DOTS option. The responses to open-ended questions 
indicated that adoption of a specific DOT option was based on patient-related 
factors, socio-cultural-related factors, socio-economic-related factors, structural-
related factors and health system-related factors. 
 
5.2.4.2   Conclusions 
 
Patients’ selection of CTBC or FBTC was influenced by the perceptions of their own 
self-determination, the adequacy of their information about CTBC and the availability 
of TB diagnostic services.  However, TB patients’ selection of a specific DOT option 
was also influenced by numerous other factors related to the patients themselves, 
socio-cultural aspects, socio-economic issues, structural factors and aspects related 
to the health system itself. 
 
5.2.4.3    Recommendations 
 
Future qualitative and quantitative studies should attempt to identify and prioritise  
TB patients’ perceptions about the mentioned aspects that might influence their 
decisions about their selected DOT option.  It is vital that such factors should be 
identified, prioritised and addressed if Botswana’s MOH aims to treat more TB 
patients in the CTBC programme in future. 
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5.2.5       Factors influencing participation of TB patients in the CTBC 
 
5.2.5.1    Findings 
 
The findings based on the logistic regression, indicate that the main predictors for 
participation of the respondents in CTBC included knowledge and attitudes towards 
CTBC (p=0.0003), perceived barriers and enablers impacting on this programme 
(0.0279) and patients’ satisfaction levels with this programme, p=0.0315. 
 
5.2.5.2   Conclusions 
 
TB patients are more likely to select the CTBC DOT option if they have adequate 
knowledge about this programme, if their attitudes are positive towards it, if they can 
overcome barriers and utilise enablers to implement the CTBC option. 
 
5.2.5.3   Recommendations 
 
Not only TB patients but all community members should be informed about TB, and 
especially about the CTBC programme.  Sustained evaluations should be conducted 
about TB patients’ experiences of the CTBC programme and any identified 
shortcomings should be addressed. Patients should be assisted to identify and 
address barriers and enablers that might impact on their selection of the CTBC 
option. 
 
5.3      LIMITATIONS OF THE STUDY 
 
The research findings might be limited to TB services offered by the GOB in the 
Lobatse area only, because the study was conducted in government health facilities 
implementing the BNTP guidelines about CTBC in Lobatse.  The sample might not 
be representative of all public health facilities in Botswana that implement the same 
policy. Lobatse is an urban area and rural areas might encounter different challenges 
in implementing a CTBC programme. 
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The study had initially planned to recruit 144 respondents but due to various reasons 
such as deaths, ill-health, lack of contacts and relocations, 43 of the prospective 
respondents could not be reached.  
 
The BNTP policy guidelines for CTBC were launched in 2011 in Botswana.  
Consequently only two years had elapsed since this implementation of the CTBC 
guidelines and the collection of data for this study.  This relatively short period of 
time since the implementation of the CTBC guidelines, might have impacted on the 
respondents’ answers to some questions during the structured interviews. 
 
This study was quantitative, using only structured interviews to collect data, hence  
indepth information about factors affecting the uptake of CTBC in Lobatse might not 
have been obtained.  
 
5.4       CONCLUDING REMARKS 
 
Although progress, in terms of meeting CTBC programme targets, was evident in 
Lobatse, efforts should be intensified to involve the community and patients who 
have completed their TB treatment to advance CTBC programme implementation in 
this area. These patients could become treatment supporters and be part of the 
ACSM strategy. They could also assist in reaching hard to reach TB patients and TB 
defaulters in the area and thereby help to improve treatment outcomes. Existing 
knowledge gaps about TB and CTBC need to be addressed to enhance treatment 
outcomes and also to help in scaling up the uptake of the CTBC programme. The 
Lobatse DHMT has to enhance enablers and deal with barriers impacting on the 
adoption of CTBC. Patients’ satisfaction issues regarding CTBC should be monitored 
consistently.  
 
Effective implementation of the CTBC programme in Lobatse, in Botswana and in 
many other countries, could help to improve TB treatment outcomes, offer affordable 
TB treatment to many TB patients, reduce the incidence and prevalence figures of 
TB in specific communities, combat MDR TB and XDR TB and reduce TB-related 
morbidity and mortality statistics.  These objectives can only be attained if TB 
patients adopt the CTBC DOT option and if the health services provide effective 
106 
 
health education, support, diagnostic services and medicines.  More could be 
achieved if TB patients who completed their treatment could become treatment 
supporters and health educators.  These aspects need to be addressed by the 
GOB’s health services in Lobatse to enhance the positive outcomes of the CTBC 
programme in Lobatse, and probably throughout Botswana  . 
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STRUCTURED INTERVIEW SCHEDULE: PATIENTS 
RESEARCH PROJECT: FACTORS AFFECTING THE UPTAKE OF CUMMUNITY TUBERCULOSIS 
CARE AS EXPERIENCED BY PATIENTS IN LOBATSE DISTRICT OF BOTSWANA. 
Instructions  to the interviewers: 
Where required please indicate your interviewee’s answer with a cross (X) in the appropriate 
box or write a response in the space provided, using a black ballpoint pen. For the open-
ended questions, please write your interviewee’s responses clearly and legibly in the space 
provided.  
 
Respondent Code Number ------------------Interviewer number ----------------Date of interview  
SECTION A: BIOGRAPHICAL DATA 
 
 
Indicate your interviewee’s choice by marking the appropriate selected blank block with an “X”. 
 
 
The following questions are for statistical purposes only. 
 
Q1. Gender:    
Male 1  
Female 2  
 
Q2. Age in years:         
21 – 25 years      1  
26 – 30 years 2  
31-35 years 3  
36 – 40 years 4  
41 – 45 years 5  
46-50 years 6  
51-55 years 7  
56-60 years 8  
61-64 years 9  
 
 
 
  2  
 
Q3. Educational status:      
No schooling 1  
Primary 2  
Secondary (Junior/Senior) 3  
Certificate 4  
Diploma 5  
Degree 6  
Masters 7  
PHD 8  
Others (specify) 
............................................................. 
9  
 
Q4. Religion: 
 
Christian 1  
Muslim 2  
Traditional African 3  
No affiliation 4  
Others (specify) 
............................................................. 
5  
 
Q5. What is your employment status? 
 
Unemployed 1  
Full time formally employed 2  
Part-time formally employed 3  
Self employed 4  
Others (specify) 
............................................................. 
5  
 
 
 
  3  
 
 
Q6. What is your home language? 
------------------------------------------------------------------------------------------------------------- 
 
Q7.  What is your marital status? 
Single 1  
In a committed relationship with a man 2  
In a committed relationship with a woman 3  
In an open relationship (multiple partners) 4  
Co-habiting (living together) 5  
Married 6  
Separated 7  
Divorced 8  
Widowed 9  
Others (specify) 
............................................................. 
10  
 
Q.8. Who do you normally live with? 
 
Alone 1  
Spouse 2  
Parents 3  
Others (specify) 
............................................................. 
4  
 
 
 
 
 
 
 
 
 
  4  
 
SECTION B: TB KNOWLEDGE 
 
Q9. When were you first diagnosed with TB? Please state the month next to the appropriate year. 
2009 1  
2010 2  
2011 3  
2012 4  
2013 5  
Others (specify) 
............................................................. 
6  
 
Q10. What type of TB were you diagnosed with? 
 
Lungs 1  
Other parts of the body 2  
 
 
Q11. Which of the following signs and symptoms led you to seek treatment? Please state each  
         sign or symptom that  applies to you. 
 
Coughing for ‹ 2 weeks 1  
Coughing for › 2 weeks 2  
Coughing up blood 3  
Chest pains 4  
Shortness of breath 5  
Sweating at night 6  
Fever 7  
Loss of appetite 8  
Loss of weight 9  
Others (specify) 
............................................................. 
10  
 
 
  5  
 
Q12.      How long did the above signs and symptoms take before seeking medical help? 
------------------------------------------------------------------------------------------------------------------------------- 
 
 
 
Q13.Where did you first go for treatment when you experienced signs and symptoms of TB? 
 
Health facility 1  
Herbalist  2  
Traditional doctor 3  
Sangoma 4  
Church 5  
Others (specify) 
............................................................. 
6  
 
 
Q14. Please indicate whether the following statements are true or false in terms of Identification of 
TB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Question Statement 
True False 
Do 
not 
know 
Q14a) TB  is preventable 1 2 3 
Q14b)  TB  is curable  1 2 3 
Q14c) Coughing without covering the mouth by a patient 
with TB of the lungs can spread TB germs and 
infect other persons without TB 
1 2 3 
Q14d) Sneezing by a patient with TB of the lungs    can 
cause TB infection of  other people 1 2 3 
Q14e) TB of the lungs  is spread through talking 1 2 3 
Q14f)  Plenty of fresh air reduces the chances of 
spreading TB 1 2 3 
Q14g) Covering the mouth and nose with hands when 
coughing or sneezing is an effective way of 
preventing the spread of TB germs. 
1 2 3 
Q14h) TB infected sputum can spread TB germs and 
infect other people with TB 1 2 3 
Q14i) People living with a TB patient have a low risk of 
getting TB 1 2 3 
  6  
 
 
Q15. Please indicate whether each of the following TB-related statements is true or false  
 
 
 
 
 
 
 
 
Q16. Please indicate whether each of the following TB treatment-related statements is true or false  
 
 
 
 
 
 
 
 
 
 
 
 
 
Q17. Please indicate whether each of the following TB/HIV-related statements is true or false  
 
 
 
 
 
 
 
 
 
Question Statement 
True False 
Do 
not 
know 
Q15a) Coughing for more than two weeks  1 2 3 
Q15b) Fever for  two days  1 2 3 
Q15c) Shortness of breath with persistent cough 1 2 3 
Q15d) Chest pains with night sweats  1 2 3 
Q15e) Blood stained sputum  1 2 3 
Q15f) TB is caused by poisoning “sejeso”  1 2 3 
Q15g) Thibamo “birth complications” spread TB 1 2 3 
Q15h) Sleeping with a widow/ widower spreads TB 1 2 3 
Question Statement 
True False 
Do 
not 
know 
Q16a) TB treatment has to be taken daily under direct 
supervision 1 2 3 
Q16b) Missing TB treatment carries the risk of spreading 
TB that does not respond to treatment 1 2 3 
Q16c) A TB patient who travels has to arrange with the 
clinic that he/she gets enough medicines 1 2 3 
Q16d) A patient with TB of the lungs must have regular 
sputum checks done 1 2 3 
Q16e) A TB patient has to know the drugs he/she takes  1 2 3 
Q 16f) A TB patient has to know side effects of drugs 
he/she takes 1 2 3 
Q16g) TB can get cured by traditional medicine 1 2 3 
Q16h) Healthy food is an important factor to cure TB 1 2 3 
Q 16i) I have been given health education on the  
importance of taking treatment daily 1 2 3 
Q 16j) My family has been given health education on the  
importance of taking treatment daily 1 2 3 
Question Statement 
True False 
Do 
not 
know 
Q17a) A person can suffer  from TB and HIV at the same 
time 1 2 3 
Q17b) All TB patients should be  examined for HIV 1 2 3 
Q17c)  Early treatment of TB and HIV can improve the 
chances of curing TB 1 2 3 
Q17d) TB/HIV services are well integrated into CTBC  1 2 3 
Q17e) HIV infection is a definite cause of TB 1 2 3 
  7  
 
 
SECTION C:  CTBC KNOWLEDGE AND ATTITUDES 
Q18. Please rate each of the following as “Yes”, or “No”, or “Uncertain”.   
 
 
 
 
 
 
 
 
 
 
 
 
 
SECTION D: DOT OPTION 
Q19. Please indicate factors that are likely to have influenced your current DOT option as (either 
FBTC or CTBC) “Yes”, or “No”, or “Uncertain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Question Statement  Yes  No Uncertain 
Q18a) Can reduce the number of 
people who miss TB treatment 
1 2 3 
Q18b) Can increase the identification 
of people with TB of the lungs 
in the community 
1 2 3 
Q18c) Has been fully explained to 
me 
1 2 3 
Q18d) I do not see the value of the 
CTBC 
1 2 3 
Q18e) I have already enrolled in  the  
CTBC 
1 2 3 
Q18f) CTBC makes me 
uncomfortable 
1 2 3 
Q18g) It does not feel good to enroll 
for the CTBC 
1 2 3 
Q18h) Treatment supporters are not 
difficult to find 
1 2 3 
Q18i) Health care providers are 
committed to the CTBC 
1 2 3 
Q18j) I am tired of learning about the  
CTBC  
1 2 3 
Question Statement  Yes  No Uncertain 
Q 19a) A chance for a personal 
decision about my dot option 
1 2 3 
Q19b) Adequate information on TB 1 2 3 
Q19c) Adequate information on the 
DOT option chosen  
1 2 3 
Q19d) Cost saving opportunities 1 2 3 
Q19e) Desire to fight TB stigma 1 2 3 
Q19f) Desire to control TB in the 
community 
1 2 3 
Q19g) Nearness of the DOT option 1 2 3 
Q19h) Awareness of TB patients’ 
rights 
1 2 3 
Q19i) Adequate integration of TB 
services with other health care 
services  
1 2 3 
Q19j) Adequate community support 1 2 3 
Q19k) Adequate TB drug supply  1 2 3 
Q19l) Regular TB diagnostic 
services 
1 2 3 
Q19m) Availability of incentives 1 2 3 
Q19n) Quality of health care services  1 2 3 
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Question 19o) – briefly explain reasons for your choice of DOT option over the other 
------------------------------------------------------------------------------------------------------------------ 
----------------------------------------------------------------------------------------------------------------- 
----------------------------------------------------------------------------------------------------------------- 
 
SECTION E: TB AND MY RESPONSIBILITIES 
Q20.  Are you currently on TB treatment? 
Yes 1  
No 2  
 
Q21. When did you start TB treatment? Please indicate the month and year. 
 
……………………………………………………………………………………………………………………… 
Q22a. Have you completed your treatment? 
Yes 1  
No 2  
 
Q22b.   If yes, when did you complete your treatment? Please indicate the month and year. 
……………………………………………………………………………………………………………………… 
Q22c. If no, please state the reasons for having not completed your treatment? 
 ……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
Q23a. Are you cured of TB? 
Yes 1  
No 2  
 
Q23b. If no, please state the reasons for not being cured? 
…………………………………………………………………………………………………………………… 
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…………………………………………………………………………… ……………………………………… 
…………………………………………………………………………………………………………………… 
 
Q24a. Have you ever missed a dose of your treatment? 
Yes 1  
No 2  
 
Q24b. If yes, for how long did you miss your treatment dosage? 
1 day 1  
2 days 2  
Others (specify) 
............................................................. 
3  
 
Q24c. Please state the reasons for missing your treatment 
----------------------------------------------------------------------------------------------------------------------------- 
----------------------------------------------------------------------------------------------------------------------------- 
----------------------------------------------------------------------------------------------------------------------------- 
 
Q25a. Have you ever been re-started on treatment?  
Yes 1  
No 2  
 
Q25b. if yes, please state the reasons you were re-started on treatment?  
…………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………… 
 
Q26a. Have you ever stopped taking your treatment? 
Yes 1  
No 2  
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Q26b. If yes, for how long did you stop taking your treatment? 
‹ a month 1  
1 month 2  
2 months 3  
Others (specify) 
............................................................. 
4  
 
Q26c. If yes, please state the reasons for stopping treatment? 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
 
Q27. Please rate each of the following TB patient- related responsibility statements as “Yes”, or 
“No”, or “Uncertain”. 
 
 
 
 
 
 
 
 
 
 
Q28a. Have you done your sputum checks regularly? 
Yes 1  
No 2  
 
Q28b. If no, please state the reasons for failure to do sputum checks regularly. 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
Question Statement Yes No Uncertain 
Q27a) I regularly attend TB 
support group meetings 1 2 3 
Q27b) I encourage others to 
seek treatment if they 
experience possible signs 
of TB 
1 2 3 
Q27c) I encourage others to 
adhere to their TB 
treatment 
1 2 3 
Q27 
d) 
I have publicly given 
health education on TB 
related messages 
1 2 3 
Q27e) I am a TB treatment 
supporter    
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……………………………………………………………………………………………………………………… 
 
Q29.  Any other comments? 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
Thank you for answering my questions. 
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Reference number of re MOALO WA THULAGANYO YA POTSOLOTSO: BALWETSE 
LENANEO LA PATLISISO: MABAKA A A AMANANG LE KAMOGELO YA LENANEO LA 
TLHOKOMELO YA MOLWETSE WA TB KWA LWAPENG JAAKA LE ITEMOGELWA KE BALWETSE 
MO KGAOLONG YA LOBATSE MO BOTSWANA. 
Ditaelo go ba botsolotsi: 
Fa go tlhokegang teng o kopiwa go supa karabo ya moarabi ka letshwao la sefapano (X) mo 
lebokosong le le lebanyeng kana kwala karabo mo phatlheng e o e filweng, o dirisa pene e 
ntsho. Mo dipotsong tse di tlhokang tlhaloso, o kopiwa go kwala dikarabo tsa moarabi ka 
tsela ee tlhaloganyesegang le mokwalo o o balegang mo phatlheng e o e filweng. 
 
Nomoro ya sephiri ya moarabi------------- nomoro  ya mmotsolotsi ------------letsatsi la potsolotso 
 
KAROLO YA NTLHA: DINTLHA KA BOTSHELO JWA GAGO 
 
Supa tlhopho ya moarabi ka go dirisa letshwao la sefapano “X”mo lebokosong le le senang 
sepe lele lebanyeng. 
 
Dipotso tse di latelang ke tse di dirisediwang go itse dipalo fela. 
 
  Potso 1.     Bong: 
Monna 1  
Mosadi 2  
 
 
 
 
 
Potso 2. Dingwaga tsa matsalo:  
     
21 – 25        ya  dingwaga 1  
26 – 30        ya dingwaga 2  
31-35          ya  dingwaga 3  
36 – 40       ya dingwaga 4  
41 – 45       ya dingwaga 5  
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46-50          ya  dingwaga 6  
51-55          ya dingwaga 7  
56-60          ya dingwaga 8  
61-64          ya dinwaga  9  
 
Potso 3. Seemo sa thutego: 
 
Ga ke a tsena sekole 1  
Sekole se se botlana 2  
Sekole se se golwane (fomo 2/3/5) 3  
Setlankana  4  
Dipoloma 5  
Digarata 6  
Dimastas 7  
PHD 8  
Tse dingwe (tlhalosa)  
............................................................. 
9  
 
Potso 4. Tumelo: 
Mokeresete 1  
Mommoseleme 2  
 Badimo 3  
 Ga kena tumedi 4  
Tse dingwe (Tlhalosa) 
............................................................. 
5  
 
  Potso 5.  Maemo a tsa pereko? 
Ga ke bereke 1  
Phiro e e tlhomameng 2  
Phiro ya nakwana 3  
ke a  ipereka 4  
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Tse dingwe (tlhalosa) 
............................................................. 
5  
 
 
Potso 6. Teme ya gaeno ke efe ? 
 
----------------------------------------------------------------------------------------------------------------- 
 
Potso 7.  Seemo sa nyalo ya gago ke sefe? 
Gake a nyala/ nyalwa 1  
Botsalano jo bo tlhoafetseng le monna 2  
Botsalano jo bo tlhoafetseng le mosadi 3  
Ke na le bakapelo ba le bantsi 4  
Re nna mmogo re sa nyalana 5  
Nyetse/ Nyetswe 6  
 Re kgaogane  e se ka fa molaong 7  
Tlhadile/tlhadilwe 8  
Tlhokafaletswe 9  
Tse dingwe (Tlhalosa) 
............................................................. 
10  
 
Potso 8.  Ka gale o nna le mang? 
ke le esi 1  
Monna/ Mosadi wa lenyalo 2  
 Batsadi 3  
Tse dingwe (Tlhalosa) 
............................................................. 
4  
 
KAROLO YA BOBEDI: KITSO KA TB 
Potso 9. O tshwerwe ka TB leng ele lantlha?  O kopiwa go supa kgwedi e e tsamaelang le ngwaga 
e e lebanyeng. 
 
2009 1  
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2010 2  
2011 3  
2012 4  
2013 5  
Tse dingwe (Tlhalosa) 
............................................................. 
6  
 
 
Potso 10. O tshwere ka mofuta o fe wa TB? 
 Mafatlha 1  
 Dikarolo tse dingwe tsa mmele 2  
 
Potso 11. Ke dife  dikai tse dilatelang tse di dirileng gore o batle kalafi? O kopiwa go supa sekai 
sengwe le sengwe se se go amang. 
Go gotlhola mo go fetang lobaka  la beke 
tse pedi 
1  
Go gotlhola mo go sa feteng beke tse 
pedi 
2  
Go gotlhola sehuba se senang le madi 3  
Setlhabi sa mafatlha 4  
Go hema ka bonako o hupela 5  
Go fufula bosigo o robetse 6  
Go gotela mmele 7  
Go sulafalelwa ke dijo 8  
Go latlhegelwa ke nama 9  
Tse dingwe (Tlhalosa) 
............................................................. 
10  
 
 
      
 
Potso 12.     Go tsere lebaka le lekae pele ga o batla thuso ya ba bongaka? 
 
--------------------------------------------------------------------------------------------------------------- 
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Potso 13. One wa batla kalafi kae lantlha fa o itemogela dikai tsa TB? 
 
Kokelo 1  
 Ba ditlhare tsa setso 2  
Ngaka ya setso 3  
Sangoma 4  
Basebeletsi 5  
Ba bangwe  (Tlhalosa) 
............................................................. 
6  
 
 
Potso14. O kopiwa go supa gore a diele tse dilatelang di boammaaruri kana nyaa mapapi le go 
lemoga TB? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potso15. O kopiwa go supa gore a sengwe le sengwe sa diele tse di tsamaelannag le TB tse di 
latelang se boammaaruri kana nnyaa. 
 
Potso Seele Go 
jalo  
Ga go 
jalo 
Ga ke 
itse 
Potso14a) 
 
TB e a thibelwa 1 2 3 
Potso14b) 
 
 TB ea alafesega 1 2 3 
Potso14c) 
 
Go gotlhola ga molwetse wa TB ya mafatlha  a sa 
bipe molomo go ka anamisetsa  mogare wa TB 
mo go ba ba senang yone 
1 2 3 
Potso14d) 
 
Go ethimola ga molwetse wa TB ya mafatlha  go 
ka baka TB go tsena ba bangwe 1 2 3 
Potso14e) 
 
TB ya mahatlha e anama ka go bua 1 2 3 
Potso 14f) 
 
 Phefo e e phepa e ntsi e fokotsa kgonafalo ya 
kanamo ya TB 1 2 3 
Potso14g) 
 
Go itshwara molomo le dinko ka matsogo fa o 
gotlhola kana o ethimola ke tsela ee nonofileng 
ya go thibela kanamo ya mogare wa TB 
1 2 3 
Potso14h) 
 
Segotlhola se senang le mogare wa TB se ka 
anamisa megare  ya  TB mo bathong ba bangwe 1 2 3 
Potso14i) 
 
Batho ba batshelang le molwetse wa TB ba mo 
diphatseng tse di ko tlase go ka tsenwa ke 
mogare waTB. 
1 2 3 
Potso Seele Go 
jalo 
Ga go 
jalo 
Ga ke 
itse 
Potso15a) 
 
 
Go gotlhola go feta beke tse pedi 1 2 3 
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Potso 16.O kopiwa go supa gore a sengwe le sengwe sa diele tse di tsamaelanag le kalafi ya TB 
tse di latelang se boammaaruri kana nnyaa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potso 17.O Kopiwa go supa gore a sengwe le sengwe  seele sa tse di latelang tse di amanang le 
TB/ HIV se boammaaruri kana nnyaa. 
Potso15b) 
 
Go gotela malatsi a le mabedi 1 2 3 
Potso15c) 
 
 
Gohema ka bonako le go gotlholela ruri 1 2 3 
Potso15d) Setlhabi sa mafatlha le go huhula bosigo o 
robetse 1 2 3 
Potso15e) 
 
Segotlhola se se madi 1 2 3 
Potso15f) 
 
 
 
TB e bakwa ke sejeso 1 2 3 
Potso15g) 
 
Thibamo e anamisa TB 1 2 3 
 
Potso15h) 
 
Go tlhakanela dikobo le motlholagadi/moswagadi 
go anamisa TB 
1 2 3 
 
Potso 
 
Seele Go jalo 
Ga 
go 
jalo 
Gakeitse 
Potso16a)   
 
 
Kalafi ya TB e tshwanetse ya nowa tsatsi le le 
tsatsi ka fa tlase ga tlhokomelo 1 2 3 
Potso16b) 
 
Go tlodisa kalafi ya TB go baka diphatsa tsa go 
anamisa TB e e sa alafesegeng 1 2 3 
Potso16c) 
 
Molwetse wa TB yo o tsayang mosepele o 
tswanetse go rulaganya le ba kokelwana gore a 
tseye melemo  e e lekanyeng 
1 2 3 
Potso16d) 
 
Molwetse wa TB ya mafatlha o tshwanetse  go 
tlhomamisa gore segotlhola se  tlhatlhobiwa nako  
ee beilweng 
1 2 3 
Potso16e) 
 
 
 
Molwetse wa TB o tshwanetse go itse kalafi e a e 
tsayang 
1 2 3 
Potso16f) 
 
Molwetse wa TB o tshwanetse go itse ditlamorago 
tsa  kalafi e a e tsayang 1 2 3 
Potso16g) 
 
 
TB e ka alafesega ka melemo ya setso 1 2 3 
Potso16h) 
 
Dijo tse dinang le dikotla ke karolo e e botlhokwa 
mo kalafing ya TB 1 2 3 
Potso16i) 
 
Ke rutilwe  ka botlhokwa ja go tshegetsa ditaelo 
tsa kalafi 1 2 3 
Potso16j) 
 
Ba lwapa  lame ba rutilwe ka botlhokwa ja go 
tshegetsa ditaelo tsa kalafi 1 2 3 
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KGAOLO YA BORARO: MAIKUTLO A GAGO 
Potso 18. O kopiwa go kala nngwe le nngwe ya diele tse di latelang tse di amanang le tlhokomelo 
ya balwetse ba TB mo malwapeng ka karabo ya “Ee”, “Nnyaa”, kgotsa “Ga ke tlhomamise” 
 
 
 
 
Potso Seele Go 
jalo 
Ga 
gojalo 
Ga ke 
itse 
Potso17a) 
 
Motho o ka nna le  mogare wa TB le wa HIV nako 
e le nngwe fela 1 2 3 
Potso17b) 
 
Balwetse botlhe ba TB ba tshwanetse go 
tlhatlhobelwa HIV 1 2 3 
Potso17c) 
 
 Go simolola kalafi ya TB le ya HIV ka nako go ka 
thusa mo phodisong ya TB 1 2 3 
Potso17d) 
 
Dithulaganyo tsa TB/HIV di lomagantswe sentle le 
tsa lenaneo la tlhokomelo ya molwetse wa TB 
kwa lwapeng 
1 2 3 
Potso17e) 
 
 
HIV ka tlhomamo e baka TB 1 2 3 
Potso  Seele Ee Nyaa Ga ke 
tlhomamis
e 
Potso18a) 
 
E ka fokotsa dipalo tsa balwetse 
ba ba sa tseeng kalafi sentle 
1 2 3 
Potso18b) 
 
E ka oketsa temogo ya batho ba 
banang le TB mo setshabeng 
1 2 3 
Potso 18c) 
 
Ke le tlhaloseditswe ka botlalo 1 2 3 
 
Potso18d) 
 
Gake bone mosola wa lenaneo la  
tlhokomelo ya molwetse wa TB ko 
lwapeng  
1 2 3 
Potso18e) 
 
 Ke setse ke ikwadisitse mo 
lenaneong la tlhokomelo ya 
molwetse wa TB ko lwapeng 
1 2 3 
Potso18f) 
 
 
Lenaneo la tlhokomelo ya 
molwetse wa TB ko lwapeng  ga 
le ntseye sentle 
1 
 
 
 
 
 
2 3 
Potso 18g) Ga go molemo go ikwadisetsa 
lenaneo la tlhokomelo ya 
molwetse wa TB kwa lapeng 
1 
 
 
 
 
2 3 
Potso 18h) Ga go thata go bona 
baemanokeng ba kalafi ya TB 
1 
 
 
2 3 
Potso 18i) Ba botsogo ba ikemiseditse  
goema nokeng lenaneo la 
tlhokomelo ya molwetsi wa TB 
kwa lwapeng 
1 2 3 
Potso18j) Ke lapiswa ke go ithuta ka 
lenaneo la tlhokomelo ya 
molwetse wa TB ko lwapeng 
1 2 3 
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KAROLO YA BONE: THLOPHO YA LENANEO LA GONWA DIPILISI 
 
Potso 19. O kopiwa go  supa lengwe le lengwe la mabaka aa lateleng go supa se se ka tswang se 
go rotloeditse go itlhophela lenaneo la gago la go nwa dipilisi (mo kokelong kana kwa lapeng) ka 
karabo ya “Ee”, “Nnyaa”, kgotsa “Ga ke tlhomamise” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potso 19o O kopiwa go tlhalosa ka bokhutswane ka tshwetso ya gago ya go nwa dipilisi tsatsi le 
letsasti  
-------------------------------------------------------------------------------------------------------------------------------------------- 
-------------------------------------------------------------------------------------------------------------------------------------------- 
-------------------------------------------------------------------------------------------------------------------------------------------- 
 
 
 
 
KAROLO YA BOTLHANO: BOLWETSE JWA TB LE BOIKARABELO JWA ME 
Potso 20.  A o santse o tsaya kalafi ya TB? 
Question Seele Ee Nnyaa Ga ke  
tlhomamise 
Potso 19 
a) 
Sebaka sa go itlhophela 
lenaneo le le ntshwanetseng   
1 3 3 
Potso 19b) Kitso ee lekanyeng ka TB  1 2 3 
Potso 19c) Kisto ee lekanyeng ka lenaneo 
le ke le itlhophetseng  
1 2 3 
Potso 19d) Sebaka sa go somarela 
ditlamelo 
1 2 3 
Potso 19e) Keletso ya go lwantsha 
kgethololo mabapi le TB  
1 2 3 
Potso 19f) Keletso ya go lwantsha  TB 
mo setshabeng  
1 2 3 
Potso 19g) Bo gaufi jwa lenaneo 1 2 3 
Potso 19h) Ke tlhaloganya ditshwanelo 
tsa balwetes ba TB  
1 2 3 
Potso 19i) Tomagano ee lolameng ya 
lenaneo la TB le a mangwe a 
botsogo  
1 2 3 
Potso 19j) Tirisanyo mmogo ee lekaneng 
go tswa mo setshabeng  
1 2 3 
Potso 19k) Melemo ee lekaneng ya kalafi 
ya TB  
1 2 3 
Potso 19l) Ditlhatlhobo tsa bolwetse jwa 
TB nako le nako  
1 2 3 
Potso 
19m) 
Bolengteng ja dithuso ka 
ditlamelo 
1 2 3 
Potso 19n) Boleng jwa ditirelo tsa botsogo  1 2 3 
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Ee 1  
Nnyaa 2  
 
Potso 21. O simolotse leng go alafelwa TB? O kopiwa go supa ngwaga le kgwedi. 
……………………………………………………………………………………………………………………… 
Potso 22a. A o feditse go tsaya kalafi ya gago? 
Ee 1  
Nyaa 2  
 
Potso 22b.   Fa karabo e le ee  bolela gore o feditse kalafi leng ? O kopiwa go supa kgwedi le 
ngwaga . 
……………………………………………………………………………………………………………………… 
Potso 22c.Fa karabo ele nnyaa, o kopiwa go bolela mabaka a a go kgoreleditseng go fetsa kalafi? 
 ……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
Potso 23a. A o fodile TB? 
Ee 1  
Nnyaa 2  
 
Potso 23b. Fa karabo ele nnyaa,o kopiwa go tlhalosa gore ke eng o sa fola? 
…………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………… 
 
Potso 24a. A o kile wa tlodisa go tsaya kalafi ya gago? 
Ee 1  
Nnyaa 2  
 
Potso 24b.Fa karabo ele ee, o tlodisitse go tsaya kalafi ga kae? 
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1 Letsatsi 1  
2 Malatsi a mabedi 2  
Tse dingwe (Tlhalosa) 
............................................................ 
3  
 
Potso 24c. O kopiwa go tlhalosa mabaka a a go dirileng gore o tlodise kalafi 
 
------------------------------------------------------------------------------------------------------------------------------ 
------------------------------------------------------------------------------------------------------------------------------ 
------------------------------------------------------------------------------------------------------------------------------ 
Potso 25a. A o kile wa simolodisiwa sesha mo kalafing?  
Ee 1  
Nnyaa 2  
 
Potso 25b. Fa karabo ele ee, tlhalosa mabaka a go simolodisiwa sesha?  
…………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………… 
Potso 26a. A o kile wa emisa go tsaya kalafi? 
Ee 1  
Nnyaa 2  
 
Potso 26b. Fa karabo ele ee, o emisitse go tsaya kalafi nako ee kae? 
Kwa tlase ga kgwedi 1  
Kgwedi  e le nosi 2  
Dikgwedi tse pedi 3  
Tse dingwe (Tlhalosa) 
............................................................. 
4  
 
Potso 26c. Fa karabo  ele ee, o kopiwa go tlhalosa mabaka aa dirileng gore o emise kalafi? 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
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……………………………………………………………………………………………………………………… 
 
Potso 27. O kopiwa go kala mafoko aa supang boikarabelo jwa molwetse wa TB ka “Ee”, “Nnyaa” 
kgotsa “Ga ke tlhomamise” 
 
 
 
 
 
 
 
 
 
 
Potso 28a.A o isitse  segotlhola sa gago go tlhatlhobiwa ka nako ee beilweng? 
Ee 1  
Nnyaa 2  
 
Potso 28b. Fa karabo ele nnyaa, o kopiwa go tlhalosa mabaka a a go kgoreleditseng go isa 
segotlhola go tlhathlobiwa ka nako ee beilweng. 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
 
Potso 29.  A ona le nngwe kakgelo gape? 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………… 
Relebogela go araba dipotso tse. 
Nomoro ya sephiri ya moarabi......................................... 
Letsatsi.............spondent......................................... Date............................ 
Potso Seele Ee Nnyaa Gaketlhomamise 
Potso 27a) Ketsenelela makgotlana a 
thotloetso a TB gangwe le 
gape 
1 2 3 
Potso 27b) Ke rotloetsa ba bangwe go 
kopa kalafi fa ba itemogela 
kgonafalo ya dikai tsa TB 
1 2 3 
Potso 27c) Ke rotloetsa ba bangwe go 
tsaya kalafi ya TB 1 2 3 
Potso 27d) Ke setse ke kile ka gasa 
thuto phatlalatsa ya 
melaetsa ee amanang le 
TB 
1 2 3 
Potso 27e) Ke moema nokeng wa 
kalafi ya TB 1 2 3 
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